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Abstract  
Lipins are a family of highly conserved proteins found from yeasts to humans. Lipins have dual 
functions, serving as phosphatidate phosphatase enzymes (PAP) in the synthesis of neutral fats 
(triacylglycerols, TAG) and as transcriptional co-regulators that affect the expression of genes 
involved in lipid and fatty acid metabolism. Thus, they play central roles in metabolic control. 
Disruption of Lipin function has been implicated in lipodystrophy, obesity and insulin resistance. 
Using dLipin, the Drosophila homolog of Lipin, as a model, I aimed to elucidate the relationship 
between the two biochemical functions of Lipin and metabolic homeostasis. I discovered there is 
a strong interconnection between TAG synthesis and insulin pathway activity. Reduced activity 
of dLipin and other enzymes involved in TAG synthesis disrupted insulin pathway activity by 
interfereing with phosphatidylinositol (3,4,5)-trisphosphate (PIP3) synthesis. Mosaic analysis 
revealed that cell-autonomous loss of dLipin activity in fat the body negatively affects cell 
growth. Genetic interaction experiments indicated that dLipin and the insulin pathway regulate 
adipogenesis in an interdependent fashion. Furthermore, I found that the nutrient sensing 
complex TORC1 regulates dLipin activity in lipid metabolism by controlling dLipin’s 
subcellular localization. Hence, the insulin pathway as well as the TORC1 pathway each appears 
to be a central regulator of dLipin activity and its functions in lipid metabolism. Nuclear 
functions of dLipin did not seem to have an effect on insulin pathway activity. Thus, metabolic 
disturbances observed after dLipin knockdown seem to be primarily caused by reduced PAP 
activity provided by dLipin. Taken together, the results position dLipin as a central target to 
further study the link between TAG synthesis and insulin and TORC1 pathway activity.  
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I. Introduction 
With obesity constituting a rising epidemic in the USA and worldwide, research into fat 
metabolism has become a hot topic. As of 2013, more than 2/3 of the adult population in the 
USA were overweight (Body Mass Index (BMI) > 25) and of these, about 1/3 were obese (BMI> 
30). Being overweight or obese poses numerous health hazards and current healthcare costs 
attributed to obesity are estimated to be 254 billion US$ (Go et al., 2013). Health risks associated 
with obesity include the metabolic syndrome, hypertension, coronary artery disease and stroke, 
respiratory defects, cancers, infertility and impotence, osteoarthritis, liver and gall bladder 
disease and diabetes (Kopelman; 2007). 90 Ninety % per cent of people with type 2 diabetes 
have a BMI> 23 suggesting that even being only slightly overweight puts individuals at an 
immediate risk of developing type 2 diabetes (Kopelman, 2007). Prevalence of childhood obesity 
and associated type 2 diabetes is rising steadily (Deckelbaum and Williams, 2001). As of 2012, 
9.3% of the US population has diabetes and 33% of the adult population over the age of 20 
shows signs of prediabetes (National Diabetes Statistics Report, 2014). With obesity and diabetes 
representing the 2nd and 7th leading cause of death in the USA research into how fat metabolism 
and insulin sensitivity are connected and controlled is more important than ever.  
1. Characterization of Lipin 
During times of excess nutrient uptake energy can be stored either as triacylglycerol 
(TAG) or glycogen and saved for times of nutrient deprivation. In animals, TAG is stored in lipid 
droplets within adipocytes, specialized fat storage cells, but virtually all cells have the capacity to 
synthesize and store TAG in lipid droplets. Lipid droplets consist of a core of neutral lipids 
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(TAGs), which is enclosed by a layer of phospholipids and associated proteins (Thiele and 
Spandl, 2008).  
A mutant mouse strain, the fatty liver dystrophy mouse (fld), displays significant loss of 
fat tissue (lipodystrophy) in concert with ectopic fat accumulation in the liver and other 
imbalances in lipid metabolism (Langner et al., 1991). The fld mouse was later shown to carry a 
mutation in a novel gene, named lipin1. Two additional mouse lipin genes were identified by 
sequence similarity, lipin2 and lipin3 (Peterfy et al., 2001). Homologs of mouse lipin genes were 
also discovered in Homo sapiens and many genetic model organisms like Saccaromcyes 
cerevisae, Arabidopsis thaliana, Caenorhabditis elegans, Drosophila melanogaster as well as 
Shizosaccharomyces pombe, Plasmodium falsiparum and Trypanosoma brucei, indicating that 
the lipin gene family is evolutionary conserved (Pelletier et al., 2013; Peterfy et al., 2001). 
Inadequate adipose tissue in the fld mice was associated with glucose intolerance and increased 
atherosclerosis (Reue et al., 2000). Studies with mammalian lipin1 revealed that lipin1 is not 
only a lipodystrophy gene, but also an obesity gene, as overexpression of lipin1 in adipose tissue 
and skeletal muscle of transgenic mice caused excess fat accumulation (Phan and Reue, 2005). 
All three Lipins were identified as Mg2+-dependent phosphatidate phosphatase enzymes (PAP) 
(Donkor et al., 2007). PAP activity is required for the conversion of phosphatidic acid (PA) into 
diacylglycerol (DAG), an important step of the glycerol-3-phosphate pathway pictured below 
(Fig. 1).   
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Fig. 1. The glycerol phosphate pathway for glycerolipid synthesis
Lipin proteins catalyze the conversion of phosphatidic acid (PA) to diacylglycerol (DAG),
which is the penultimate step in triacylglycerol (TAG) and zwitterionic phospholipid
synthesis via the glycerol phosphate pathway. The acyltransferase enzymes in this pathway
reside within the ER membrane, but lipin proteins can transit from the cytosol to the ER
membrane to catalyze their enzymatic reaction; lipin proteins may also localize to the
nucleus. GPAT, glycerol-3-phosphate acyltransferase; AGPAT, acylglycerol-3-phosphate
acyltransferase; DGAT, acyl coenzyme-A:diacylglycerol acyltransferase; LPA,
lysophosphatidic acid.
Csaki et al. Page 19























Fig. 1: Canonical glycer l-3-phosphate pathway that leads to the synthesis of TAG. 
Gycerol-3-phosphate (G-3-P) is converte  into lysophos at dic acid (LPA) by glycerol-3-
phosphate 2-O-acyltransferase (GPAT). 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) 
subsequently transforms LPA into phosphatidic acid (PA). Lipin then catalyzes the conversion of 
PA into diacylglycerol (DAG), followed by the conversion of DAG into triacylglycerol (TAG) 
by diglyceride acyltransferase (DGAT). The final product, TAG, is then stored in fat droplets. 
Figure modified from Csaki et al, 2013.  
 
In their role as essential glycerolipd synthesis enzymes, Lipins emerged as attractive 
targets for research that aims to elucidate the correlation between fat and glucose metabolism.  
1.2. lipin gene family  
As mentioned above, lipin genes are present in organisms ranging from Homo sapiens to 
yeast. I will shortly summarize the major findings concerning molecular Lipin function(s). Lipin 
proteins possess dual cellular roles, serving as PAP enzymes for TAG and phospholipid 
synthesis and as transcriptional co-regulators in the regulation of lipid metabolism and 
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adipogenesis genes (Finck et al., 2006; Reue and Zhang, 2008). All mammalian lipin homologs 
possess PAP activity (Donkor et al., 2007).  
 
Fig. 2: Lipin proteins possess dual function as PAP enzymes and transcriptional co-
regulators. Lipin functions as a PAP enzyme in the glycerolipid synthesis pathway, thus 
contributing to TAG and phospholipid production. Lipin can also participate in the control of fat 
metabolism by altering gene transcription in concert with nuclear receptors and other 
transcription factors.  Image modified from Reue and Zhang, 2008. 
 
1.2.1. Mammalian Lipins 
Mammalian Lipin functions have so far been most extensively studied and this is 
especially true for lipin1, the gene disrupted in the fld mouse.  Disruption of lipin1 results in 
lipodystrophy accompanied by insulin resistance, neuropathy, atherosclerosis, abnormal 
triglyceride levels and neonatal fatty liver in mice (Langner et al., 1989; Peterfy et al., 2001; 
Reue et al., 2000). 
Fig. 2. Dual cellular functions of lipin proteins
Lipin-1, -2, and -3 all exhibit phosphatidate phosphatase activity, which plays a role in
triglyceride and phospholipid biosynthesis. Lipin-1 has also been shown to act as a
transcriptional coactivator in liver, directly interacting with nuclear receptors such as
PPARα and the coactivator PGC-1α.
Reue and Zhang Page 13
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Lipin1 accounts for virtually all PAP activity in white and brown adipose tissue and in 
skeletal muscle, and for most of of the PAP activity in liver and brain (Donkor et al., 2007). 
Overexpression of lipin1 in adipose tissue led to increased fat accumulation, as did 
overexpression of lipin1 in muscle (Phan and Reue, 2005). Hence, Lipin1 is required for cellular 
lipid accumulation through its role as a PAP enzyme. Furthermore, secretion of very low density 
lipoproteins (VLDL) was negatively affected after loss of Lipin1 activity, which implicates 
Lipin1 in processes involved in VLDL sequestration (Khalil et al., 2009).  
Lipin1 was also identified as a transcriptional co-regulator that influences expression of 
genes involved in fatty acid oxidation  (Finck et al., 2006). Fatty acid oxidation takes place in 
hepatic mitochondria and represents a catabolic pathway that produces energy.  
During times of starvation, hepatic fatty acid oxidation is upregulated. Peroxisome 
proliferator-activated receptor (PPAR) α is a gene encoding a nuclear receptor that regulates 
numerous genes involved in fatty acid oxidation. Accordingly, PPARα expression is induced 
upon starvation. It was shown that starvation-induced PPARα expression is dependent on Lipin1 
activity and mediated in concert by Lipin1 and peroxisome proliferator activated receptor γ 
coactivator-1 α (PGC-1α). To regulate gene expression, Lipin1 and PGC-1α interact directly 
(Finck et al., 2006). The nuclear receptor hepatocyte nuclear factor 4 α (HNF4α) was identified 
as an interaction partner of nuclear Lipin1. The interaction between HNF4a and Lipin1 positively 
regulates expression of genes involved in fatty acid catabolism (Chen et al., 2012). Thus, Lipin1 
affects transcription of genes involved in hepatic fatty acid oxidation via modulation of PPARα 
expression and interaction with HNF4a.  
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Lipin1 also influences adipogenic gene expression by regulating transcriptional activity 
of peroxisome proliferator-activated receptor γ (PPARγ) and CAAT/enhancer binding protein α 
(C/EBPα) in preadipocytes (Peterfy et al., 2005; Phan et al., 2004). During the process of 
adipogenesis cells differentiate from preadipocytes to adipocytes and final cell number of 
adipose tissue is determined. PPARγ and C/EBPα are master regulator genes of adipogenesis and 
together, control the terminal differentiation process (Farmer, 2006). It was later shown that 
Lipin1’s PAP activity is required for PPARγ transcriptional activity and it was furthermore 
suggested that Lipin1 affects PPARγ activity by adjusting PA levels (Zhang et al., 2012). New 
data points to the possibility that Lipin1 might also directly bind to PPARγ and thereby induce a 
conformational change in PPARγ. This conformational change in PPARγ is proposed to cause a 
release of co-repressors and in turn enhance recruitment of PPARγ co-activators (Kim et al., 
2013). This would then allow PPARγ to activate gene expression. Lipin1 is thus involved in 
controlling transcriptional activity of PPARγ and C/EBPα by mechanisms that require further 
investigation, but that might rely on Lipin1’s PAP activity.  
Lipin1 also controls lipogenic and cholesterogenic gene expression in hepatocytes by 
directly affecting sterol regulatory element binding protein (SREBP) protein levels (Peterson et 
al., 2011). SREBPs are transcription factors that control biosynthesis of cholesterol and fatty 
acids. In the presence of low cellular sterol levels, SREBPs are activated and partake in 
transcription of lipogenesis and cholesterogenesis genes. Peterson et al. (2011) identified Lipin1 
as a negative regulator of nuclear SREBP function.  
In addition, Lipin1 negatively regulates transcriptional activity of the nuclear factor of 
activated T cells c4 (NFATc4) in adipocytes. NFATc4 activity is repressed by direct protein-
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protein interaction with Lipin1. These data suggest a possible role for Lipin1 in mediating 
inflammatory response in adipose tissue (Kim et al., 2010).  
In summary, Lipin1 functions as a PAP enzyme and a transcriptional co-regulator. 
Lipin1’s PAP activity is indispensable for TAG synthesis and is possibly also involved in the 
control of adipogenic gene expression. Lipin1’s transcriptional co-regulator activity contributes 
to fatty acid metabolism by directly controlling PPARα expression and HNF4a activity and 
influences inflammatory gene transcription via interaction with NFATc4. SREBP-mediated lipid 
biogenesis is also affected by Lipin1 activity but the exact mechanisms underlying this 
interaction remain elusive.     
Lipin2 and Lipin3 were identified based on amino acid similarity to Lipin1 (Peterfy et al., 
2001). Lipin2 and 3 also exhibit PAP activity, but so far these two members of the lipin family 
have been much less well characterized. lipin1, lipin2 and lipin3 display distinct tissue 
expression levels, suggesting that the different lipin genes have independent physiological roles 
(Donkor et al., 2007). lipin2 is predominantly expressed in liver, kidney and brain (Donkor et al., 
2007). A possible involvement of Lipin2 in adipogenesis has been postulated (Donkor et al., 
2009; Grimsey et al., 2008). Even less is known about Lipin3. lipin3 is expressed in the 
gastrointestinal tract and, to a much smaller degree, in the liver (Donkor et al., 2007).  
The three human Lipins display 44-48% amino acid identity to the corresponding mouse 
paralogs. The human Lipin proteins are encoded by LPIN1, LPIN2 and LPIN3. Human lipin 
homologs are less well studied than their mouse counterparts. In contrast to studies in mouse, 
LPIN1 expression in human adipose tissue is not always positively correlated with adiposity 
(Chang et al., 2010, Miranda et al., 2007; Mlinar et al., 2008). Expression levels of PPARγ in 
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adipose tissue were positively correlated with LPIN1 expression, as were ADIPOQ (adiponectin) 
expression levels. This suggests that higher LPIN1 levels promote maturation of adipocytes with 
increased TAG content (Chang et al., 2010). LPIN1 expression in adipose tissue is furthermore 
positively correlated with insulin sensitivity and with expression of genes involved in fatty acid 
oxidation and lipolysis. An especially strong correlation was found between LPIN1 expression 
and PPARα. Thus, LPIN1 might play a critical role in human fatty acid oxidation comparable to 
mouse lipin1 (Donkor et al., 2008). Glucose transporter 4 (GLUT4) gene expression was also 
positively correlated with LPIN1 mRNA levels (van Harmelen et al., 2007). Thus, LPIN1 
expression correlates positively with insulin sensitivity and increased fatty oxidation in humans.  
Studies of human populations found that certain LPIN1 and LPIN2 polymorphisms are 
associated with type 2 diabetes and other metabolic traits (Aulchenko et al., 2007; Chang et al., 
2010).  
Deficiency in LPIN1 has been implicated in recurrent acute myoglobinuria during 
childhood and statin-induced myopathy (Zeharia et al., 2008). LPIN2 deficiency can lead to 
Majeed Syndrome (Ferguson et al., 2005) and psoriasis (Milhavet et al., 2008).  
It thus appears that human LPIN genes overall seem to affect metabolic processes involved in 
glucose and lipid homeostasis in a similar way as mouse lipin homologs.  
1.2.2. Lipin homologs in yeast, C. elegans and A. thaliana 
In 2009 the C. elegans lipin1 homolog was identified (Golden et al., 2009; Gorjanacz and 
Mattaj, 2009), lpin-1. Loss of LPIN-1 activity in C. elegans resulted in defects in fat storage, ER 
organization and nuclear membrane breakdown, irregular nuclear morphology and abnormal 
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chromosome segregation. Worms with lpin-1 knockdown were reduced in size (Golden et al., 
2009).  
Mutations of PAH1, the lipin homolog in S. cerevisae resulted in lower TAG content in 
mutant cells along with elevated PA levels (Han et al., 2006). PAH1 function was also required 
for fat droplet formation (Adeyo et al., 2011). PAH1 was further implicated in the transcriptional 
control of phospholipid biosynthesis genes (Santos-Rosa et al., 2005). Cells with PAH1 
deficiency exhibited excess nuclear expansion, possibly caused by transcriptional changes of 
phospholipid synthesis genes induced by elevated PA levels (Han et al., 2007). Thus, PAH1 may 
influence phospholipid synthesis directly as a transcriptional co-regulator by repressing 
expression of phospholipid synthesis genes and additionally by modulating PA levels via its PAP 
activity (Siniossoglou, 2009). The lipin homolog of the fission yeast (ned1+) affects 
chromosomal segregation and ER expansion (Tange et al., 2002). Thus, both PAH1 and C. 
elegans lpin-1 appear to contribute to nuclear envelope dynamics.  
lipin homologs in A. thaliana (AtPAH1 and AtPAH2) contribute to galactolipid synthesis 
and phosphate starvation resistance (Nakamura et al., 2009).  
1.2.3. Lipin homolog in D. melanogaster 
Mutations in the Drosophila lipin homolog dLipin resulted in animals with decreased 
TAG content, which suggests that dLipin also functions as a PAP enzyme (Ugrankar et al., 2011; 
Valente et al., 2010). Expression of dLipin was found to be strongest in the fat body, ring gland, 
ovaries, Malphigian tubules, midgut and ceca. dLipin showed both cytoplasmic and nuclear 
staining, which indicates that dLipin might also possess nuclear function in Drosophila 
(Ugrankar et al., 2011). Like mice deficient in lipin1, Drosophila larvae deficient for dLipin 
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displayed severe lipodystrophy. Lipodystrophy was accompanied by changes in fat body cell 
shape and size and a reduction in fat droplet size (Ugrankar et al., 2011). Cells were rounded in 
appearance and exhibited a wide variability in cell size. Ketone body formation was increased in 
animals deficient for dLipin. Thus, it appears that fatty acid metabolism was altered. Larval 
development was delayed, larval lethality increased, and the few animals reaching the pupal 
stage died as pharate adults. This suggests that dLipin is required for the formation of energy 
stores in developing larvae. Ultrastructure analysis showed that dLipin is required for proper 
assembly and function of mitochondria, autophagosomes and cell nuclei. It was also shown that 
dLipin is required for starvation resistance (Ugrankar et al., 2011). These data on dLipin indicate 
that Lipin’s function in TAG synthesis is conserved between mammalian species and 
Drosophila, as defects observed in flies lacking dLipin resemble the mammalian lipin phenotype.  
2. Lipin protein structure  
Lipin PAP activity depends on a short amino acid motif that is conserved among species 
(DXDXT motif) and a conserved serine (S734) residue (Donkor et al., 2009). The PAP motif is 
located in the conserved CLIP domain of the protein and it is present in Lipin homologs from 
mammals to protists (Donkor et al., 2006, Pelletier et al., 2013) (Fig. 3). In addition to the PAP 
motif, Lipin homologs of mammals and Drosophila contain a co-regulator motif (LXXIL motif) 
that is evolutionarily conserved and also located in the CLIP domain (Finck et al., 2006; Peterfy 
et al., 2001). The LXXIL motif is required for Lipin’s transcriptional co-regulator activity (Finck 
et al., 2006). Mutations in the PAP motif have no effect on transcriptional activity, whereas 
changes in the co-regulator motif not only reduce transcriptional, but also PAP activity (Reue 
and Brindley, 2008). In addition to the PAP and co-regulator motifs, Lipin also has a nuclear 
localization signal (NLS). The NLS is required for nuclear localization, but might also affect 
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membrane association and physiological functions of Lipin (Khalil et al., 2009). The 
conservation of CLIP and NLIP domains is summarized in Fig. 3.  
Fig. 2. Domain structure and evolutionary conservation of lipin proteins
Lipin proteins are evolutionarily conserved from yeasts to humans. Mammalian genomes
encode three lipin proteins, some of which have multiple splice variants (not shown). Lower
organisms possess two (Arabidopsis) or one lipin ortholog (invertebrates, single-celled
eukaryotes). Lipin proteins possess two highly conserved domains, N-LIP and C-LIP
(yellow bars); the PAP enzyme active site motif (DXDXT, green bar) is present within the
C-LIP domain. Most lipin orthologs contain an identifiable basic motif that is required for
nuclear localization and/or PA binding (blue bar), and mammalian and Drosophila lipins
contain a motif that is required for lipin interaction with transcriptional activators and
coactivators (orange bar).
Csaki et al. Page 20














Fig. 3: A comparison of the structure of Lipin proteins across species shows that protein 
domains are evolutionarily conserved. Lipin homologs from the indicated species are 
schematically depicted. Lipin possesses two highly conserved domains, the NLIP domain and the 
CLIP domain (yellow bars). Presence of nuclear localization signals (blue) is shown. The PAP 
motif (green) and the transcriptional co-regulator motif (orange) are both located in the CLIP 
domain. The PAP motif is conserved among all species, whereas the transcriptional co-activator 
motif is only present in ammals and Dros phila. Image modifi d from Csaki et al., 2013.  
 
Regulation of Lipin activity 
In 2008, it was found that lipin1 expression is positively regulated by glucocorticoids and 
cAMP. The stimulatory effect of glucocorticoids was antagonized by insulin (Manmontri et al., 
2008; Zhang et al., 2008). A glucocorticoid-response element was identified in the promoter 
	   12 
region of lipin1. Increased glucocorticoid levels during adipogenesis induced expression of 
lipin1 in preadipocytes and thus promoted cell differentiation (Zhang et al., 2008). 
Glucocorticoid levels are also elevated during times of physiological stress, like starvation, 
diabetes, hypoxia and obesity (Manmontri et al., 2008).  
In addition, SREBP-1 activates LPIN1 expression (Ishimoto et al., 2009). SREBPs are 
transcription factors that control biosynthesis of cholesterol and fatty acids. In the presence of 
low cellular sterol levels, SREBPs are activated and partake in transcription of lipogenesis and 
cholesterogenesis genes. Thus, cellular sterol levels also regulate LPIN1 expression. 
In adipose tissue, lipin1 expression is also triggered by thiazolidinediones and harmine; 
both of which promote insulin sensitivity (Park et al., 2010; Yao-Borengasser et al., 2006). lipin1 
expression is further influenced by estrogen levels, as high estrogen levels negatively correlate 
with lipin1 expression in the uterus and liver (Gowri et al., 2007). Cytokines, tumor necrosis 
factor α and interleukin-1 negatively regulate Lipin1 expression, which leads to an increase in 
lipolysis in adipose tissue and hence a reduction in fat stores during infection (Reue and 
Brindley, 2008).  
In addition to control at the transcriptional level, Lipin1 activity can be modulated at the 
protein level. It was shown that PAP activity is primarily cytosolic and translocates to the ER in 
response to fatty acids (Gomez-Munoz et al., 1992). The ER represents the major site of TAG 
biosynthesis and fat droplet formation (Wilfling et al., 2013). Thus, subcellular localization of 
Lipin corresponds with molecular Lipin function. The change in Lipin1’s subcellular localization 
has been attributed to a change in Lipin’s phosphorylation status (Gomez-Munoz et al., 1992; 
Harris et al., 2007; Huffmann et al., 2002). High cellular concentrations of fatty acids, as well as 
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the presence of epinephrine and oleic acid, induce dephosphorylation of Lipin1 and recruitment 
of Lipin1 to the ER (Harris et al., 2007). Multiple rapamycin-sensitive phosphorylation sites 
have been identified in Lipin1 (Harris et al., 2007; Peterson et al., 2011). Rapamycin-sensitivity 
of the phosphorylation sites indicates that phosphorylation at these residues is dependent on the 
Ser/Thr kinase target of rapamycin (TOR). Rapamycin acts as an inhibitor of TOR action. TOR 
is part of a nutrient sensing protein complex (TOR complex 1, TORC1) and integrates both 
nutrient and growth factor/insulin signaling (Dibble and Manning, 2013). Mammalian TORC1-
mediated (mTORC1) phosphorylation of Lipin1 promotes cytoplasmic Lipin1 retention and loss 
of mTORC1 activity has been shown to promote nuclear translocation of Lipin1 (Peterson et al., 
2011). Thus, dephosphorylation of Lipin1 seems to be required for nuclear translocation and ER 
association of Lipin1.  
Insulin signaling promotes cytoplasmic retention of Lipin1 by stimulating an interaction 
between Lipin1 and 14-3-3 proteins (Peterfy et al., 2009). Furthermore, Lipin1’s serine106 
residue has been identified as being specifically phosphorylated upon insulin signaling in a 
rapamycin-sensitive manner (Harris et al., 2007), which indicates that TOR and insulin pathway 
might control Lipin localization in concert. The PAP activity of Lipin1 itself was not modified 
by phosphorylation events, suggesting that Lipin1’s phosphorylation status does not affect its 
enzymatic activity (Harris et al., 2007), but rather that TOR and insulin influence Lipin1’s 
activity by modulating its subcellular localization. 
Lipin1’s serine106 residue was later identified to be the target site for the phosphatase 
Dullard (Wu et al., 2011). This is consistent with the observation that yeast PAH1 is 
dephosphorylated by Nem1, the yeast homolog of Dullard (Santos-Rosa et al., 2005). In neuronal 
cells, it was found that sumoylation of Lipin1 resulted in its nuclear localization (Liu and Gerace, 
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2009). Furthermore, recent work by Eaton et al. (2013) suggests that Lipin1’s membrane 
association, and hence its catalytic activity, may be regulated by pH levels and membrane 
phospholipid composition (Eaton et al., 2013).  
In summary, Lipin activity is regulated on a transcriptional level by glucocorticoids and 
metabolic status as well as on a posttranslational level via phosphorylation and sumoylation. 
Intracellular pH and membrane composition may also influence Lipin activity. The effects of 
posttranslational modifications on Lipin activity still require more investigation and are not well 
understood at this point. It also appears that Lipin activity is closely associated with TOR and 
insulin pathway activity. In the next section, I will outline general aspects of TOR and insulin 
pathway activity and the influence of TOR and insulin pathway activity on lipid metabolism.  
4. Roles of TOR and insulin signaling in metabolic homeostasis 
Animals need to balance nutritional status with growth while maintaining overall energy 
homeostasis. Thus, pathways evolved that coordinate metabolic demands with dietary input. 
From yeast to mammals, favorable nutritional conditions promote cell growth by activation of 
the TOR pathway (Dann and Thomas, 2006). TOR is an effector of cell growth by integrating 
signals from growth factors/insulin and nutrients, especially amino acids and cellular energy 
status (AMP/ATP ratio). TOR activity is reduced in response to certain physiological cues. 
These cues include hypoxia, reducing conditions, DNA damage and starvation (Wullschleger et 
al., 2006). TOR functions in two distinct complexes, TOR Complex 1 (TORC1) and TOR 
Complex 2 (TORC2). Mammalian TORC1 (mTORC1) consists of mTOR, raptor and mLST8. 
mTORC2 is made up of mTOR, rictor, SIN1, mLST8 and Protor.  
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4.1. General functions of mTORC1 
mTORC1 is activated by nutrients and by growth factor signaling/insulin signaling. 
Insulin pathway input is communicated to mTORC1 via protein kinase B (AKT). AKT 
phosphorylates the mTORC1 inhibitor complex tuberous sclerosis complex 1/2 (Tsc1/2) and thus 
allows ras homolog enriched in brain (Rheb), an mTORC1 activator, to phosphorylate mTORC1 
(Manning and Cantley, 2003). AKT also phosphorylates and thus inhibits proline-rich AKT 
substrate 40 (PRAS-40), which is an mTORC1 inhibitor (Sancak et al., 2007).  
How exactly amino acids activate mTORC1 is still subject to research, but it is proposed, 
that the ragulator-rag complex recruits mTORC1 to lysomes, the site of Rheb activity (Dibble 
and Manning, 2013; Sancak et al., 2010). Activated mTORC1 then phosphorylates downstream 
targets, S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1), and 
consequently promotes cell growth (Magnuson et al., 2012). S6K positively regulates protein 
synthesis in numerous ways, including translation initiation, translational elongation and mRNA 
processing, and thus promotes cell growth (Magnuson et al., 2012). S6K activation also increases 
nucleotide synthesis required for DNA and RNA synthesis (Ben-Sahra et al., 2013). 4EBP1 is an 
inhibitor of cap-dependent translation as it binds to the eukaryotic translation initiation factor 4F 
(eIF4F) (Gingras et al., 1999). mTORC1-mediated phosphorylation of 4EBP1 releases eIF4F 
from 4EBP1 and in turn activates translation (Gingras et al., 1999). Furthermore, ribosome 
biogenesis is also mediated by mTORC1 (Iadevaia et al., 2014).  
Autophagic processes are negatively regulated by mTORC1 as mTORC1 was identified 
to directly phosphorylate and consequently inactivate Unc-51-like autophagy activating kinase-1 
(ULK1) and death-associated protein 1 (DAP1) (Kim et al, 2011; Koren et al., 2010). Thus, 
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mTORC1 mediates cell growth by coordinating protein synthesis, nucleotide synthesis and 
autophagy (Betz and Hall, 2013).   
4.2. General functions of mTORC2 
The mechanisms leading to mTORC2 activation are still unknown, but believed to be 
initiated by growth factors (Kim and Guan, 2011). Once activated, mTORC2 affects AKT 
activity by phosphorylation of the hydrophobic motif in AKT (serine473) (Sarbassov et al., 
2005). mTORC2 also phosphorylates and activates protein kinase C ζ (PKCζ) and, thus, 
regulates cell migration and cytoskeleton formation (Li and Gao, 2014). mTORC2-mediated 
phosphorylation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) implicates 
mTORC2 activity in the mediation of cell proliferation/survival (Garcia-Martinez and Alessi, 
2008). SGK1 is a kinase that positively influences cell proliferation and inhibits apoptosis (Lang 
et al., 2006). A possible negative feedback loop exists between mTORC1 and mTORC2 activity 
that is speculated to lead to changes in mTORC2 protein interactions (Treins et al., 2010). In 
summary, mTORC2 mediates cell growth by coordinating cytoskeleton formation, cell migration 
and cell proliferation.  
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Fig. 3: Overview of mTORC1 and mTORC2 signaling pathways. These images summarize 
the mTORC1 (A) and TORC2 (B) pathways. For further explanation, please refer to main text. 
Image modified from Kim and Guan, 2011.   
 
4.3. Functions of mTORC1 and mTORC2 in lipid metabolism 
The above figure displays effects of mTORC1/mTORC2 activity on general metabolism, 
cell survival and cytoskeleton dynamics (Fig. 3). TOR-induced cell growth has been mostly 
studied by measuring protein synthesis as a biological output but it is becoming clear that other 
anabolic pathways are also affected by TOR activity, likely also lipid synthesis (Birse et al., 
2010; Laplante and Sabatini, 2009 and 2012). Research shows that mTORC1 and mTORC2 
directly affect lipid biogenesis.  
Adipogenesis is promoted by both mTORC1 and mTORC2 activity. Inhibition of 4EBP1 
by TORC1 is believed to allow for PPARγ translation and thus activates adipogenic gene 
expression (Zhang et al., 2009). Activation of S6K is also implicated in adipogensis, as S6K 
knock out mice show a lack of fat accumulation due to a defect in adipocyte formation 
(Carnevalli et al., 2010). Recently it has been discovered that mTORC2 plays a role in 
adipogenesis as well. It was demonstrated that mTORC2 positively affects adipogenesis by 
phosphorylation of AKT (Yao et al., 2013).  
In addition to adipogenesis, mTORC1 also has a role in hepatic lipid biogenesis. 
mTORC1 appears to modulate hepatic lipogenesis mainly by regulation of SREBP activity. The 
regulation of SREBP might be mediated by mTORC1 activation of S6K (Duevel et al., 2010). 
Additionally, SREBP regulation by mTORC1 may be communicated through Lipin1 (Peterson et 
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al., 2011). As mentioned previously, Lipin1 is a target of mTORC1-dependent phosphorylation, 
which in turn affects Lipin1’s subcellular localization. Upon loss of mTORC1 activity, 
dephosphorylated Lipin1 enters the nucleus and represses SREBP activity and thus lipid 
biogenesis (Peterson et al., 2011). Hence, mTORC1 regulates lipid biogenesis via S6K and 
Lipin1, although the exact molecular mechanisms still remain elusive.  
mTORC2 also influences lipogenesis, although substrates and pathways involved remain 
largely unknown. It has been proposed that part of the influence of mTORC2 on lipogenesis 
results from its effects on SGK1 and AKT activity (Laplante and Sabatini, 2012). mTORC2 was 
identified as a suppressor of lipolysis in adipose tissue (Kumar et al., 2010). In addition, hepatic 
lipogenesis appears to be subject to mTORC2 regulation as mice with a reduction in mTORC2 
activity display reduced expression of key lipid synthesis genes in the liver (Yuan et al., 2012).  
These data implicate both mTOR complexes as central regulators of lipid metabolism and 
also suggest that aspects of mTOR-mediated regulation of lipid homeostasis might be brought 
about by changes in Lipin1 activity.  
4.4. General functions of the insulin pathway 
As mentioned previously, Lipin activity appears to be regulated by the insulin pathway. 
The insulin pathway integrates growth factor/insulin signaling with anabolic cellular processes. 
In mammals, circulating insulin-like growth factors (IGFs) promote cell and tissue growth, and 
circulating insulin regulates carbohydrate and lipid metabolism (Siddle, 2012). Dimerization of 
insulin or insulin-like growth factor receptors (IR/IGRF) triggers autophosphorylation of the 
receptors, which in turn promotes recruitment and phosphorylation of insulin receptor substrate 1 
and 2 (IRS1, IRS2) proteins (Manning and Cantley, 2007). IRS1/2 phosphorylation activates 
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phosphatidylinositol-4,5-bisphosphate 3-kinase	  (PI3K) (Hemmings and Restuccia, 2012). PI3K 
consists of a regulatory p85 subunit and a catalytic p110 subunit (Vogt et al., 2010). The 
catalytic p110 subunit phosphorylates phosphatidylinositol (4,5) bisphosphate (PIP2) to produce 
phosphatidylinositol (3,4,5) trisphosphate (PIP3) (Vogt et al., 2010). This phosphorylation step is 
antagonized by phosphatidylinositol 3, 4, 5 trisphosphate 3-phosphatase (PTEN) (Kishimoto et 
al., 2003). PIP3 at the plasmamembrane recruits phosphoinositide-dependent kinase-1 (PDK1) 
and AKT. At the plasma membrane, PDK1 activates AKT through phosphorylation. In addition, 
mTORC2-mediated phosphorylation of AKT is required for maximal AKT activation 
(Hemmings and Restuccia, 2012). AKT then phosphorylates many downstream substrates and 
promotes cell survival by blocking proapoptotic proteins and processes (Manning and Cantley, 
2007). Forkhead box protein O (FOXO) transcription factors are phosphorylated by AKT, which 
leads to FOXO’s removal from the nucleus. By removing FOXO transcription factors from the 
nucleus, AKT inhibits expression of proapoptotic and cell cycle arrest genes (Burgering and 
Kops, 2002). AKT positively affects cell growth by activation of mTORC1 via Tsc1/2 and 
PRAS-40 phosphorylation (Manning and Cantley, 2007). Metabolic processes are also targeted 
by AKT. AKT promotes glucose transporter 4 (GLUT4) membrane translocation and thus 
promotes glucose uptake (Cong et al., 1997). In addition, glycogen synthesis is stimulated by 
AKT through inhibition of glycogen synthase kinase 3 (GSK3) (Manning and Cantley, 2007). 
Cell proliferation is regulated by AKT in part by interfering with p27 function (Manning and 
Cantley, 2007; Taguchi and White, 2008). Thus, insulin pathway activity is involved in 
upregulation of many cellular anabolic pathways.  
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Figure 1. Upstream Activation of Akt by Growth Factors
Also depicted is the complex relationship between Akt signaling and mTOR. Activated
receptor tyrosine kinases (RTKs) activate class I phosphatidylinositol 3-kinase (PI3K) through
direct binding or through tyrosine phosphorylation of scaffolding adaptors, such as IRS1, which
then bind and activate PI3K. PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate
(PIP2) to generate phosphatidylinositol-3,4,5-trisphosphate (PIP3), in a reaction that can be
reversed by the PIP3 phosphatase PTEN. AKT and PDK1 bind to PIP3 at the plasma membrane,
and PDK1 phosphorylates the activation loop of AKT at T308. RTK signaling also activates
mTOR complex 2 (mTORC2) through a currently unknown mechanism, and mTORC2
phosphorylates Akt on the hydrophobic motif S473, which can be dephosphorylated by the
S473 phosphatase PHLPP. Akt activates mTOR complex 1 (mTORC1) through multisite
phosphorylation of TSC2 within the TSC1-TSC2 complex, and this blocks the ability of TSC2
to act as a GTPase-activating protein (GAP) for Rheb, thereby allowing Rheb-GTP to
accumulate. Rheb-GTP activates mTORC1, which phosphorylates downstream targets such
as 4E-BP1 and the hydrophobic motif on the S6 kinases (S6Ks; T389 on S6K1). PDK1
phosphorylates the activation loop on the S6Ks (T229 on S6K1) in a reaction independent of
PDK1 binding to PIP3. Akt can also activate mTORC1 by phosphorylating PRAS40, thereby
relieving the PRAS40-mediated inhibition of mTORC1. Once active, both mTORC1 and S6K
can phosphorylate serine residues on IRS1, which targets IRS1 for degradation, and this serves
as a negative feedback mechanism to attenuate PI3K-Akt signaling. See text for references to
recent reviews detailing Akt regulation and mTOR signaling.
Manning and Cantley Page 20























Fig. 4: Overview of the insulin pathway. The insulin pathway activity modulates glucose and 
lipid metabolism and cell survival, proliferation and growth. For further explanation, please refer 
to the main text.  Image modified from Manning and Cantley, 2007. 
 
4.5. Functions of the insulin pathway in lipid metabolis  
Insulin pathway activity also influences li id metabolism. In the next section I will 
elaborate on the relationship between insulin and lipid metabolism. Insulin pathway activity is 
closely associated to lipid homeostasis, as evidenced by the development of insulin signaling 
imbalances induced by either lipodystrophy or obesity. Impaired insulin pathway activity is 
strongly associated with an incre se in circulatin  free fatty acids and TAGs (Frayn et al., 2001). 
Also, ectopic lipid accumulation is a common side effect of reduced insulin sensitivity (Frayn et 
al., 2001).  
	   22 
In adipocytes, insulin signaling enhances TAG production and downregulates lipolysis 
(Czech et al., 2013). Two lipolytic pathways exist; one mediated by protein kinase A (PKA) and 
the other by protein kinase G (PKG) (Czech et al., 2013; Miyoshi et al., 2007; Sengenes et al., 
2003). Insulin signaling reduces activity of both lipolysis pathways (Czech et al., 2013). AKT 
also inhibits hydrolysis of TAG through upregulation of mTORC1 activity, which results in a 
reduction of adipose triglyceride lipase (ATGL) mRNA (Chakrabarti et al., 2010). Therefore, 
adipocyte lipolysis is attenuated in response to insulin pathway activation. At the same time, 
lipogenic mechanisms in adipocytes are upregulated; in particular fatty acid uptake and de-novo 
fatty acid synthesis (Czech et al., 2013; Stahl et al., 2002).  
In the liver, insulin pathway activity increases de-novo fatty acid synthesis via activation 
of acetyl-CoA carboxylase (ACC), a key enzyme in fatty acid synthesis (Berggreen et al., 2009). 
In addition, insulin pathway activity also modifies lipogenic gene transcription 
(Assimacopoulos-Jeannet et al., 1995; Sul et al., 2000). In hepatocytes, this is mediated by 
insulin/mTOR-stimulated processing of SREBPs (Ferre and Foufelle, 2007; Shimomura et al., 
1998). The exact mechanism of how SREBP control is communicated remains elusive, but as 
mentioned before, Lipin1 activity appears to play an important role as a negative regulator of 
nuclear SREBP activity (Peterson et al., 2011).  
In conclusion, both the TOR and the insulin pathway contribute to lipid metabolism 
control, in some instances in concert. Lipin activity appears to be targeted by both pathways with 
regard to SREBP control. Thus, Lipin could represent an important mediator between 
TOR/insulin pathway and lipid homeostasis. The exact mechanisms of the TOR/insulin pathway-
induced and Lipin-communicated effects on lipid metabolism still warrant further investigation. 
Drosophila melanogaster has been used as a model system to investigate fat metabolism as well 
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as TOR/Insulin signaling (Baker and Thummel, 2007; Grewal, 2008; Teleman, 2009). 
Drosophila only has one lipin homolog, dLipin, which simplifies genetic studies. In the next 
section, I will summarize insulin and TOR pathways of the fly and point to shared and distinct 
characteristics between mammalian and Drosophila insulin/TOR signaling. I will summarize the 
most important aspects of lipid and glucose metabolism in the fly. 
5. Lipid and glucose metabolism in D. melanogaster 
Drosophila shares most of the basic metabolic functions found in mammals. Flies have a 
gastrointestinal tract that is similarly functionally segregated as the mammalian counterpart, fat 
body that functions as mammalian liver and white adipose tissue, oenocytes that perform basic 
hepatocyte-like functions in lipid-processing and specific neurosecretory cells in the brain that 
maintain insect metabolic homoeostasis in a way comparable to mammalian pancreatic β cells 
(Canavoso et al., 2001; Gutierrez et al, 2007; Rulifson et al., 2002). Organismal growth in 
Drosophila is restricted to the larval stages. After metamorphosis the adult fly no longer 
increases in size. Like mammals, Drosophila stores energy as TAG and glycogen. Lipid stores 
are the primary energy source for insects during diapause, embryonic development and 
prolonged flight (Arrese and Soulages, 2010). Both TAG and glycogen are stored in the fat body, 
though TAG represents the major energy reserve. TAG is synthesized via the glycerol-3 
phosphate pathway involving dLipin and stored in intracellular lipid droplets. Mobilization of 
TAG reserves is mediated by triglyceride lipases. In Drosophila the Brummer gene encodes a 
lipid droplet associated TAG lipase homologous to the mammalian adipocyte triglyceride lipase 
(ATGL) (Groenke et al., 2005). Glycogen is mobilized mostly in the form of the dissacharide 
trehalose (Thompson, 2003). TAG and glycogen stores can be mobilized by adipokinetic 
hormone (AKH) released from the corpora cardiaca (Arrese and Soulages, 2010). TAG and 
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glycogen from fat body stores are mobilized during times of energy depletion like starvation, 
flight and during embryogenesis.  
Both, the insulin and TOR pathways can activate TAG production in the fat body of 
Drosophila (Birse et al., 2010; DiAngelo and Birnbaum, 2009, Teleman et al., 2005). This 
suggests that in Drosophila, lipid metabolism is regulated by the insulin and TOR pathways, 
similarly compared to mammalian systems.  
6. Functions of TOR in D. melanogaster   
The Drosophila homolog of mammalian TOR, dTOR functions in many ways 
comparable to mammalian TOR in processes controlling cell growth and metabolism (Oldham et 
al., 2000). Amino acid input is the major trigger for dTOR-induced cell growth, and cellular 
amino acid status is most likely communicated to dTOR via the amino acid transporter, slimfast 
(Colombani et al., 2003). dTOR activates metabolic gene expression in an amino acid sensitive 
fashion and controls cell cycle progression (Li et al, 2010; Patel et al., 2003). Furthermore, 
dTOR is known to coordinate endocytotic and nutrient uptake processes to control cell growth in 
the fat body (Hennig et al., 2006). Cell growth was strongly targeted by dTOR in endoreplicative 
tissue (Britton and Edgar, 1998). dTOR, like mammalian TOR, inhibits autophagy (Scott et al., 
2004).  
dTOR also influences lipid metabolism (Birse et al., 2010; Teleman et al., 2005). Birse et 
al. (2010) demonstrated that systemic reduction of TOR activity resulted in decreased overall 
TAG stores in animals fed a high-fat or normal diet. This was caused by a decrease in 
lipogenesis in combination with increased lipolysis (Birse et al., 2010). Teleman et al. (2005) 
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observed that animals with reduced TOR activity displayed significantly reduced fat stores. 
Thus, it appears that dTOR is an important regulator of systemic lipid metabolism.  
Drosophila has two TOR complexes, TORC1 and TORC2. As in mammalian systems, 
Drosophila TORC2 phosphorylates AKT at the hydrophobic motif while the rapamycin-sensitive 
TORC1 is believed to primarily control cell growth and overall metabolism of the fly (Sarbassov 
et al., 2005, Teleman, 2009). The signaling pathway leading to TORC1 activation in Drosophila 
is basically identical to the pathway in mammalian systems, and is summarized in Fig. 5. Like its 
mammalian counterpart, dTOR appears to be involved in the insulin pathway cascade. However, 
the crosstalk between the dTOR and insulin pathways seems to be complicated and dTOR and 
insulin pathway activity are not always directly connected but can also be uncoupled (Colombani 
et al., 2003; Oldham et al., 2000; Pallares-Cartes et al., 2012).   
7. Functions of the insulin pathway in D. melanogaster 
The insulin pathway in Drosophila strongly resembles the mammalian insulin signaling 
systems. Not only are molecular components of the pathway conserved, but also physiological 
output. Drosophila has eight insulin-like peptides (dILPs), which are homologous to mammalian 
insulin in action and protein sequence (Kannan and Fridell, 2013). Each dILP has a distinct 
expression pattern, which implies that each dILP possesses a unique physiological function. 
dILPs 1, 2, 3 and  5 are expressed in neurosecretory brain cells, whereas dILPs 4 and 5 are 
expressed in the midgut. dILP 6 is mainly produced in the fat body, dILP 7 in the ventral nerve 
cord of the brain and the newly discovered dILP 8 in imaginal discs (Kannan and Fridell, 2013). 
Larval ablation of the neurosecretory cells that are responsible for releasing dILPs 2, 3 and 5 
resulted in a phenotype that mirrors the physiological effects of insulin resistance in mammals 
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(Rulifson et al., 2002; Broughton et al., 2005). dILP binding activates the Drosophila homolog 
of the mammalian insulin receptor, InR. Two insulin receptor substrate proteins exist in 
Drosophila, namely Chico and Lnk. As in the mammalian insulin pathway, phosphorylation of 
IRS recruits PI3K (p60 and p110 subunits) to the plasma membrane where it catalyzes the 
generation of PIP3. PIP3 accumulation activates PDK1 and AKT. These protein interactions are 
all highly conserved between flies and mammals (Teleman, 2009). The interaction between AKT 
and FOXO has been especially well studied in flies (Teleman, 2009). It was found that 
overexpression of FOXO led to growth arrest and food avoidance as well as reduced cell size, 
cell number and reduced lipid stores (Kramer et al., 2003; Puig et al., 2003; Teleman et al., 
2005). By modulating FOXO activity, AKT affects growth, cell proliferation and metabolism in 
Drosophila. As is the case in mammals, lipid metabolism might be controlled by dTOR and 
insulin pathway through SREBP regulation in Drosophila (Porstmann et al., 2008).  
Thus, the insulin pathway output of Drosophila is comparable to that in mammals, with 
effects on overall metabolism and growth; although the exact mechanisms involved still require 
further elucidation. Overall, the high degree of functional conservation of TOR/insulin signaling 
and the physiological similarities regarding lipid and glucose metabolism between mammals and 
flies predispose Drosophila as a prime candidate to elucidate the interconnection and crosstalk 
amongst TOR/insulin pathway activity and lipid/glucose homeostasis. Figure 5 summarizes the 
TOR/insulin pathway in Drosophila. 
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Fig. 5: TOR/insulin pathway in Drosophila. dILPs are secreted by insulin-producing cells 
throughout the body and bind to the insulin receptor homolog, InR. This leads to dimerization 
and subsequent autophosphorylation of InR, followed by binding of the fly IRSs, Chico and Lnk. 
Phosphorylation of the IRSs recruits PI3K to the plasma membrane where it catalyzes the 
generation of PIP3. PIP3 located at the plasma membrane triggers the activation of PDK1 and 
AKT. Thereby PDK1 phosphorylates and thus activates AKT. AKT is further phosphorylated by 
TORC2. Activated AKT then targets downstream components to adjust metabolic and growth 
related cellular responses. Amongst the targets are TORC1, FOXO and GSK3β. Image modified 
from Teleman, 2009. 
 
There are also differences in insulin pathway dynamics between Drosophila and 
mammals. One important difference is that in Drosophila glucocorticoids do not play a role in 
insulin signaling because flies do not synthesize glucocorticoids (Teleman, 2009). Another 
difference is that in Drosophila the complexity of the insulin cascade is reduced. Drosophila 
possesses homologs for all components of the insulin pathway present in mammals, but a single 
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fly homolog often represents multiple mammalian signaling components. This means that 
mutations in fly insulin signaling cascade components may give more direct and clear effects, 
but it also implies that direct comparisons of fly and mammalian protein function is sometimes 
not straightforward, as mammalian proteins might exhibit specialized functions (Teleman, 2009).  
8. Goals of PhD research 
Drosophila represents an ideal model for genetic manipulation and interaction 
experiments. As described earlier, the insulin and TOR pathways are highly conserved on both 
the physiological and molecular level between flies and mammals. In addition, Lipin function 
appears to be conserved between flies and mammals. Thus, I conducted experiments aimed to 
further elucidate the relationship between dLipin’s dual activity in fat metabolism and 
TOR/insulin signaling using Drosophila as a model system. With the fat body representing the 
major site for TAG and glycogen storage, I focused my research on the fly fat body. In my 
research I addressed the following questions: 
1. How are dLipin and insulin pathway activities linked in Drosophila? I investigated the 
relationship between dLipin and insulin signaling by exploring the effects of dLipin activity on 
cell growth and by measuring insulin pathway activity in flies with reduced dLipin expression. 
Genetic interaction studies were carried out to shed light on the epistatic relationship between 
dLipin and the insulin cascade and to investigate the effects of insulin pathway activity on dLipin 
function. To investigate the role of insulin pathway activity in dLipin regulation, I examined the 
effect(s) of insulin pathway modifications on dLipin localization.  
2. How is insulin resistance induced in animals that lack Lipin activity? As previously 
mentioned, lipin1 deficiency results in insulin resistance but it is not known whether the lack of 
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PAP or transcriptional co-regulator activity is responsible for this effect. Therefore, I aimed to 
address how the loss of either of these activities affects insulin pathway activity in Drosophila. 
To this end, I expressed dLipin lacking the PAP motif and dLipin lacking its NLS in animals 
with RNAi-mediated dLipin knockdown and examined insulin pathway activity in the larval fat 
body.  
3. How are Lipin and TOR activities linked in Drosophila? To address the question of 
whether dLipin activity is also subject to regulation by TOR in Drosophila, I examined cellular 
localization and abundance of dLipin in the larval fat body upon reducing TOR activity. The 
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II. Materials and Methods 
1. Fly stocks 
Simplified genotype Genotype Description Source 
w1118 w1118 white mutant used as a 
recipient strain for P 
element 
transformations and as 


























piggyBac element in 




LipinWT6M w1118; UASdLipinWT GAL4 driven 
expression of wildtype 
dLipin. 
Lehmann Laboratory 
lipin1 w1118; UASlipin1 Gal4 driven 
expression of homo 
sapiens lipin1. 
Sandra Schmitt 
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lipin2 w1118; UASlipin2 Gal4 driven 
expression of homo 
sapiens lipin2. 
Sandra Schmitt 
lipin3 w1118; UASlipin3 Gal4 driven 
expression of homo 
sapiens lipin3. 
Sandra Schmitt 
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BDSC #41912 





stranded rictor RNA. 
BDSC #36699 





stranded Tsc1 RNA. 
BDSC #35144 
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v[+t1.8]=TRiP.GL003
21}attP2 
stranded Tsc2 RNA. 










Activation of TOR Lehmann Laboratory 
Insulin signaling 
pathway 
   




expression of wild 
type PI3K92E. 
BDSC #8287 




expression of a 
dominant negative 
version on PI3K92E. 
BDSC #8288 






version of PI3K21B. 
BDSC #25899 




















expression of a 
constitutive active 
BDSC #8248 
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expression of a 
dominant negative 
version of InR. 
BDRC #8253 
AKTmyr  GAL4 driven 
expression of 
myristoylated, active 
form of Akt. 
Lehmann Laboratory 
AKTmyrlacZ  GAL4 driven 
expression of 
myristoylated, active 
form of Akt. 
Lehmann Laboratory 
chico UASchico Gal4 driven 
expression of chico. 
Saitoe laboratory, 
Tokyo Metropolitan 
Institute of Medical 
Science 




of GFP fused to PIP2 




tGPH w1118; P{tGPH}4 Ubiquitous expression 
of GFP fused to PIP3 
specific PH domain. 
BDSC #8164 
DcgGFP Gal4Dcg; DcgGFP Fat body GFP marker.  Graff Laboratory, 
UT Southwestern 
Medical Center  
Gal4 driver lines    
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FB(cg) w1118; P{CgGAL4.A}2 Expression of GAL4 
in fat body, hemocytes 
and lymph gland.  
BDSC #7011 
FB(r4) y[1] w[*]; 
P{w[+mC]=r4-
GAL4}3 
Expression of Gal4 in 






GAL4 expression in 
all larval tissues 
except CNS and 
imaginal discs.  
BDSC #8185 
hsGAL4 w; P(GAL4-hsp70) Heat-shock induced 







TubCD2GAL4 TubCD2GAL4 Inducible driver used 
in FLIP-out technique 






hsflp; UASGFP/CyO hsflp;UASGFP/CyO Expression of heat 
shock induced Flip 



















expression of double 
stranded DGAT2 
VDRC #48584 












   
dLipin knockdown    

















Knockdown of dLipin 



















PI3K92E and dLipin 








Localize PIP3 fat body 
cells with active 
dLipin knockdown. 
Sandra Schmitt 





680;  P{tGPH}4 










Fat body labelled with 
GFP in animals 










dLipin and InRDN in 





































TOR pathway and 
dLipin interaction 
   
FB(cg); TORRNAi P{CgGAL4.A}2;P{TRi
P.HMS00904}attP2 
Knockdown of TOR in 
fat body cells. 
Sandra Schmitt 
FB(cg); raptorRNAi P{Cg-GAL4.A}2;  Knockdown of raptor Sandra Schmitt 
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P{TRiP.HMS00124}at
tP2 
in fat body cells. 
FB(cg); rictorRNAi P{Cg-GAL4.A}2; 
P{TRiP.HMS01588}at
tP2 
Knockdown of rictor 







Knockdown of Tsc1 in 
fat body cells. 
Sandra Schmitt 
FB(cg); Tsc2RNAi P{Cg-GAL4.A}2;  
v[+t1.8]=TRiP.GL003
21}attP2  
Knockdown of Tsc2 in 








PIP3 localization after 











and raptor knockdown 













and raptor knockdown 












and raptor knockdown 
in the fat body with 
simultaneous 
Sandra Schmitt 
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hsGal4; 
dLipinWT6M 
w; P(GAL4-hsp70);  
P{GD14004}v36007 
Expression of dLipin 
in salivary gland for 
chromosome staining. 
Sandra Schmitt 
FB(cg); TORRNAi P{Cg-GAL4.A}2; 
P{TRiP.HMS00904}at
tP2  
TOR knockdown in fat 
body tissue.  
Sandra Schmitt 








WTdLipin in fat body 








Expression of dLipin 
lacking NLS in fat 









Expression of dLipin 
lacking PAP motif in 











expression of dLipin 








expression of human 
Sandra Schmitt 
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680;UASlipin1/tubP-
Gal4 









expression of human 










expression of human 








Expression of human 








Expression of human 








Expression of human 









Expression of human 
lipin1 in nearly all 









Expression of human 
lipin2 in nearly all 









Expression of human 
lipin3 in nearly all 
larval tissues of dLipin 
mutants. 
Sandra Schmitt 
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Table 1: List of all fly lines used in experiments described in this thesis. Fly lines are listed 
with genotype, a short description of the experiment(s) they were used in and the source they 
were obtained from. 
 
2. Plasmids 
Name Description Source 
pUASTattB Fly transformation vector 
containing attB site. 
Basler Laboratory, University of Zurich 
pBluescriptKSII Cloning vector Stratagene 
pCMV-
SPORT6 lipin1 
Vector containing human 
lipin1 cDNA 




Vector containing human 
lipin2 cDNA 
Mammalian Gene Collection 
pCR-XI-TOPO 
lipin3 
Vector containing human 
lipin3 cDNA 
Mammalian Gene Collection 
GH19076 dLipin cDNA in POT2 vector Berkley Drosophila Genome Project 
(BDGP) 
pTV2 Fly transfomation vector; 
Ends-in-Mutagenesis 
Sekelsky Laboratory, University of North 
Carolina 
pTarget Fly transformation vector; 
Ends-in-Mutagenesis 
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Table 2: List of all plasmids used. A short description of each plasmid is given and the source 




Name Host Dilution Source 








rabbit Western Blot: 1:1000 Cell Signaling Technology #4060 
anti-panAKT rabbit Western Blot: 1:1000 Cell Signaling Technology #2125 
anti-4EBP1 rabbit Western Blot: 1:2000 Nahum Sonenberg Laboratory, 
Goodman Cancer Center 
anti-phospho 
4EBP1 
rabbit Western Blot: 1:1000 Cell Signaling 
Technology #2855 
anti-actin rabbit Western Blot: 1:500 Sigma Aldrich #A2066 
anti-tubulin rabbit Western Blot: 1:1000 Cell Signaling Technology #2125 
anti-p110 goat Immunohistochemistry: 
1:400 to 1:50 




Name Conjugate Host Source 
anti-rabbit Alexa Fluor 647 Goat Life Technologies 
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anti-rabbit Rhodamine Donkey Jackson ImmunoResearch 
anti-rabbit Alkaline Phosphatase Donkey Jackson ImmunoResearch 
anti-goat Alexa Fluor 647 Donkey Jackson ImmunoResearch 
Table 3: List of all primary and secondary antibodies used. For primary antibodies host 
species and dilution as well as source are listed. For secondary antibodies host species, conjugate 
and source are listed.  
 
4. Primers 






Introduced deletion of nuclear 





Introduced point mutation 
changing GAC codon into GAG 
within phosphatidic phosphatase 




mutagenic reverse primer. 
lipinfwdnew 5’GCTGCGGCCGCGTTGCTATGGCT
GTGGCCAC3’ 
Site-directed mutagenesis: Used to 
amplify 6kb of dLipin gene. 




Site-directed mutagenesis: Used to 
amplify 6kb of dLipin gene. 
Introduced KpnI restriction site at 
3’ end. 







Introduction of ISceI site and 
SexA1 restriction site. 
NLSseqfwd 5’CTTCAAACGAAGCTGAGACGA3’ Site-directed mutagenesis: 
Verification of NLS deletion after 
site directed mutagenesis. 
GCseqfwd 5’GCACCAATGCAAGCTTCAATGC3’ Site-directed mutagenesis: 
Verification of base exchange after 
site directed mutagenesis. 
ISceseqfwd 5’CCCAGGTGCAGCAAAGCGAGC3’ Site-directed mutagenesis: 




Amplification of human Lipin2 




Amplification of human Lipin2 




Amplification of human Lipin3 




Amplification of human Lipin3 
cDNA. Introduces XbaI cutting 
site. 
rp49rev 5’ GCGCTTGTTCGATCCGTA 3’  Amplification of rp49 transcript 
for qRT PCR analysis. 
rp49fwd 5’ CGGATCGATATGCTAAGCTGT 3’  Amplification of rp49 transcript 
for qRT PCR 
Fruit Fly 
PI3k92E 
Sequence not published; Qiagen RT2 
qPCR primer set for amplification of 
PI3K92E fragment (#330001) 
Amplification of Dp110 transcript 
for qRT PCR analysis. 
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Table 4: List of all primers used in experiments. Primer name, sequence as well as a short 
description of how they were used in given.  
 
5. Fly maintenance 
Flies were grown and maintained on standard fly food prepared with 1.8% yeast, 6.1% 
cornmeal, 1.3% corn syrup, 1.1% agar and 8.2% malt extract in tap water. The food contained 
0.75% propionic acid and 1% tegosept to suppress bacterial and fungal growth. Flies were kept 
at 25 °C.  
6. Molasses agar plates 
500ml of distilled H2O containing 3.5% agar and 14% molasses. The mixture was 
autoclaved for 20minutes at 15 psi on liquid cycle, and then after cooling to about 60°C, poured 
into small petri dishes. The molasses plates were stored at 4°C. 
7. Media 
Liquid Broth (LB) was used to grow bacterial cultures. For 1 liter of LB 950ml distilled 
H2O was mixed with 10g tryptone, 5g yeast extract and 10g NaCl. The pH was adjusted to 7.0 
with 10N NaOH. The volume was then adjusted to 1Liter with distilled H2O. The medium was 
sterilized by autoclaving for 20 minutes at 15 psi on liquid cycle. For LB media plates, 15g/L of 
Bacto Agar was added to the medium before autoclaving. Antibiotics were added to media at the 
following concentrations: Ampicillin (50mg/ml): 150µg/ml; Chloramphenicol (34mg/ml): 
170µg/ml; Kanamycin (10mg/ml): 50µg/ml. 
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8. Preparation of competent E.coli cells 
5ml of LB were inoculated with a single colony of Escherichia coli (E. coli). The 
bacterial culture was grown overnight at 37°C with constant shaking. 1ml of the overnight 
culture was transferred into 100ml of preheated (37°C) LB and grown at 37°C and 240 rpm for 2 
hours or until final OD600 of 0.3-0.6. The cells were then placed on ice, divided into two pre-
chilled 50 ml polypropylene tubes and pelleted by centrifugation in a tabletop centrifuge at 1,600 
x g and 4°C for 7 minutes. The supernatant was discarded and the bacterial pellet re-suspended 
in 10 ml ice cold 0.1M CaCl2 followed by centrifugation at 1,100 x g and 4°C for 5 minutes. The 
cells were kept overnight at 4°C. The next day, 480µl 80% glycerol was added to the cells. 
Aliquots of 100µl were pipetted into pre chilled Eppendorf tubes and immediately stored at -
80°C. 
9. Transformation of competent cells 
Competent cells were defrosted on ice and 100µl 0.1M CaCl2 added. DNA was added to 
the cells in a volume not exceeding 5% of the volume of the competent cells. Contents of the 
tube were gently mixed followed by a 30 minute incubation period on ice. Cells were heat 
shocked at 42°C for 2 minutes in a water bath, and immediately transferred back to ice. 800µl of 
LB broth were added and the cells grown at 37°C and 220 rpm for 90 minutes. Cells were plated 
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10. Ligation 
All ligations were carried out using T4 DNA Ligase (New England BioLabs # M0202S) 
according to the manufacturer’s recommendations. The ligation reactions were kept at 16°C in a 
water bath overnight and transformed into competent E. coli cells the following day.  
11. Generation of pUASTattBlipin1, pUASTattBlipin2 and pUASTattBlipin3 constructs 
The human genome encodes three lipin paralogs. To test whether Lipin function is 
conserved between Drosophila melanogaster and Homo sapiens, and in order to determine 
whether any human lipin paralog can replace the single Drosophila melanogaster lipin gene 
(dLipin), UAS responder lines for all three human lipin paralogs were created. These responder 
lines were then expressed in dLipin mutant animals (Df7095/ dLipine00680). To this end, each 
human lipin paralog was cloned into the Drosophila pUASTaTTB transformation vector.  
The plasmid pCMV-SPORT6 lipin1 (Table 2) was grown in LB media containing ampicillin 
overnight at 37°C with shaking. Plasmid DNA was prepared from the overnight culture using the 
GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). lipin1 cDNA was cut from the 
vector backbone using KpnI and AvrII and the lipin1 fragment separated from the plasmid DNA 
by agarose gel electrophoresis. The lipin1 fragment was cut out from the gel, and the DNA 
purified using the QuickCleanII Gel Extraction Kit from Genscript (# L00418). The final 
destination vector, pUASTattB, was prepared by cutting with KpnI and and XbaI (XbaI and AvrII 
have compatible ends for ligation), and a ligation reaction with both components was set up.  
pENTR223.1-Sfi lipin2 plasmid (Table 2) was grown in LB overnight at 37°C with 
shaking and chloramphenicol added as the selective antibiotic. Plasmid DNA was isolated the 
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following day using the GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). lipin2 
cDNA was amplified using PCR (forward primer: lipin2fwdNot; reverse primer: lipin2Kpnrev; 
Table 4). Phusion High-Fidelity DNA Polymerase (New England BioLabs #F-S30S) was used to 
amplify the fragment. The lipin2 fragment was then digested with NotI and KpnI as was the 
destination vector pUASTattB. A ligation reaction with both components was set up. 
pCR-XI-TOPO lipin3 plasmid (Table 2) was grown in LB overnight at 37°C with shaking 
and kanamycin added as the selective antibiotic. Plasmid DNA was purified the following day 
using the GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). lipin3 cDNA was 
amplified in a PCR reaction (forward primer: lipin3fwd; reverse primer: lipin3rev; Table 4). 
Phusion High-Fidelity DNA Polymerase (New England BioLabs #F-S30S) was used to amplify 
the fragment according to manufacturer’s recommendations. lipin3 cDNA and the destination 
vector pUASTattB were cut with NotI and XbaI, and ligated.  
All three ligation reactions were transformed into E.coli cells and plated on LB plates 
with ampicillin as the selective antibiotic. Colonies were picked the next day and DNA prepared 
using GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). Analytical restriction 
digestions were conducted to verify the presence of lipin inserts in the clones picked. . To screen 
for presence of lipin1 fragment the construct was digested with KpnI and XmaI, lipin2 presence 
was detected by cutting with NotI and KpnI whereas lipin3 presence was verified by restriction 
digest with NotI and XbaI. Positive clones were grown up in 50ml ampicillin containing LB 
medium overnight at 37°C with shaking and plasmid was DNA purified using Qiagen HiSpeed 
Plasmid Midi Kit (# 12643). The DNA was sent off to BestGene Inc for injection into fly 
embryos. For the sake of simplicity, these constructs are being referred to as lipin1, lipin2 and 
lipin3 in the remainder of the text. 
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12. Site-directed mutagenesis and generation of pUASTattBWTdLipin, pUASTattBΔPAPdLipin 
and pUASTattBΔNLSdLipin constructs 
dLipin cDNA (plasmid GH19076) was used to create three different UAS responder 
lines. WTdLipin is a construct used to express wild type dLipin. ΔPAPdLipin encodes dLipin 
with a point mutation at position 2886 of the nucleotide sequence. This point mutation leads to 
an encoded protein with a glutamate (Glu or E) residue at position 812 of the protein instead of 
an aspartate (Asp or D) residue (D812E). This change in the amino acid sequence results in a 
loss of phosphatidic acid phosphatase activity (PAP activity) (Finck et al.; 2006). ΔNLSdLipin 
encodes a mutant dLipin lacking the nuclear localization signal (NLS; amino acid positions 276-
281), thus this protein is not able to translocate to the nucleus and affect gene regulation. I 
targeted the NLS instead of the co-regulator motif because previous research showed that 
deletion of the co-regulator motif not only affects nuclear activity, but also PAP activity of 
Lipin1 (Reue and Brindley; 2008). To identify the putative NLS in dLipin I used the openly 






















Putative NLS; PAP active site; Co-activator motif 
Fig 6: Protein (CG8709-PA) sequence of dLipin isoform A with nuclear localization signal 
(NLS), PAP active site and co-activator motive. The NLS is deleted in ΔNLSdLipin construct 
and the PAP site changed from DIDGT to EIDGT in the ΔPAPdLipin construct via site-directed 
mutagenesis.  
 
Plasmid GH19076 was grown in LB with chloramphenicol acting as the selective 
antibiotic. Site-directed mutagenesis was carried out using the Change-IT Multiple Mutation Site 
Directed Mutagenesis Kit by USB (# 78480) to create ΔPAPdLipin cDNA (forward primer: G-
Cmutafwd; reverse primer: nonmutarev; Table 4) and ΔNLSdLipin (forward primer: 
NLSmutafwd; reverse primer: monmutarev; Table 4). Successful mutagenesis was confirmed by 
sequencing (primers: GCseqfwd and NLSseqfwd; Table 4). The mutated and wild- type dLipin 
cDNAs were isolated from the pOT2 vector using XhoI and EcoICRI and the cDNA fragment 
separated from the vector backbone by agarose gel electrophoresis. The cDNA fragments were 
cut out from the gel and the DNA was purified using the QuickCleanII Gel Extraction Kit from 
Genscript (# L00418). pUASTattB served as the final transformation vector. The vector was cut 
with XbaI and the 5’ overhang filled in with Klenow enzyme. This was followed by digestion 
with XhoI. To reduce religation of potentially partially digested plasmid, the vector was treated 
with Shrimp Alkaline Phosphatase (Promega # M9910) according to the manufacturer’s 
recommendations. The prepared pUASTattB vector was then used for ligation with the cDNA 
fragments. Transformed cells were plated onto LB agar plates with ampicillin as the selective 
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antibiotic and incubated at 37°C overnight. Clones were picked and grown in LB with ampicillin 
at 37°C overnight. DNA was purified from bacterial cultures using GenScript QuickCleanII 
Plasmid Miniprep Kit (# L004320). Identification of positive bacterial transformants was 
achieved by analytical digestion of extracted DNA with EcoRI and XhoI. Positive clones were 
grown up in 50ml ampicillin containing LB medium overnight at 37°C with shaking and DNA 
was then purified using Qiagen HiSpeed Plasmid Midi Kit (# 12643). The DNA was sent to 
BestGene Inc for injection into fly embryos. From this point onwards, for the sake of simplicity, 
I will refer to these lines as WTdLipin, ΔNLS dLipin and ΔPAPdLipin.  
13. Site-directed mutagenesis and cloning of pTV2ΔPAPdLipin and pTargetΔNLSdLipin donor 
constructs for ends-in-targeting gene replacement 
Bac-Clone #RP98-9N11 (BACPAC Resources Center) served as a template to amplify 
6kb of the dLipin gene. The clone was grown in LB with chloramphenicol as the selective 
antibiotic. Phusion High-Fidelity DNA Polymerase (New England BioLabs #F-S30S) was used 
to amplify the fragment (forward primer: lipinfwdnew; reverse primer: NLSREV; Table 4). The 
6kb fragment was cloned into pBluescriptKSII via KpnI and NotI restriction sites. T4 DNA 
Ligase (New England BioLabs # M0202S) was used to ligate vector DNA with the 6kb 
fragment, colonies were picked and DNA extracted with GenScript QuickCleanII Plasmid 
Miniprep Kit (# L004320). Presence of the 6kb dLipin insert was verified in an analytical 
digestion with KpnI and NotI. Site-directed mutagenesis was then carried out with positive 
clones using the Change-IT Multiple Mutation Site Directed Mutagenesis Kit by USB (# 78480). 
To knock out the PAP activity (ΔPAP) of dLipin, D812 was converted into E (D812E, forward 
primer: G-Cmutafwd; reverse primer: nonmutarev; Table 4). In order to eliminate the nuclear co-
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regulator function of dLipin, the Nuclear Localization Signal was deleted (ΔNLS) (NLS; AA 
276-281; forward primer: NLSmutafwd; reverse primer: monmutarev; Table 4). For a more 
detailed description please refer to Materials and Methods 12. Clones were screened for 
successful mutagenesis/deletion by sequencing (primers: GCseqfwd and NLSseqfwd; Table 4). 
An I-SceI site was inserted into these sequences using PCR (forward primer: 
lipinfwdnew; reverse primer: GCISceIrevnew; Table 4). Thereby, 3kb of the mutated dLipin 
gene were amplified via PCR and an I-SceI recognition sequence attached to the generated 
fragment’s 3’end. The I-SceI sequence was added to the reverse primer. Additionally, a NotI 
cutting site was introduced at the 5’ and of the PCR fragment, and a SexAI site at the very 3’ 
end. Using SexAI and NotI restriction sites in the plasmid containing the original mutated DNA, 
3kb were cut out and replaced with the 3kb PCR that now contain the I-SceI site. The 3kb I-SceI 
fragment and the plasmid containing the remainder 3kb of dLipin were ligated. The Ligation 
reaction was transformed into methylation negative cells (dam-/dcm- Competent cells; New 
England Biolabs # 29521) as SexA1 cuts only unmethylated DNA. Cells were plated on to LB 
plates containing ampicillin as the selective antibiotic and incubated at 37°C overnight. Plasmid 
DNA was extracted from colonies using the GenScript QuickCleanII Plasmid Miniprep Kit (# 
L004320) and presence of the I-SceI site confirmed via sequencing (primer: ISceseqfwd; Table). 
Using KpnI and NotI restriction sites, the entire 6kb fragment containing the D812E mutation 
was cut out and ligated into the pTV2 plasmid that had been cut with the same restriction 
enzymes to generate pTV2ΔPAPdLipin. The ΔNLSdLipin fragment was cut with KpnI and NotI 
and ligated into the pTarget plasmid that had been digested with the same restriction enzymes to 
create pTargetΔNLSdLipin. Analytical digest with KpnI and NotI was used to verify the presence 
of the 6kb fragments in the final constructs. Positive clones were grown in 50ml ampicillin 
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containing LB medium overnight at 37°C with shaking and DNA purified using Qiagen HiSpeed 
Plasmid Midi Kit (# 12643). DNA for both constructs was sent off to BestGene Inc for injection 
into fly embryos.  
14. Genetic interaction experiments between dLipin and members of the TOR and Insulin 
pathways 
To test whether dLipin and Insulin/TOR signaling affect each other, genetic interaction 
experiments were conducted. Therefore, dLipin was knocked down or overexpressed in concert 
with members of the Insulin and TOR signaling pathways. Offspring with both genetic 
modifications, should exhibit either an enhancement or rescue of the dLipin or Insulin/TOR 
phenotype if there are any interactions. To this end, fly lines expressing dLipinRNAi or 
dLipinWT6M or hypomorphic dLipin mutants were crossed with lines expressing RNAi against 
genes involved in the TOR and insulin pathways gene, hypomorphic TOR and insulin pathway 
mutants or TOR and insulin pathway overexpression lines.  
The following is a list of genotypes created to study possible genetic interactions between dLipin 
and genes of the TOR and insulin pathways. 
Simplified genotype Description 
dLipinRNAi/InRcont.active;FB(r4) Expression of constitutive active form of InR in 
concert with dLipinRNAi using fat body-specific 
driver. 
dLipinRNAi/InRcont.active; DJ761 Weak ubiquitous expression of constitutively active 
form of InR in concert with dLipinRNAi. 
dLipinRNAi/PI3K21BHA; FB(r4) Expression of dominant negative form of PI3K21B 
in concert with dLipin knockdown using fat body-
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specific driver.  
dLipinRNAi/PI3K21BHA; DJ761 Weak ubiquitous expression of constitutive active 
form of InR in concert with dLipinRNAi. 
PI3K21BHA; LipinWT6M/FB(r4) Expression of dominant negative form of PI3K21B 
in concert with WTdLipin using fat body specific 
driver. 
dLipinRNAi/FB(cg); PI3K92Edom.neg. Expression of dominant negative form of PI3K92E 
with concomitant dLipin knockdown using fat body 
specific driver.  
dLipinRNAi/FB(cg); PI3K92E Expression of wild-type PI3K92E in concert with 
dLipin knockdown using fat body specific driver. 
dLipine00680/ dLipine00680; AKTmyr/ 
FB(r4) 
Expression of activated AKT in fat body in 
hypomorphic dLipin mutant background. 
Df7095/ dLipine00680; AKTmyrlacZ/ FB(r4) Expression of activated AKT in fat body in 
transheterozygous dLipin mutant background. 
Dp110CAAX; dLipinRNAi/ FB(cg) Expression of constitutively active form of Dp110 
in concert with dLipinRNAi using fatbody specific 
driver. 
dLipinRNAi/FB(cg); InRdom.neg. Expression of dominant negative form of InR in 
concert with dLipinRNAi using fat body specific 
driver.  
dLipine00680/ dLipine00680;Rheb/hsGal4 Expression of Rheb with fatbody specific driver in 
hypomorphic dLipin mutant background. 
dLipinRNAi/FB(cg); Rheb/InRdom.neg. Simultaneous expression of Rheb, dLipinRNAi and 
InRdom.neg. using fat body specific driver.  
dLipinRNAi/FB(cg); TORRNAi Simultaneous RNAi-mediated knockdown of TOR 
and dLipin using fat body specific driver. 
dLipinRNAi/FB(cg); raptorRNAi Simultaneous RNAi-mediated knockdown of 
raptor and dLipin using fat body specific driver. 
dLipinRNAi/FB(cg); rictorRNAi Simultaneous RNAi-mediated knockdown of rictor 
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and dLipin using fat body specific driver. 
dLipinRNAi/FB(cg); Tsc1RNAi Simultaneous RNAi-mediated knockdown of Tsc1 
and dLipin using fat body specific driver. 
dLipinRNAi/FB(cg); Tsc2RNAi Simultaneous RNAi-mediated knockdown of Tsc2 
and dLipin using fat body specific driver. 
Table 5: List of genetic interaction experiments conducted to investigate the relationship 
between dLipin and Insulin/TOR pathway.  
 
To detect potential interaction between dLipin and genes of the TOR/insulin pathways, 
offspring was examined for different parameters, depending on the genetic makeup of the 
animals. The parameters included: effects on larval development and fat body morphology (fat 
droplet size, cell size, cell shape).  
15. Analyses of genetic interaction between dLipin and insulin receptor (InR) 
To investigate larval viability in animals with concomitant dLipin and InRdom.neg. 
expression, flies with the following genotype were generated: dLipinRNAi/FB(cg); InRdom.neg.. 
To this end the following cross was set up: 
Parental cross: FB(cg)/FB(cg)  X  dLipinRNAi/CyOGFP; InRdom.neg./Tb,TM6B 
! FB(cg)/CyOGFP; Tb,TM6B: Control animals; 25% genotype frequency expected. 
     FB(cg)/CyOGFP; InRdom.neg.: Experimental animals expressing InRdom.neg.; 25 % genotype 
frequency expected. 
     FB(cg)/dLipinRNAi; Tb,TM6B: Experimental animals expressing dLipinRNAi; 25 %  
genotype frequency expected. 
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     FB(cg)/dLipinRNAi; InRdom.neg.: Experimental animals expressing both transgenes; 25% 
genotype frequency expected.  
As a measure for larval lethality, I counted pupae formed for each genotype. As genotype 
frequencies for each genotype were known, it was possible to directly compare the number of 
pupae formed by control animals with any of the three experimental genotypes. I analyzed the 
numbers using Chi-square statistical analyses.  
16. Rescue of dLipin mutants by expression of human lipin transgenes 
To investigate functional conservation between dLipin and the three human lipin paralogs 
(lipin1, lipin2 and lipin3) transgenic fly lines were generated for expression of each of the 
homologs in Drosophila (11).  
Crosses were set up to analyze rescue effects for each of the three homologous genes. Flies of the 
two following genotypes were analyzed: 
Df7095/ dLipine00680; lipin1/2/3 / DJ761   
Df7095/ dLipine00680; lipin1/2/3 / TubGAL4  
Df7095/ dLipine00680; lipin1/2/3 / FBGAL4. 
Animals transheterozygous for dLipin mutations and carrying both human lipin transgene 
and driver were analyzed with regard to fat body development and larval lethality. To compare 
larval lethality between different genotypes, I examined the number of pupae formed by animals 
of the different genotypes. I set up individual crosses for each human lipin transgene. The 
genotype frequency for resulting genotypes was known, thus I was able to compare the number 
of pupae formed with the control genotype (Df7095/ dLipine00680; lipin1/2/3) to the number of 
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pupae formed with experimental genotype (Df7095/ dLipine00680; lipin1/2/3 / Gal4)., Chi-Square 
analyses were conducted to assess statistical significance.  
Parental cross exemplified for lipin1:  
Df7095/ CyOGFP; lipin1/lipin1  X  dLipine00680/CyOGFP; Gal4/ Tb,TM6B 
" Genotypes that were compared: Df7095/ dLipine00680; lipin1/ Gal4: experimental animals  
                                                         Df7095/ dLipine00680; lipin1/Tb,TM6B: control animals 
Genotype frequencies for both genotypes were 50% compared to each other. I compared 
the number of pupae formed with control genotype to the number of pupae formed with 
experimental genotype using Chi-Square analysis. The number of pupae formed with control 
genotype was set to 100% and % for the number of pupae formed with experimental genotype 
was calculated. 
17. Rescue of dLipin mutants or animals with RNAi mediated dLipin knockdown by expression 
of ΔPAPdLipin, ΔNLSdLipin and WTdLipin constructs 
To determine the rescue effects of dLipin lacking either catalytic or transcriptional co-
regulator activity, ΔPAPdLipin, ΔNLSdLipin and WTdLipin transgenes were expressed in a 
dLipin transheterozygous mutant background, or concomitant with dLipinRNAi. Animals of the 
following genotypes were generated: 
Df7095/ dLipine00680; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / daGAL4  
Df7095/ dLipine00680; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / TubGAL4  
Df7095/ dLipine00680; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / FBGAL4 
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dLipinRNAi / FBGal4; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / tGPH. 
These fly strains were observed with regard to fat body development, fat body 
morphology, larval lethality and PIP3 localization. Animals of the genotypes 
dLipinRNAi/FBGal4; ΔPAPdLipin/tGPH, dLipinRNAi/FBGal4; ΔNLSdLipin/tGPH and 
dLipinRNAi/FBGal4; WTdLipin/tGPH were examined for PIP3 localization. Transheterozygous 
dLipin mutants with concomitant expression of ΔPAPdLipin, ΔNLSdLipin or WTdLipin were 
examined with regard to fat body morphology and larval lethality. I set up individual crosses for 
each dLipin construct. To compare larval lethality between control (Df7095/ dLipine00680; Gal4) 
and experimental genotypes (Df7095/dLipine00680; ΔPAPdLipin, ΔNLSdLipin or 
WTdLipin/GAL4), I examined the number of pupae formed for the specific genotypes. The 
genotype frequency for resulting genotypes was known thus, I was able to compare the number 
of pupae formed with control genotype (Df7095/dLipine00680; ΔPAPdLipin, ΔNLSdLipin or 
WTdLipin) to the number of pupae formed with experimental genotype (Df7095/dLipine00680; 
ΔPAPdLipin, ΔNLSdLipin or WTdLipin/Gal4). To assess statistical significance, Chi-Square 
analysis was conducted.  
Parental cross exemplified for WTLipin:  
Df7095/ CyOGFP; Gal4/Tb   X    dLipine00680/CyOGFP; WTdLipin/WTdLipin 
" Genotypes that were compared: Df7095/ dLipine00680; WTdLipin/Gal4: experimental animals  
                                                         Df7095/ dLipine00680; WTdLipin/Tb: control animals 
Genotype frequencies for both genotypes were 50% compared to each other. I compared 
the number of pupae formed with control genotype to the number of pupae formed with 
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experimental genotype using Chi-Square analysis. The number of pupae formed with control 
genotype was set to 100% and % for the number of pupae formed with experimental genotype 
was calculated. 
18. Generation of mosaic animals for dLipinRNAi 
The goal of this experiment was to generate larval fat body tissue with single cells that 
lack dLipin activity in an otherwise wild type dLipin background. These mosaic animals were 
generated using the flip-out technique (Blair, 2003). Animals were kept at 25 °C on standard 
food. At this temperature basal expression of a heat-shock induced FLP (flippase) recombinase 
led to the activation of the TubGAL4 driver in only a small number of cells.  This is possible 
because the FLP recombinase targets the FRT (flippase recognition target) sites flanking a CD2 
cassette that was introduced to prohibit the expression of Gal4 from the driver promoter (Tubulin 
α promoter). The CD2 cassette was subsequently removed via site-specific recombination by the 
FLP recombinase, which allowed for the expression of Gal4 from the Tubulin promoter. 
Presence of Gal4 then triggered dLipinRNAi expression in these cells. Mosaic cells were further 
marked with UASGFP (Green fluorescent Protein). Hence, only very few cells expressed both 
dLipinRNAi as well as the marker GFP. 
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Fig. 7: Depiction of the FLP-out process in mosaic cells. In single cells, expression of FLP 
recombinase was triggered. FLP recombinase subsequently targets the FRT sites flanking a CD2 
cassette and removes it. This allows expression of Gal4 form the Tubulin promoter. The 
transcription factor Gal4 then binds to its target sequence UAS (upstream activating sequence) 




hsflp/hsflp; UASGFP X dLipinRNAi; Tub-CD2-Gal4 
=> Mosaic animals: hsflp; UASGFP/dLipinRNAi; Tub-CD2-Gal4 
Fat body from mosaic animals was dissected in PBS pH7.4 (137mM NaCl, 2.7mM KCl, 
10mM Na2HPO4, 1.8mM KH2PO4; pH adjusted with HCl) and fixed in 4% formaldehyde for 30 
minutes. To verify successful dLipin knockdown the tissue was stained with anti-Lipin antibody. 
Visualization of lipid droplets was achieved by staining with HCS LipidTOX Deep Red neutral 
lipid stain (Invitrogen # H34477). After staining was completed the tissue was mounted in 
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Slowfade Gold antifade reagent with DAPI (Invitrogen # P36931) and examined under a Carl 
Zeiss AxioVision microscope. 
19. Fat droplet staining 
Fat droplets were stained with Bodipy 493/503 (Invitrogen # D2191) or HCS LipidTOX 
Deep Red neutral lipid stain. Fat body was dissected in PBS, pH7.4 followed by fixation in 4% 
formaldehyde for 30 minutes. The stains were diluted in PBS, pH 7.4. BODIPY was diluted to a 
final concentration of 1 µg/ml, whereas HCS LipidTOX Deep Red was used at a 1:400 dilution. 
Fixed tissue was stained for 30-60 minutes at room temperature. Tissue was protected from light 
during this step to prohibit photo bleaching. After staining was completed, tissue was mounted in 
Slowfade Gold antifade reagent with DAPI (Invitrogen # P36931). Images were taken using a 
Carl Zeiss AxioVision microscope. Bodipy stained fat droplets were viewed with a GFP filter, 
and HCS LipidTOX Deep Red stained fat droplets with a Cy5 filter. DNA was viewed using the 
DAPI filter setting. 
20. dLipin antibody staining 
Tissue was dissected on ice in PBS, pH 7.4 and fixed in 4% formaldehyde for 30 
minutes. After fixation, tissue was washed 4 times in PBST (PBS plus 0.2% Tween20) for 10 
minutes and then blocked in PBST with 1% Normal Donkey serum (NDS) or Normal Goat 
Serum (NGS), depending on the secondary antibody used. Blocking lasted for at least 2 hours at 
room temperature accompanied by gentle shaking. Affinity purified anti-dLipin antibody was 
added at 1:400 dilution in PBST with 1% NDS or NGS, and tissue was stained overnight at 4°C 
with gentle shaking. Tissue was then washed four times in PBST for 10 minutes each and the 
secondary antibody was added. Secondary antibodies used were Rhodamine conjugated donkey 
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anti-rabbit IgG (Jackson ImmunoResearch #69532; Table 3) and Alexa Fluor 647 conjugated 
goat anti-rabbit IgG  (Life Technologies #A21244; Table 3), both used at a 1:1000 dilution (in 
PBST with 1% NDS or NGS). The incubation period lasted 2 hours during which samples were 
wrapped in aluminium foil to prohibit photo bleaching. Tissue was then washed 4 times in PBST 
for 10 minutes each, and mounted in Slowfade Gold antifade reagent with DAPI (Invitrogen # 
P36931). Images were captured with a Carl Zeiss AxioVision microscope. 
21. Measurement of hemolymph sugar levels 
The Glucose Assay Kit by Cayman Chemical Company (#10009582) was used to 
measure the hemolymph sugar levels of feeding third instar larvae. Hemolymph of five 
Df(2R)Exel7095/ dLipine00680 feeding third instar larvae and five heterozygous larvae was 
collected. Triplicate samples were analyzed for each genotype (total n for each genotype: 15). 
0.5µl of hemolymph were mixed with 19 µl PBS, pH7.4. After centrifugation at 13,000 x g for 
10 min, 10µl of supernatant were added to 100 µl Assay Buffer (100mM PBS at pH 6.5). 0.05 
units/ml trehalase (Sigma #T8778) were added to samples and standards and the tubes incubated 
at 37°C overnight. 50 µl of samples and standards were then transferred to 500 µl Enzyme Mix 
and incubated for 10 min at 37°C. 150 µl of the reactions were pipetted to a cuvette and 
absorption measured at 514nm in a UV-spectrophotometer. A linear regression graph for 
standards was created and glucose concentrations in samples calculated.  
22. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
A BioRAD Mini-PROTEAN® System was used for SDS Gel electrophoresis. First, the 
components of the resolving gel were mixed in a flask and poured between the glass slides. The 
resolving gel consisted of Acrylamide-bis (30%-0.8%), Lower Buffer (3M Tris Base, 0.8% SDS, 
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pH 8.8 adjusted with concentrated HCl), 75% Sucrose, TEMED, 5% Ammoniumpersulfate and 
distilled H2O. The pipetting scheme for the resolving gel depended on the desired thickness of 
the gel.  
The gel was covered with layering Buffer (1:8 dilution of Lower Buffer) and left to 
polymerize. After completion of the polymerization process, the layering buffer was removed 
with Whatman filter paper, and the stacking gel added. The stacking gel was made up of the 
following components: Acrylamide-bis (30%-0.8%), Upper Buffer (0.5M Tris Base, 0.4% SDS, 
pH 6.8 adjusted with concentrated HCl), 75% Sucrose, TEMED, 5% Ammoniumpersulfate and 
distilled H2O. The comb was inserted quickly after addition of the resolving gel mix, and the gel 
left to polymerize. Upon completion of this polymerization process, the comb was removed and 
the gel inserted into the electrophoresis chamber. Gel Running Buffer (0.025 M Tris Base, 0.192 
M Glycine, 1% SDS) was poured into the tank. The samples and Protein Marker (Prestained 
Protein Marker, New England Biolabs # P7708S or PAGE RULER Prestained Plus, Thermo 
Scientific # 26619) were loaded. Prior to loading, samples were dissolved in Sample Buffer (4% 
SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromphenol blue, 0.125 M Tris HCl) and 
heat denatured for 5 minutes at 95°C.  After marker and samples were loaded, the gel was run at 
250V until clear separation of the marker bands was achieved (~30min). The BioRad 
PowerPac™ HC Power Supply served as the power source for the electrophoresis process. 
23. Western Blot Analysis 
Protein Transfer 
The Mini Trans-Blotcell from BioRad was used for Western-Blotting. After completion 
of gel electrophoresis, the gel was placed onto a PVDF membrane, which had been pre-wetted in 
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100% methanol for 5minutes. Whatman filter paper sheets and a layer of fiber pads held the gel 
and PVDF membrane together. It is important to prevent the formation of air bubbles between 
the gel and the PVDF membrane when setting up this sandwich. This can be achieved by running 
a pasteur pipette gently across the sandwich. The sandwich was placed into the buffer tank in a 
gel holder cassette and the buffer tank was filled with transfer buffer (25 mM Tris, 192 mM 
Glycine, 20% (v/v) methanol (pH 8.3)). After addition of a magnetic stirrer and the BioIce 
Cooling unit, the cables were connected with the electrodes of the power source (BioRad 
PowerPac™ HC Power Supply) and the proteins transferred onto the membrane at 100V for 
65minutes. After the protein transfer was completed the membrane was soaked in 5% powdered 
milk in TBST ( 50 mM Tris, 150mM NaCl, 0.05% Tween 20) for 1 hour. The membrane was 
then washed in TBST for a short time, and 5ml 5% powdered milk in TBST was added. The 
primary antibody was added to the TBST and the membrane incubated in the primary antibody at 
4°C with light shaking overnight. Alternatively, the primary antibody was diluted in 5% Bovine 
Serum Albumin in TBST. For dilution ratios of primary antibodies please refer to Table 3. Three 
washing steps in TBST followed this incubation period, with every washing step lasting 10 
minutes. 5ml TBST plus secondary antibody (dilution 1:2000, Table 3) was added to the 
membrane and the membrane incubated for at least 2 hours at room temperature. Excess 
antibody was washed away in TBS-T for 10 minutes. This washing step was repeated 3 times.  
Detection 
Proteins were detected in a colorimetric reaction using alkaline phosphatase conjugated 
to the secondary antibody. After antibody treatment the membrane was prepared for detection by 
soaking in TBS-MgCl2 (50mM Tris, 150mM NaCl, 5mM MgCl2) for 5minutes. During this 
incubation step the substrate solution was prepared (15ml TBS-MgCl2, 0.10ml NBT (50mg/ml), 
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0.05ml BCIP (50mg/ml); BCIP/NBT Color Development Substrate from Promega #S3771).	  A 
combination of NBT and BCIP was used, as combining the two substrates yields an intense, 
black-purple precipitate that provides much greater sensitivity than either substrate alone. The 
pretreated membrane was put into the substrate solution and developed until protein bands were 
visible. To stop the colorimetric reaction, the membrane was transferred into 10% acetic acid.  
24. Salivary gland chromosome staining 
Before the staining procedure, Buffer A was freshly prepared (10X: 150mM Tris-HCl pH 
7.4, 600mM KCl, 150mM NaCl, 5mM Spermidin, 1.5mM Spermin). Salivary glands of 
wandering third instar larvae were dissected in physiological solution A (0.7% NaCl in distilled 
H2O). These animals expressed hsGal4; dLipinWT6M. Wandering third instar larvae were 
subjected to an hour-long heat shock at 37°C. . Dissection of larval salivary glands was 
conducted immediately after heat shock, 2hs after heat shock and 24hs after heat shock. 
Dissected glands were placed into solution B for 25 sec. for fixation (for 1ml: 10% of 37% 
formaldehyde, 70% distilled H2O, 10% Triton X100, 10% Buffer A). After fixation, glands were 
quickly rinsed in solution C (for 1ml: 10% of 37% formaldehyde, 40% distilled H2O, 50% 
glacial acetic acid), and placed on a cover slip containing a drop of solution C for 3-4 minutes. 
The coverslip with salivary glands was picked up with a microscopic slide and pressure was 
applied by pressing down with a finger or the handle of the forceps. The slide was then turned 
around and the coverslip/slide sandwich pressed tightly between two sheets of blotting paper. 
The slide was flash frozen in liquid N2 and the coverslip removed with a razorblade. The area of 
the chromosome squash was labeled with a pencil and the slide immersed into 100% ethanol for 
at least 10 min. Slides were then washed in KP-Buffer (10X: 1.4M NaCl, 0.1M 
Potassiumphosphate ph 7.4) twice for 10 min. Any residual KP-Buffer was removed by shaking 
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the slide quickly and 20µl primary antibody solution added (dLipin: 1:200 to 1:2000). Slides 
were incubated in moist chamber overnight at 4°C. The primary antibody and the cover slip were 
removed by two washes in KP-Buffer, with each wash lasting 10 min. 40µl of secondary 
antibody solution (Rhodamine conjugated anti-rabbit 1: 1000) was pipetted onto a coverslip and 
the coverslip placed upon the slide. Incubation in the secondary antibody solution lasted for 2 hrs 
at room temperature. The cover slip was removed by swirling it through KP-Buffer, and the slide 
washed twice in KP-Buffer for 10 min. The slides were mounted in Slowfade Gold antifade 
reagent with DAPI (Invitrogen # P36931), and images taken with a Carl Zeiss AxioVision 
microscope. 
25. Fat body chromosome staining 
Fat body tissue of third instar larvae was dissected in physiological solution (0.7% NaCl 
in distilled H2O), and the fat body tissue transferred to 6µl fixative solution (40% acetic acid. 
30% lactic acid, 30% distilled H2O) that had been pipetted onto a coverslip. After 3-5 minutes a 
slide was lowered onto the coverslip and pressure was applied by pressing down with a finger. 
The slide was then turned around and the coverslip/slide sandwich pressed tightly between two 
sheets of blotting paper. The slide was then immersed into liquid N2 and the coverslip removed 
with a razorblade. The slide was immediately transferred into PBS at room temperature. This 
was followed by an immersion into PBST (PBS plus 1% Triton X-100) for 20minutes at room 
temperature. For blocking, slides were immersed into blocking solution (PBS plus 1% non fat 
dry milk) and left there for a 30 minute incubation period. Slides were then treated with the 
primary antibody (dLipin: 1:200 to: 2000), diluted in PBS, 1% BSA for 60 minutes at RT or 
overnight at 4°C in humid chamber. Excess antibody was removed by washing 3 consecutive 
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times in PBS, 0.5% nonfat dry milk for 5 minutes. The secondary antibody (Rhodamine 
conjugated anti-rabbit 1: 1000) was added diluted in PBS, 1% BSA and the slides incubated for 
60 min at room temperature. Excess antibody was washed away in 3 washing steps, each lasting 
5 min, in PBS at 4°C. Slides were mounted in Slowfade Gold antifade reagent with DAPI 
(Invitrogen # P36931), and images taken with a Carl Zeiss AxioVision microscope. 
26. Quantitative RT-PCR 
To measure transcript levels of dp110 following dLipin knockdown, quantitative RT-
PCR was utilized. Fat body tissue from 100 w1118 larvae and 140 dLipinRNAi/FBcg larvae 
(feeding stage) was collected and RNA extracted using TRIzol Reagent (Invitrogen #15596-
018). The extracted RNA was then treated with DNaseI (New England Biolabs #M0303S) to 
remove traces of genomic DNA and further purified using Direct-zol RNA MiniPrep (Zymo 
Research #R2050S). To determine changes in expression levels of dp110 following dLipin 
knockdown dp110 transcripts were amplified using specific primers (Fruit Fly PI3k92E). rp49 
(ribosomal protein 49) a housekeeping gene ubiquitously expressed in D. melanogaster was 
selected as the normalizer gene or endogenous control. rp49 was amplified using the rp49fwd 
and rp49rev primerset (Table 4). HotStart-IT SYBR Green One-Step qRT-PCR Master Mix Kit 
(Affymetrix # 75770) was used for qPCR reactions. To determine the reaction efficiencies of 
dp110 and rp49, a standard curve was generated for each gene by plotting the log of known 
template concentrations against the Ct (threshold cycle) values for those concentrations. Relative 
dp110 expression levels were quantified using the standard curve method (REAL-TIME PCR 
from Theory to Practice, Invitrogen).  
Fold difference: (EDp110)ΔCtDp110/(Erp49)ΔCtrp49 
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E= efficiency from standard curve E=10(-1/slope) 
ΔCtdp110= Ctdp110w1118 – Ctdp110dLipinRNAi 
ΔCtrp49= Ctrp49w1118 – Ctrp49dLipinRNAi 
RNA samples were analyzed in triplicates.  
27. PIP2 and PIP3 visualization 
Phosphatidylinositol 4,5-bisphosphate (PIP2) and Phosphatidylinositol (3,4,5)-
triphosphate (PIP3) can be visualized taking advantage of the fact that specific Pleckstrin homoly 
domains (PH domain) show a specific binding affinity for either of these phospholipids. To 
visualize PIP3, the PIP3 specific PH domain of general receptor for phosphoinositides-1 (GRP1) 
was fused to green fluorescent protein (GFP), which generates a fusion protein called GPH. 
Expression of the GPH construct was under control of the Tubulin promoter, hence the whole 
construct is called tGPH (Britton et al., 2002).  
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Figure 2. tGPH, a PH-GFP Fusion Protein Used as an Indicator of PI3K Activity
(A) Amino acid sequence alignment of the PH domains of Drosophila GRP1 (tGPH) and mouse GRP1 (mGRP1). Amino acids generally conserved
in PH domains are indicated by asterisks above the protein sequence. Two conserved amino acids that vary in the Drosophila gene are
indicated by filled circles.
(B) Schematic representation of the tGPH fusion protein.
(C) GPH localization in S2 cells transiently transfected with the pMT-GPH gene. Left: cells starved for serum for 2 hr. Center: serum-starved
cells treated with 200 nM insulin for 5 min. Right: serum-starved cells treated with insulin for 10 min followed by the PI3K inhibitor wortmannin
at 100 nM.
3I). Similar effects were observed in other larval tissues but it was also present in the cytoplasm and nucleus.
When these cells were cultured for 4 hr without serum(data not shown). Despite their reduced growth, p60-,
and thus deprived of insulin, membrane localization of!p60-, and PTEN-expressing cells were found at ap-
GPH was reduced. Under these conditions, GPH wasproximately the same frequencies as control GFP-
largely cytoplasmic and nuclear (Figure 2C, left). Whenmarked cells. Apoptotic cells were not observed. Thus,
serum-starved cells were treated with 200 nM insulin,reductions in PI3K activity were not incompatible with
GPH was recruited to the membrane within 2 min (Figurecell viability. Overt effects on cell morphology that might
2C, middle). To verify that membrane recruitment in re-reflect changes in cell adhesion, motility, or identity were
sponse to insulin reflected PI3K activity, insulin-stimu-also not observed. We conclude that reducing Inr/PI3K
lated cells were subsequently treated with 100 nM wort-activity in the differentiated tissues of the larva has cell-
mannin, a specific inhibitor of PI3K activity. This causedautonomous effects that are limited to reducing cell
membrane localization of GPH to rapidly be lost, produc-growth and DNA replication.
ing cells that resembled those starved for serum (Figure
2C, right).
PI3K Activity Is Nutritionally Regulated For in vivo studies, the GPH gene was placed under
These observations and data from the literature (see control of the Drosophila "-tubulin promotor, generating
Stocker and Hafen, 2000) suggested that PI3K activity a gene called “tGPH” (tubulin-GPH; Figure 2B), and in-
might be responsive to nutritional conditions. To directly troduced into Drosophila by P element-mediated trans-
test this possibility, we made a fusion protein for use formation. Flies transgenic for the ubiquitously ex-
as an in vivo reporter for PI3K activity. The pleckstrin pressed tGPH gene were viable and had no obvious
homology (PH) domain of the Drosophila homolog of growth delay. Membrane localization of tGPH was ob-
general receptor for phosphoinositides-1 (GRP1) was served in the larval epidermis, fat body, salivary glands,
fused to green fluorescent protein (GFP), generating a malpighian tubules, and wing imaginal discs (Figure 3
protein called GPH (GFP-PH domain; Figures 2A and and data not shown). Cytoplasmic and nuclear tGPH
2B). PH domains from mammalian GRP1 genes bind was also visible in these cell types. Plasma membrane
specifically to phosphatidylinositol-3,4,5-P3 (PIP3), the localization was not distinct in other larval tissues such
second messenger generated by class I PI3-kinases as the body wall muscles. The degree of membrane
(Gray et al., 1999; Lietzke et al., 2000). Since PIP3 gener- localization depended upon the developmental stage.
ally resides in lipid membranes, particularly the plasma Epidermal cells showed little membrane localization of
membrane, GRP1 is recruited to membranes when PI3- tGPH in embryos or newly hatched first instar (L1) larvae,
kinase activity raises cellular levels of PIP3. Fusion pro- but had strong membrane localization in second (L2)
teins containing the GRP1 PH domain are likewise re- and early third (L3) instar larvae (Figures 3A and 3B).
cruited to plasma membranes by binding PIP3, and thus Later, in wandering stage L3 larvae, membrane-associ-
serve as in situ reporters for PI3K activity (Gray et al., ated tGPH was again diminished. Similar trends were
1999; Oatey et al., 1999). observed in the fat body. These variations might reflect
Tests for specificity were performed in cultured Dro- changes in the levels of Inr, PI3K, PTEN, or insulin-like
sophila S2 cells transfected with a metallothionein- peptides (dILPs) in the larva as it feeds and grows.
inducible construct, pMT-GPH. In serum-stimulated S2 To test whether tGPH localization was responsive to
PI3K activity in vivo, we overexpressed Inr or Dp110cells, some GPH was localized to the cell membrane,
 
Fig. 8: Schematic representation of the tGPH construct. Image modified from Britton et al., 
2002.  
 
As the GPH protein exhibits a specific affinity for binding to PIP3, PIP3 present in the 
cell will be labeled green upon GPH binding. PIP2 was tracked by a PIP2 specific PH reporter. 
To this end the PIP2-specific PH domain of phospholipase Cδ	  (PCLδ)	  was fused to a GFP 
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reporter to generate the fusion protein PLCδPH-GFP (Gervais et al., 2008). Expression of the 
PLCδPH-GFP construct was under control of a Tubulin promoter. PLCδPH-GFP binds 
specifically to PIP2, thus PIP2 presence in the cell will be represented by green fluorescence.  
As PIP2 and PIP3 are both generated at the plasma membrane, presence of these 
phospholipids will be reflected in GFP signaling that concentrates at the plasma membrane. Fat 
body tissue from third instar feeding larvae was dissected in PBS and the tissue fixed for 10 
minutes in 4% formaldehyde. After fixation, tissue and cell staining was documented using a 
Carl Zeiss AxioVision microscope. 
28. dLipin localization following alterations of TOR/Insulin signaling 
dLipin localization was analyzed after knockdown of TOR signaling in third instar 
wandering larvae. Genotypes investigated were the following: FB(cg); TORRNAi and FB(cg); 
raptorRNAi. Additionally, insulin pathway activity was reduced and any effects on dLipin 
localization documented. The observed genotypes analyzed were: FB(cg); InRdom.neg. and FB(cg) 
/ PI3K21BHA. Fat body tissue from larvae of these genotypes was stained with dLipin antibody 
and samples mounted in Slowfade Gold antifade reagent with DAPI (Invitrogen # P36931). To 
determine any change in dLipin localization, images were taken with a Carl Zeiss AxioVision 
microscope. 
29. Cell measurements 
Cell area was measured using the AxioVision software (available on Carl Zeiss 
AxioVision microscope) or ImageJ software (http://rsb.info.nih.gov/ij/download.html). To 
determine the cell size of cells that did not show clear cell boundaries, the distance between 
neighboring nuclei was measured. In cells where the nucleocytoplasmic ratio was analyzed, 
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nuclear area was measured in addition to cell area, and the ratio between the two calculated. Data 
was analyzed statistically using unpaired two-tailed Student’s t-Test. 
30. Embryo collection and timing of larvae for dLipin/raptor genetic interaction studies 
To ensure that larval development was as homogenous as possible, parental adult flies 
were allowed to lay eggs on molasses plates for a period of 4 hours only. To prohibit the 
deposition of retained eggs, flies were put on food for two hours beforehand so they could lay 
any retained egg. The eggs laid within the 4 hour time period were transferred with a wet brush 
onto standard fly food, and kept at 25°C. Larvae were allowed to develop for 5 or more days 
before larval size and fat body development was compared. Larval and fat body tissue 
morphology was examined using a Carl Zeiss Stereomicroscope and a Carl Zeiss AxioVision 
microscope, respectively.  
31. Ecdysone rescue experiments 
Standard fly food containing 120µg/ml 20-Hydroxyecdysone (20 HE) was prepared. 20 
HE was diluted in 100% ethanol and added to the food after it had cooled down to approximately 
50°C. Ethanol was also added to the food of control flies, to ensure that there were no differences 
between the 20 HE food and the normal food, except for the addition of 20 HE. Adult flies were 
kept on food at 25°C and transferred daily onto new food. Number of pupae formed and 
developmental timing of control and experimental offspring was compared and data were 
analyzed with the Chi-Square test. The following cross was set up: 
Parental cross: TubGal4/Tb  X  ΔNLSdLipin/ΔNLSdLipin either on food with or without 20-HE 
! TubGal4; ΔNLSdLipin: Experimental animals 50% genotype frequency expected. 
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III. Results 
A. Linking dLipin and insulin pathway activity in D. melanogaster 
 Studies with mice and humans have established a strong connection between the 
mammalian homologs of dLipin and insulin signaling. Mice with the fld (fatty liver dystrophy) 
mutation display reduced glucose tolerance and decreased sensitivity to insulin stimulation (Reue 
et al., 2000). The fld mutation was subsequently identified as a mutation within the lipin1 gene 
(Peterfy et al., 2001). Similar findings were described for human adipose tissue, where low lipin1 
transcript levels correlate with increased insulin resistance (Suviolahti et al., 2006). Furthermore, 
insulin signaling influences subcellular localization and phosphorylation of Lipin1 in human 
adipocyte cell lines (Harris et al., 2007). All these results were collected in either mice or 
humans, both of which possess multiple lipin paralogs in their genomes, a fact that complicates 
research in these organisms due to redundancy among the different lipin paralogs. Drosophila 
melanogaster on the other hand has one lipin gene (dLipin) (Peterfy et al., 2001) making this 
model organism a prime candidate to examine effects of Lipin on insulin signaling.  
1. dLipin is necessary for cell growth 
 The fat body has emerged as the main tissue of dLipin activity in Drosophila (Ugrankar 
et al., 2011). Diacylglycerol (DAG) produced by dLipin is the immediate precursor for 
triacylglycerol (TAG) synthesis. The larval fat body functions as the storage organ for TAG and 
is the major metabolic organ of the developing larvae. As TAG synthesis is dependent on proper 
dLipin function, any effect of dLipin loss should be especially prominent within the tissue of 
TAG production. It is for this reason, that I concentrated my work on the fat body.  
 
	   72 
1.1. Cell-autonomous loss of dLipin activity in the fat body affects cell growth and fat content 
One telltale sign of disrupted insulin signaling is a reduction in cell growth (Lehner, 
1999; Johnston and Gallant, 2002). To test whether dLipin deficiency leads to a cell size defect, 
mosaic animals were generated. These mosaic animals had single cells within the fat body that 
exhibited diminished dLipin levels. By knocking down dLipin in single cells only, it is possible 
to observe the cell-autonomous effects of dLipin loss. Knockdown of dLipin activity was 
achieved by downregulation of dLipin mRNA via RNAi in single cells. A TubulinGal4 driver 
was used to express a RNAi transgene in single cells, which resulted in a cell specific reduction 
of dLipin mRNA and, consequently, dLipin protein. 
 
Fig. 9: dLipin is required cell-autonomously in the fat body for normal fat droplet 
formation and cell growth.  Fat body cells in mosaic animals that were deficient in dLipin 
protein contained few fat droplets and were reduced in size. Fat droplets were stained with 
LipidTOX Deep Red (LT) and dLipin protein was detected using an affinity-purified dLipin 
antibody (dLipin). Note that although strongly reduced in some knockdown cells, residual dLipin 
can still be detected in the cell nucleus. Depicted are cells of feeding third instar larvae. Scale 
bar: 100µm. 
 
A reduction of dLipin affected cell size in a cell-autonomous fashion (Fig. 9). Cells with 
successful dLipin knockdown are outlined. Antibody staining indicated that dLipin protein was 
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strongly reduced in these cells. The dLipin deficient cells were not only reduced in size, but also 
exhibited reduced fat content. Thus, not only cell size, but also fat synthesis is controlled by 
dLipin cell-autonomously. 
1.2. Ubiquitous knockdown of dLipin results in cell size variability 
Ugrankar et al. (2011) described a dLipin mutant phenotype that was characterized by a 
wide variability of cell sizes in the fat body, including many hypertrophic cells. It was 
hypothesized that this phenotype constituted a secondary compensatory effect caused by the 
reduced total fat mass in these animals. I reproduced these data by knocking down dLipin 
ubiquitously in third instar larvae using a strong TubulinGal4 driver and a dLipinRNAi construct. 
Cells size following dLipin knockdown was highly variable, a phenotype mirroring the dLipin 
mutant phenotype (Fig. 10).  
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Fig. 10: Systemic knockdown of dLipin results in cell size heterogeneity and cells with 
reduced fat content. TubulinGal4>dLipinRNAi fat body cells displayed a change in cell 
morphology, cell size and fat content. Cells were rounded, of very variable size and often 
contained smaller fat droplets, or lacked fat droplets. This phenotype closely resembled the 
dLipin mutant phenotype (Ugrankar et al., 2011). Fat droplets were stained with Bodipy (green) 
and cell membranes with with CellMask Plasma stain (orange). Some very small cells, visualized 
by plasma membrane staining, lacked fat droplets (arrow). Fat body cells from wild-type dLipin 
control flies (w1118) were polygonal with normal fat content and fat droplets of normal size. 
Depicted are fat body cells of feeding third instar larvae. Scale bar: 100µm. 
 
Data concerning cell growth collected by mosaic analysis and ubiquitous dLipin 
knockdown differed drastically. Cell-autonomous dLipin knockdown resulted in a cell growth 
deficit, whereas systemic dLipin knockdown resulted in extreme cell size variability. This 
discrepancy in cell growth defects emphasizes the importance of investigating not only system 
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1.3. Comparison of cell-autonomous and ubiquitous dLipin knockdown 
To further analyze the cell growth defects observed after dLipin knockdown, I measured 
the cell and nuclear area of fat body cells (Fig. 11). Whereas a strong statistical difference 
between the size of control cells and cells with cell-autonomous expression of dLipinRNAi was 
observed, no statistically significant difference was found between cell size of control cells and 
cells after systemic dLipinRNAi expression. However, the standard deviation value for the 
system-wide knockdown was extremely high, reflecting the extreme variability in cell size. 
Conducting the F-test to compare the variance in fat body cell size from control animals to the 
variance in fat body cell size from animals with systemic dLipin knockdown revealed a 
significant difference between the variances of the two samples (p< 0.0001). Thus, systemic 
knockdown of dLipin causes significant cell size variability, which indicates that cell growth was 
altered upon systemic dLipin knockdown. Cell-autonomous loss of dLipin activity resulted in a 
reduction of nuclear area. This points to a decrease in the number of endoreplication cycles, 
which would suggest that cell-autonomous dLipin knockdown induces an overall growth 
phenotype that affects cytoplasmic cell growth as well as genome replication. Following 
systemic dLipin knockdown, nuclear area is not reduced, but increased. Hence, genome 
replication does not seem to be negatively affected by systemic dLipin knockdown. Looking at 
the nucleocytoplasmic ratio, I further characterized the nature of growth defects observed after 
dLipin knockdown (Fig. 12). 
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 Fig. 11: Knockdown of dLipin affected cell and nuclear area. A) Systemic knockdown of 
dLipin (TubGal4>dLipinRNAi) led to extreme variability of cell size, hence the big standard 
deviation. In contrast, cell autonomous loss of dLipin resulted in cell size reduction. Cell area in 
fat bodies was measured from feeding third instar larvae. As a control, cells from mosaic animals 
without dLipinRNAi expression were measured. Cell area was measured using the Axioware 
software package. Unpaired t –Test, ∗∗∗ p < 0.0001. B) The mosaic dLipin deficient fat body 
cells displayed a reduction in nuclear area, which indicates that endoreplication was negatively 
affected in these cells. After systemic knockdown of dLipin, fat body cells displayed larger 
nuclei when compared to control cells. Nuclei of feeding third instar larvae were measured. 
Nuclear area was determined using the Axioware software package. Unpaired t-Test, *** p < 
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Fig. 12: Cytoplasmic growth was negatively affected in cells following knockdown of 
dLipin. The nucleocytoplasmic ratio was elevated in cells with, either cell-autonomous or 
systemic dLipin knockdown, indicating that cytoplasmic growth was affected, and affected to a 
stronger extent than endoreplicative growth. Fat body cells of feeding third instar larvae were 
measured. Unpaired t-Test, *** p < 0.0001. Error bars indicate SD. 
 
 Both cell-autonomous loss of dLipin activity as well as systemic reduction of dLipin 
activity resulted in an increase in the nucleocytoplasmic ratio (Fig. 12). This implicates that 
overall cytoplasmic cell growth was more severely affected by reduced dLipin expression than 
genome replication. This effect was even more pronounced in fat body cells from animals with 
systemic dLipin knockdown.  
These data support the conclusion that dLipin is required for proper cell growth, as both 
cell-autonomous as well as systemic dLipin knockdown lead to cell size defects. Cell-
autonomous dLipin loss caused a decrease in overall cell growth indicating that dLipin activity is 
required in single cells for proper cell growth. It appears that systemic dLipin knockdown elicits 
a secondary compensatory mechanism that compensates the reduced fat body mass after dLipin 
 *** 
 *** 
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knockdown by cell overgrowth. A very similar phenotype was observed in transheterozygous 
dLipin mutants (Ugrankar et al., 2011).  
Having established a connection between dLipin and cell growth, it was of interest to see 
whether insulin signaling was affected by dLipin activity.  
2. dLipin activity is necessary to ensure proper insulin signaling pathway activity in the fat body 
Figure 5 illustrates all the important steps involved in the signal transduction cascade of 
the canonical insulin pathway. One critical step is the synthesis of PIP3 from PIP2, which is 
catalyzed by PI3K at the plasma membrane. PIP3 recruits the pleckstrin homology domain (PH) 
of AKT and PDK1 to the plasma membrane, thus allowing PDK1 to phosphorylate AKT. AKT 
is then further phosphorylated by TORC2 and thereby gains full activation. Activated AKT 
dissociates from the cell membrane and targets downstream effectors of the pathway. Thus, one 
way to measure activity of the insulin pathway in the cell is by examining PIP3 levels at the cell 
membrane.  
2.1. PIP3 synthesis is dependent on dLipin 
The laboratory of Bruce Edgar generated a transgene that encodes a pleckstrin homology 
domain-green fluorescent protein fusion, PH-GFP (tGPH), which serves as an indicator for PIP3 
synthesis (Britton et al., 2002). The PH domain of the fusion protein is recruited to the plasma 
membrane upon PIP3 synthesis. Green fluorescence from the PH-GFP fusion protein thus 
reflects PIP3 levels and spatial distribution in the cell. I compared PIP3 levels/localization in fat 
body cells from animals with fat body-specific dLipin knockdown and control animals (Fig. 
13A). It was also important to determine whether knockdown of dLipin in the fat body alone 
would be enough to alter insulin pathway activity in other tissues, or whether the effect would be 
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restricted to the fat body. Thus, I looked at PIP3 localization in the salivary glands of animals 
with fat body-specific dLipin knockdown (Fig. 13B). Additionally I wanted to ensure that 
potential differences in PIP3 levels/localization were not due to decreased availability of its 
precursor PIP2. To this end, I used a transgene that encodes a PIP2 specific PH-GFP fusion 
protein (ubi-PLC) (Gervais et al., 2008). This would, as in the case for PIP3, give me 































Fig. 13: The second messenger PIP3, but not PIP2, was reduced at the cell membranes of 
fat body cells that lack dLipin. (A) dLipin was knocked down in the fat body of animals 
expressing the PIP3 reporter tGPH (green), and feeding third instar larvae were dissected 
(FBGal4> dLipinRNAi). Membrane association of PH-GFP was strongly reduced in fat body 
lacking dLipin, but not in fat body of control animals (FBGal4; tGPH). (B) In tissues not 
targeted for dLipin knockdown (salivary glands), PIP3 showed normal association with the cell 
membrane. (C) Fat body cells of animals that express the PIP2 reporter ubi-PLC showed no 
change in the association of PH-GFP with the cell membrane (green) compared to control 
animals (FBGal4; ubiPLC).  Nuclei stained with DAPI. Scale bar: 100µm. 
 
dLipin knockdown in the fat body had a clear negative effect on insulin pathway activity, 
as demonstrated by the complete lack of PIP3 at the cell membrane (Fig. 13A). In control cells, 
strong PIP3-GFP signals coincided with the cell membrane. This pattern was lost following 
PIP3-specific PH-GFP PIP3-specific PH-GFP 
PIP2-specific PH-GFP PIP2-specific PH-GFP 
PIP3-specific PH-GFP PIP3-specific PH-GFP 
	  A) control FBGal4> dLipinRNAi 
B) 
C) 
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dLipin knockdown. All PIP3 seemed to be lost from the cell membrane, which suggests a severe 
disruption of the insulin pathway. There was no observable effect on PIP3 localization in tissues 
outside of the fat body, as salivary gland cells exhibited unchanged membrane association of 
PIP3. Therefore, the consequences of dLipin knockdown in the fat body seemed to be tissue 
limited. The level and membrane association of PIP2 did not appear to be negatively affected in 
the fat body indicating that it was indeed the conversion of PIP2 into PIP3 that was disturbed.  












Fig. 14: PIP3 association with the cell membrane was lost in dLipin mutants 
(dLipine00680/Df(3R)Exel7095). A) PIP3 was no longer localized at the cell membrane in dLipin 
mutants, which confirmed the results obtained by the dLipinRNAi experiment. B) PIP2 appeared 
to be located at the cell membrane, indicating no change in PIP2 availability in these cells. PH-
GFP: green, nuclei stained with DAPI. Scale bar: 100µm. 
 
I confirmed the earlier results with this second set of experiments. Membrane association 
of PIP3 was no longer detectable, whereas PIP2 localization remained unchanged.  
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The results from the PIP3/PIP2 visualization experiments clearly indicate that pathway 
activity is disrupted after loss of dLipin, pointing to dLipin as a contributor to insulin pathway 
activity in the fat body.  
2.2. dLipin knockdown in the fat body does not result in cell growth defects 
As mentioned earlier, diminished insulin signaling pathway activity often results in a 
reduction of cell size. Cell size should therefore be negatively affected in the fat body cells after 
fat body-specific dLipin knockdown (FBGal4>dLipinRNAi) as these cells clearly showed a loss 
of PIP3 membrane association (Fig. 13).  
	    
Fig. 15: Knockdown of dLipin via RNAi in the fat body did not result in a growth defect. 
Cellular area of fat body cells after dLipin knockdown (green: FBGal4>dLipinRNAi) was 
measured and compared to control fat body cell area (red: fat body of animals carrying only the 
Gal4 transgene; blue: fat body of animals carrying only the dLipinRNAi transgene). No 
significant difference in cell area was detected for either genotype. Fat body cells were from 
wandering third instar larvae. Error bars indicate SD. 
 
The measurement of cell area showed no significant difference in cell size between the 
fat body cells following fat body-specific dLipin knockdown (FBGal4>dLipinRNAi) and control 
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cells. This was a surprising result considering the fact that PIP3 membrane association was lost 
in these cells and therefore insulin pathway activity should have been strongly decreased.  
In addition, development and size of larvae and pupae did not seem to be affected by fat 
body-specific knockdown of dLipin.  
To further elucidate the relationship between dLipin and the insulin signaling cascade I 
concentrated on genetic interaction experiments among members of the canonical insulin 
signaling cascade and dLipin. 
3. dLipin genetically interacts with the insulin signaling pathway 
To screen for potential interactions between dLipin and members of the insulin signaling cascade 
I set up numerous crosses. 
3.1. dLipin and insulin receptor act in concert in fat body development and cell growth 
To assess possible genetic interactions between dLipin and genes of the insulin pathway, 
I examined animals expressing dLipinRNAi and a dominant negative form of the insulin receptor 
(InRDN). The single knockdown of dLipin resulted in fat body cells with small fat droplets, and 
InRDN expression led to fat body cells of smaller size, but seemingly normal fat content. 
Combining both transgenes in the fat body changed the morphology of the cells dramatically, 
and reduced fat body mass. Fat body cells displayed a rounded morphology, with an increase in 
cell size. This phenotype strongly resembled the dLipin mutant phenotype described in Ugrankar 
et al. 2011, as well as the phenotype after TubulinGal4>dLipinRNAi systemic knockdown (Fig. 
10).  
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To visualize fat body mass in experimental and control larvae, I used the fat body marker 
Dcg-GFP (Suh et al., 2007). Fat body tissue of animals carrying this marker exhibits green 
fluorescence when irradiated with light of the appropriate wavelength. To characterize the cell 
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Fig. 16: dLipin and insulin signaling act in concert in fat body development and cell 
growth. (A) Feeding third instar larvae expressing a dLipinRNAi transgene and a transgene 
encoding a dominant negative form of the insulin receptor (InRDN) exhibited a severe fat body 
defect with increased cell size variability and small fat droplets; a phenotype that strongly 
resembles the dLipin mutant phenotype. Fat droplets were visualized by Bodipy staining (green) 
and nuclei with DAPI (blue). Scale bar: 100µm (B) Larvae carrying both transgenes had less fat 
body mass compared to larvae expressing either one of the transgenes.  Fat body tissue was 
labelled with Dcg-GFP (green). C) Area of fat body cells was reduced in animals expressing 
InRDN. Cells of wandering third instar larvae were measured and compared to cells of control 
animals (red: animals carrying only the Gal4 transgene; blue: animals only carrying the InRDN 
transgene). Unpaired t-Test, *** p < 0.0001. Error bars indicate SD. 
 
I tried to rescue the defects in fat body development observed in animals with fat body 
specific dLipin deficiency and InRDN expression by knocking down Dullard activity (FBGal4> 
dLipinRNAi; DullardRNAi/InRDN). Dullard is a phosphatase that targets an insulin-sensitive 
phosphorylation site within Lipin1 (Wu et al., 2011). If Dullard has the same function in 
Drosophila, reducing Dullard in the cell would increase insulin pathway input on dLipin and 
thus, possibly counteract the effect of InRDN expression on dLipin. However, RNAi knockdown 
*** 
	   86 
of Dullard in concert with dLipin knockdown and InRDN expression did not rescue phenotypes 
and did not have an obvious phenotypic affect when carried out alone (data not shown). 
Through genetic interaction experiments I was able to further weave dLipin within the 
fabric of the insulin network. It became clear that both dLipin as well as the insulin receptor are 
required for normal fat body development, and that loss of dLipin in a InRDN genetic 
background led to a cell overgrowth phenotype resembling the transheterozygous dLipin mutant 
phenotype (Ugrankar et al., 2011). This suggests that dLipin activity during adipogenesis and in 
fat synthesis is dependent on the insulin pathway. 	  
3.1.1. Reduced dLipin activity with simultaneous InRDN expression does not cause an 
organismal growth defect  
To further address the possibility of an interaction between dLipin and InRDN in cell 
growth control, I tested animals with weak ubiquitous expression of both transgenes for effects 
on organismal growth (daGal4>dLipinRNAi; InRDN). I was not able to detect any organismal 
growth defect in these animals when compared to control animals. To score for growth defects, I 
measured the size of pupae (data not shown). 
3.1.2. Viability is reduced after dLipin knockdown with concomitant InRDN knockdown 
While studying the effects of InRDN expression and dLipin knockdown on fat body 
development and morphology, I noticed that the viability of animals carrying both transgenes 
appeared to be reduced. To document this phenotype I counted pupae formed for lines carrying 
either or both transgene/s and compared them to a control fly line. All four genotypes compared 
emerged from one single cross. Thus, I could compare the number of pupae formed by animals 
with experimental genotypes (FBGal4>dLipinRNAi; FBGal4>InRDN; 
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FBGal4>dLipinRNAi;InRDN) to the number of pupae formed by animals with control genotype 
(FBGal4). I set the number of pupae formed by animals with control genotype to 100%. I 
compared each experimental genotype with the control phenotype using a Chi-Square test, as the 
expected frequency for each genotype was known. A very significant rise in larval lethality after 
knockdown of dLipin in an InRDN background was detected, whereas neither the control line nor 
single transgene carrying lines displayed any difference in pupation capacity (Fig. 17). This 
increased larval lethality was reflected by a decrease in the number of pupae formed, as most 
animals perished during larval development.   
  
Fig. 17: Viability is decreased following InRDN expression with simultaneous dLipin 
knockdown. dLipinRNAi was expressed concomitant with InRDN (dominant negative form of 
InR). Animals carrying both transgenes exhibited a decrease of viability, with very few 
individuals reaching the pupal stage. Two tailed Chi-Square Test, *** P< 0.0001. No statistically 
significant difference was found between either the single transgenes or between the single 
transgenes and the control (only FBGal4 driver). Animals carrying the driver transgene only 
were used as the control animals. 
 
At this point, I had firmly established that a change in dLipin activity elicits changes in 
insulin pathway activity, as PIP3 synthesis was reduced. It also became apparent that dLipin and 
*** 
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the insulin pathway interact in fat body development. The defect in fat body development 
appeared to be caused by a further decrease of dLipin activity upon InRDN expression, which 
indicates that dLipin activity is dependent on input from the insulin pathway.  
3.2. Interaction studies between dLipin and genes of the insulin pathway  
In addition to the genetic interaction between dLipin and InR, I investigated possible 
interactions between dLipin and numerous other genes of the insulin pathway 
All these interaction studies failed to show phenotypes or caused lethality but should be 
mentioned here for the sake of completeness.  
dLipinRNAi/InRconst.active;FB(r4): Overexpression of a constitutively active form of Insulin 
Receptor in the fat body with concomitant dLipin knockdown. No interaction detected, as 
overexpression of InRconst.active alone did not lead to an insulin overactivation phenotype in the fat 
body.  
dLipinRNAi/InRcont.active; DJ761: Ubiquitous expression of a constitutively active form of Insulin 
Receptor in concert with dLipin knockdown.  No interaction detected, as overexpression of 
InRconst.active did not lead to an insulin overactivation phenotype in the fat body. 
dLipinRNAi/PI3K21BHA; FB(r4): Simultaneous knockdown of dLipin and PI3K21B activity in 
the fat body. Neither flies of genotype dLipinRNAi; FB(r4) nor flies of genotype PI3K21BHA; 
FB(r4) could be established due to lethality.  
dLipinRNAi/PI3K21BHA; DJ761: Ubiquitous simultaneous knockdown of dLipin and PI3K21B 
activity. Neither flies of genotype dLipinRNAi; DJ761 nor flies of genotype PI3K21BHA; DJ761 
could be established due to lethality.  
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PI3K21BHA; LipinWT6M/FB(r4): Overexpression of dLipin in fat body tissue with loss of 
PI3K21B activity. No rescue of the loss-of-function phenotype observed in PI3K21BHA by 
overexpression of dLipin. 
dLipinRNAi/FB(cg); PI3K92Edom.neg.: Simultaneous dLipin knockdown and loss of PI3K92E  
activity. No interaction detected, as PI3K92Edom.neg. animals not display an insulin signaling 
knockdown phenotype.  
dLipine00680/ dLipine00680; AKTmyr/ FB(r4): Expression of constitutively active AKT in dLipin 
hypomorphic mutant. No interaction detected, as AKTmyr animals did not display an insulin 
signaling overactivation phenotype. 
dLipine00680/Df(3R)Exel7095; AKTmyrlacZ/FB(r4): Overexpression of AKT in dLipin 
transheterozygous mutant. No interaction detected, as AKTmyrlacZ did not display an insulin 
signaling overactivation phenotype. 
To confirm that insulin pathway activity was indeed interrupted downstream of PIP3 
synthesis, I examined AKT activity in fat body tissue upon dLipin knockdown. 
4. dLipin knockdown reduces insulin pathway activity downstream of InR and PIP3  
PIP3 at the cell membrane serves as an anchor for AKT. AKT migrates to the membrane 
and is activated by phosphorylation of 2 amino acid residues. One phosphorylation is carried out 
by PDK1 and the other by TORC2 at serine505 (S505).  The AKT phosphorylation at S505 
corresponds to AKT serine473 (S473) phosphorylation in mammals. Mammalian AKT S473 
phosphorylation is required for full activation of AKT (Hemmings and Restuccia, 2012).  
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To address possible changes in AKT activity upon reduced dLipin activity I examined 
S505 phosphorylation levels of AKT. dLipin deficiency resulted in a reduction of PIP3 synthesis, 
which suggests that the insulin pathway is interrupted. To test this, western blot analysis was 
carried out with antibodies against panAKT and S473 phosphoAKT and fat body samples from 
third instar larvae with fat body-specific dLipin knockdown (FBGal4>dLipinRNAi) (Fig. 18A). 
The S473 phosphoAKT antibody is known to react with Drosophila S505 phosphoAKT. By 
measuring levels of overall AKT (panAKT) as well as phosphoAKT levels, it is possible to 
deduce whether not only AKT phosphorylation but also general AKT levels are modified within 
the cell. To verify the results collected with tissue from animals expressing dLipinRNAi, I 
repeated the western blot with fat body tissue from dLipin mutants (dLipine00680/Df(3R)Exel7095) 
(Fig. 18B).  
 
 















































Fig. 18: Insulin pathway activity is interrupted downstream of PIP3. A) Western Blots show 
that levels of AKT
phospho
 were greatly reduced in fat body tissue from feeding third instar larvae 
expressing a dLipinRNAi transgene, while the overall AKT (panAKT) levels remained 
unchanged. Fat bodies from w1118 animals were used as control tissue. B) PhosphoAKT levels 
were also reduced in fat body tissue from dLipin mutant feeding third instar larvae (dLipine00680/ 
Df(3R)Exel7095).  Fat body tissue from heterozygous (either dLipine00680 or Df(3R)Exel7095) 
animals was used as control tissue. The lower band corresponds to the AKT protein. Actin 
served as a loading control. 
 
Western blot analysis shows that phosphoAKT levels in the fat body are reduced upon 
dLipin knockdown (FBGal4>dLipinRNAi) and in dLipin mutants (dLipine00680/ Df(3R)Exel7095). 
Overall AKT levels remained unchanged, indicating that TORC2 mediated phosphorylation is 
inhibited. These data confirm that insulin pathway activity downstream of PIP3 is reduced in fat 
body cells after a reduction of dLipin activity. The next question asked was whether dLipin acts 
downstream or upstream of PI3K or whether it affects PI3K activity itself to interrupt the 
signaling cascade. To this end I tested whether loss of dLipin is sufficient to counteract the 
effects of PI3K overactivation. 
A) B) 
	   92 
5. dLipin affects insulin pathway activity by either affecting PI3K or PTEN activity  
Overexpression of Dp110, the catalytic subunit of PI3K, in the fat body induces strong 
overgrowth of cells. This is due to an overactivation of the insulin pathway. If dLipin acts on, or 
downstream of PI3K, loss of dLipin activity should reduce or reverse the cell overgrowth 
observed after Dp110 overexpression.  
5.1. dLipin knockdown counteracts Dp110 overactivation-induced cell overgrowth 
I combined a transgene encoding a constitutively active form of Dp110 (Dp110CAAX) 
and dLipinRNAi with a fat body-specific driver and examined possible cell growth effects (Fig. 
19).	  	  The CAAX signal added to the C-terminus of Dp110 is a farnesylation signal that promotes 
protein-membrane interaction, and thus directs Dp110 directly to the cell membrane where it 
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Fig. 19: dLipinRNAi knockdown can suppress the overgrowth phenotype observed after 
Dp110 overactiviation. A) Fat body-specific expression of a constitutively active version of 
Dp110 (catalytic subunit of PI3K), Dp110CAAX, resulted in overgrowth of fat body cells. When 
Dp110CAAX expression was combined with dLipin knockdown, this growth effect was reversed, 
with cells appearing normal in size. There was a variability of phenotypes observed after dLipin 
knockdown. Some tissue samples displayed the typical dLipinRNAi phenotype with small fat 
droplets, while other samples showed no difference in fat droplet morphology. Fat droplets were 
stained with Bodipy (green) and nuclei visualized with DAPI (blue). Tissue was collected from 
feeding third instar larvae. Scale bar: 100µm. B) Distance between neighboring nuclei was 
measured as a means to determine cell size. The distance between nuclei in fat body tissue from 
animals expressing Dp110CAAX was significantly larger when compared to fat body tissue from 
animals expressing both, Dp110CAAX and dLipinRNAi. Unpaired t-Test, *** P< 0.0001. Error 
bars indicate SD. 
 
The cell overgrowth observed after Dp110CAAX expression in the fat body was reversed 
after reduction of dLipin transcripts via RNAi. Depending on the extent of the RNAi-induced 
knockdown of dLipin, two different manifestations of the phenotype existed. After strong dLipin 
knockdown, cell overgrowth was reduced, and fat droplets were small in size. If RNAi-mediated 
knockdown of dLipin was not as pronounced, cell overgrowth was reversed as well but fat 
droplet size was unchanged. It is apparent from both phenotypes that the overgrowth induced by 
Dp110CAAX expression was successfully repressed by dLipin knockdown.  
Paradoxically, some animals with Dp110CAAX expression in the fat body showed 
extreme hypotrophy of fat tissue (data not shown).  
5.2. dLipin knockdown suppresses Dp110-induced activation of the insulin pathway 
As Dp110CAAX expression leads to an overactivation of insulin pathway downstream of 
PI3K, I investigated whether this overactivation can be reversed by loss of dLipin activity. I 
looked at PIP3 localization in fat body cells from larvae that carry the Dp110CAAX transgene 
and from larvae with both the Dp110CAAX and the dLipinRNAi transgene (Fig. 20).  
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Fig. 20: Loss of dLipin is sufficient to downregulate insulin pathway activity in fat body 
cells with constitutively active PI3K. The PIP3 reporter PH-GPH was membrane associated in 
cells expressing Dp110CAAX. When dLipin was knocked down strongly in the fat body cells of 
these animals (FBGal4> Dp110CAAX; dLipinRNAi) the membrane association was no longer 
detectable (middle picture). In cases of weaker dLipin knockdown, PIP3 remained at the cell 
membrane (bottom picture). To have another measure of the severity of the dLipin knockdown, I 
stained fat droplets with LipiTOX (red). A strong dLipin knockdown corresponded to smaller fat 
droplets. Feeding third instar larvae were dissected. Scale bar: 100µm. 
 
PIP3 localization at the plasma membrane in animals with Dp110CAAX expression was 
intact in cases of weak dLipin knockdown but lost in animals with stronger dLipin knockdown 
(Fig. 20). This indicates, that a reduction in dLipin activity is sufficient to prohibit PIP3 synthesis 
even in the presence of PI3K overactivation and it also suggests that dLipin affects PIP3 
synthesis itself.  
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In addition to the PIP3 experiment, I also performed a western blot analysis to examine 
AKT phosphorylation levels.  
5.2.1. Dp110-induced AKT phosphorylation is suppressed by a knockdown of dLipin activity 
Overactivation of Dp110 should increase AKT phosphorylation, and RNAi-induced 
knockdown of dLipin should suppress this. To test this hypothesis, I performed a western blot 
analysis with fat body tissue from third instar feeding larvae expressing Dp110CAAX and 
compared this sample with fat body tissue from animals with dLipin knockdown and 
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Fig. 21: Reducing dLipin levels in Dp110 overactivation background reduces phosphoAKT 
levels. Overactivation of Dp110 (FBGal4>Dp110CAAX) resulted in increased phosphoAKT 
levels. When dLipinRNAi was introduced into this genetic background (FBGal4>Dp110CAAX; 
dLipinRNAi), levels of phosphoAKT were greatly reduced, although more phosphoAKT was 
present in these samples compared to dLipin knockdown alone (FBGal4>dLipinRNAi). Tissue 
samples from animals expressing only the Gal4 transgene were used as control. Fat body tissue 
was dissected from feeding third instar larvae. Actin served as a loading control.  
 
Increased AKT phosphorylation after PI3K overactivation was reduced in animals with 
concomitant dLipin knockdown. Loss of dLipin activity overrode the effect that PI3K activation 
had on AKT phosphorylation.  
This experiment showed that even in cells expressing a constitutively active PI3K it is 
sufficient to knockdown dLipin in order to downregulate insulin pathway activity.  Reduced 
dLipin activity was able to override the PI3K input on the insulin pathway downstream of PI3K.  
At this point of my work I was able to place dLipin as a contributor to insulin pathway 
activity, most likely acting at the level of PIP3 synthesis.  
5.3. Can reduced dLipin activity be compensated for by inducing expression of insulin signaling 
effectors upstream or downstream of PI3K? 
To determine whether dLipin deficiency can be compensated for by expression of insulin 
signaling cascade members downstream of PI3K, I overexpressed a constitutively active form of 
AKT in the fat body in concert with dLipinRNAi. However when performing the crosses I 
observed that AKT overexpression itself did not cause a phenotype, even when strongly 
expressed with TubulinGal4 (data not shown). I used two different AKT fly lines with the same 
result.  I also tried to rescue the PIP3 phenotype by expression of chico (the Drosophila homolog 
of the insulin receptor substrate) in cells with dLipin knockdown, but expression of chico alone 
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and in concert with dLipinRNAi appeared to have no effect. Also, expression of InR concomitant 
with dLipinRNAi in the fat body did not elicit an obvious effect. I furthermore tried to determine 
whether dLipin has a direct influence on PI3K activity by investigating PI3K transition to the 
cell membrane. To this end, I used an antibody that recognizes human p110 protein and that was 
predicted to cross react with Drosophila p110. Unfortunately this antibody did not show a 
specific reaction with Drosophila p110.  
In conclusion, I was not able to determine whether expression of insulin signaling 
cascade effectors downstream or upstream of PI3K can compensate for a reduction of dLipin 
activity. To obtain additional evidence that dLipin interferes with insulin sensitivity in the fat 
body I asked whether the reduction of PI3K and AKT activity observed after a decrease of 
dLipin expression caused an increase in circulating sugars. 
6. Circulating blood sugar levels are elevated in dLipin mutant animals 
A hallmark of diabetes is the development of insulin resistance, which results in an 
increase in circulating blood sugar in the presence of insulin. With the major metabolic tissue of 
the developing larvae displaying signs of insulin insensitivity (Fig. 13 and 14), it seemed 
reasonable to assume, that a disruption of fat body insulin sensitivity alone might be sufficient to 
raise hemolymph sugar levels.  
I measured hemolymph sugar levels of feeding third instar larvae with a 
transheterozygous dLipin mutant background (dLipine00680/Df(3R)Exel7095). The major 
circulating sugar of Drosophila melanogaster is trehalose, a sugar that can be converted to 
glucose by the enzyme trehalase. Hemolymph of feeding larvae was treated with trehalase and 
total glucose levels measured (Fig. 22). 
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Fig. 22: Titers of circulating sugars are elevated in animals lacking dLipin. Hemolymph 
samples were obtained from feeding third-instar larvae heterozygous for dLipine00680 or 
Df(3R)Exel7095 (control) or transheterozygous dLipine00680/ Df(3R)Exel7095. Trehalose was 
enzymatically converted to glucose and total glucose measured. Unpaired t-Test, *** p < 0.01; 
error bars indicate standard error of the mean.  
 
Measuring the levels of sugar in the hemolymph of mutant dLipin larvae established that 
a reduction of dLipin activity leads to insulin resistance, as hemolymph sugar levels were 
significantly increased (Fig. 22). 
In summary, these data show that dLipin is necessary for proper insulin sensitivity in the 
fat body, and that insulin resistance induced by a lack of dLipin activity in the fat body results in 
elevated hemolymph sugar levels.  
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7. dLipin levels are regulated by insulin signaling 
Studies in adipocyte cell lines suggest an influence of insulin signaling on Lipin1’s 
subcellular localization (Harris et. al. 2007, Peterfy et. al. 2009). It was demonstrated that Lipin1 
phosphorylation following activation of insulin signaling leads to an accumulation of Lipin1 in 
the cytoplasm. To test whether this was also the case for dLipin, I investigated the localization of 
dLipin in the fat body of wandering third instar larvae after knockdown of insulin signaling.  
7.1. dLipin levels, but not dLipin localization, are affected by a reduction in insulin signaling 
I either expressed a dominant negative form of the regulatory subunit of PI3K 
(PI3K21BHA) or a dominant negative form of the insulin receptor (InRDN) exclusively in the fat 
body to reduce insulin pathway activity. Animals expressing the InRDN transgene displayed 
reduced fat body cell size, but were otherwise viable and appeared to develop normally. In 
contrast, animals expressing PI3K21BHA not only showed reduced cell size, but also suffered 
from larval lethality; and the few larvae that reached the pupal stage died during metamorphosis. 
This is consistent with a moderate reduction of insulin pathway activity with InRDN expression 
and a stronger reduction of insulin pathway activity with the expression of PI3K21BHA. To 
determine how expression of the transgenes affected dLipin expression and distribution, fat body 
was stained with dLipin antibodies (Fig. 23).  
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control FBGal4> InRDN 
 
Fig. 23: dLipin levels, but not localization, are altered after knockdown of insulin pathway 
activity. A) A dominant negative form of the regulatory subunit of PI3K (PI3K21BHA) was 
expressed in the fat body (FBGal4>PI3K21BHA). Fat body tissue from third instar wandering 
larvae was dissected and stained with dLipin antibody (red). Nuclei were visualized with DAPI 
(blue). The same exposure time was used for all images. B) A dominant negative form of insulin 
receptor (InRDN) was expressed in the fat body, and the tissue stained with dLipin antibody 
(red). Nuclei were visualized with DAPI (blue). The same exposure time was used for all images. 
Scale bar: 100µm.  
 
Fig. 23 shows that dLipin localization was not affected by a reduction of insulin pathway 
activity. It does appear, however, that overall levels of dLipin were reduced in fat body tissue 
from animals with a strong knockdown of insulin pathway activity (FBGal4>PI3K21BHA). This 
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experiment was also conducted with animals expressing InRDN (FBGal4>InRDN). The fat body 

























Fig. 24: dLipin levels are reduced upon strong downregulation of insulin pathway activity. 
Western analysis with dLipin antibody confirmed that dLipin levels are lowered in fat body 
tissue after strong knockdown of insulin signaling (FBGal4>PI3K21BHA). The weaker insulin 
phenotype of FBGal4; InRDN did not cause a decrease in dLipin levels. Fat body tissue from 
w1118 animals served as a control. Wandering third instar larvae were dissected. Actin served as a 
loading control.  
 
The immunostaining results were corroborated by western analysis. dLipin antibody was 
used to detect dLipin in fat body tissue from animals expressing either PI3K21BHA or InRDN in 
the fat body. A clear reduction of dLipin was detectable after expression of PI3K21BHA, 
whereas expression of InRDN appeared to have no effect on the amount of dLipin. Thus, insulin 
pathway activity can influence dLipin protein levels, but does not appear to have an obvious 
effect on subcellular localization of the protein. 
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7.2. dLipin levels are not affected in cells with an overactivation of the insulin pathway 
I was previously able to show that downregulation of insulin pathway activity leads to a 
decrease in dLipin levels in fat body cells. Thus, it is plausible that an activation of insulin 
signaling may have the opposite effect, namely an increase in dLipin levels. I conducted a 
western blot analysis to test whether expression of Dp110CAAX has an effect on dLipin levels 











































Fig. 25: PI3K overactivation has no effect on dLipin levels. Western blot analysis with fat 
body tissue from control animals (only FBGal4 transgene), FBGal4>dLipinRNAi animals, 
FBGal4>Dp110CAAX animals and FBGal4>Dp110CAAX; dLipinRNAi animals showed that 
overactivation of PI3K had no effect on dLipin levels, and that dLipinRNAi knockdown is 
effective in FBGal4> Dp110CAAX; dLipinRNAi animals. Actin served as a loading control. 
 
	   105 
Western analysis revealed that overactivating the insulin pathway via Dp110CAAX 
expression has no discernible effect on dLipin levels in fat body cells.  
8. Summary of part A Results 
I was able to establish that dLipin influences insulin pathway activity in the larval fat 
body. Cell-autonomous loss of dLipin activity resulted in a growth defect. PIP3 synthesis by 
PI3K and, thus, PI3K activity was disrupted in cells lacking dLipin. The TORC2 mediated 
phosphorylation of AKT was consequently negatively affected in fat body from animals with fat 
body-specific dLipin knockdown and in fat body from transheterozygous dLipin mutants, which 
indicates that insulin pathway activity downstream of PI3K was indeed downregulated. 
Furthermore, it appeared that dLipin and InR act in concert in fat body development. 
Hemolymph sugar levels were significantly increased in dLipin mutants, consistent with the 
conclusion that loss of dLipin causes insulin resistance in the fat body. dLipin activity itself was 
also influenced by a disruption of insulin signaling resulting in a reduction in dLipin abundance. 
Upregulation of the insulin pathway on the other hand, did not alter dLipin levels. With regard to 
narrowing down the target of dLipin in the canonical insulin pathway, I was able to show that 
dLipin activity influences insulin pathway activity at the PIP3 synthesis step.  
I was then interested in pinpointing possible mechanisms by which dLipin is able to enact 
its effect on the insulin cascade. 
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B. To elucidate the mechanism that underlies insulin resistance caused by reduced dLipin 
activity 
An unphysiological reduction of adipose tissue is called lipodystrophy; it is a condition 
known to result in insulin resistance (Huang-Doran et. al, 2010). Lipodystrophy in mice can be 
caused by a mutation in the lipin1 gene (Reue et al., 2000). Therefore, one possible explanation 
for how dLipin influences insulin sensitivity in the fat body is through its PAP activity. A loss of 
dLipin activity results in a reduction of PAP activity in the cell, which leads to an increase in PA 
and a reduction in DAG, and hence lowered TAG content. Therefore it is possible that either 
elevated PA levels or lowered DAG/TAG levels negatively affect insulin sensitivity of the cell.  
1. Knockdown of GPAT4 or AGPAT3 mirrors dLipin knockdown with regard to PIP3 synthesis 
To test whether insulin resistance caused by the lack of dLipin is a result of the ensuing 
lipodystrophy, I examined PIP3 synthesis in fat body tissue from animals with RNAi-induced 
knockdown of fat synthesis enzymes, GPAT4, AGPAT3 and DGAT2. These enzymes are 
essential for TAG production. RNAi-induced knockdown was limited to the fat body, and 
feeding third instar larvae were dissected. I observed a reduction of fat droplet size after 
knockdown of GPAT4, knockdown of AGPAT3, but not with DGAT2 knockdown (Fig. 26, 
DGAT2 knockdown data is not shown). These phenotypes mirrored the fat body-specific effects 
of dLipin knockdown. This result then led me to look at PIP3 synthesis in fat body cells from 
animals expressing GPAT4RNAi and AGPAT3RNAi  (Fig. 26).  In concert with a decrease in fat 
droplet size I observed a loss of PIP3 membrane association upon GPAT4 or AGPAT3 
knockdown. This phenotype strongly resembled the phenotype upon dLipin knockdown. 
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FBGal4> dLipinRNAi FBGal4> AGPAT3RNAi 
PIP3-specific tGPH 
LipiTOX 
FBGal4> GPAT4RNAi control 
Fig. 26: Knockdown of TAG synthesis enzymes leads to loss of PIP3 membrane association. 
PIP3 was membrane associated in cells expressing the FBGal4 driver only (control). In fat body 
cells from animals with GPAT4 and AGPAT3 knockdown (FBGal4>GPAT4RNAi and 
FBGal4>AGPAT3RNAi), PIP3 was no longer detectable at the membrane, and fat droplet size 
was strongly reduced. This mirrored the dLipin RNAi phenotype (FBGal4>dLipinRNAi). PIP3 
was detected by tGPH (green) and fat droplets by LipiTOX (red).  Feeding third instar larvae 
were dissected. Scale bar: 100µm. 
 
Results from this experiment point to TAG synthesis or fat content as the parameter that 
influences insulin responsiveness, as PIP3 synthesis was disrupted in fat body cells upon RNAi-
induced knockdown of not only dLipin, but two other enzymes of the glycerol-3-phosphate 
pathway.   
2. PAP activity of dLipin is critical for insulin pathway activity 
To examine whether indeed the PAP activity of dLipin and not its transcriptional co-
regulator activity is required for normal insulin sensitivity of fat body cells, I generated two 
mutant forms of dLipin. In one form, the amino acid residue within the PAP motif at position 
812 was altered from aspartate to glutamate (D812E) (ΔPAPdLipin). In the other form, the 
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putative nuclear localization signal (ΔNLSdLipin) at position 276-281 was deleted. Thus, 
ΔPAPdLipin should not exhibit PAP activity, and ΔNLSdLipin should not translocate to the 
nucleus and hence should not be able to function as a transcriptional co-regulator. I conducted 
co-expression experiments with these dLipin contructs and the dLipinRNAi transgene in the fat 
body. If indeed the PAP activity of dLipin is responsible for modulating insulin pathway activity, 
then expression of ΔPAPdLipin should not rescue the loss of PIP3 synthesis in animals with 
RNAi-induced dLipin knockdown.  On the other hand, if the co-regulator activity of dLipin is 
responsible, then expression of ΔNLSdLipin should not rescue. As a positive control I expressed 
a WTdLipin construct. Before I started the PIP3 rescue experiments, I had to establish the fact 
that ΔNLSdLipin does not enter the nucleus and that ΔPAPdLipin exhibits no PAP activity. 
2.1. Characterization of ΔNLSdLipin and ΔPAPdLipin 
  ΔNLSdLipin was expressed concomitantly with TORRNAi in the fat body, and subsequent 
changes in subcellular localization examined. Knockdown of TOR activity in a wildtype genetic 
background results in a translocation of dLipin from the cytoplasm into the nucleus (Fig. 27 
upper right panel, Fig. 34). This important finding will be further documented in Part C.  
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Fig. 27: ∆NLSdLipin does not enter the nucleus and prevents endogenous dLipin from 
entering the nucleus. ∆NLSdLipin was expressed in the fat body concomitantly with TORRNAi. 
Knocking down TOR leads to a translocation of dLipin (red) into the nucleus (arrows) as 
confirmed by double-staining with DAPI (blue). When co-expressing TORRNAi and ∆NLSdLipin 
this translocation was no longer observed, indicating that ∆NLSdLipin not only cannot enter the 
nucleus, but also inhibits the endogenous dLipin from entering the nucleus. Scale bar: 100µm. 
	  
The results of this experiment confirmed that the ΔNLSdLipin was not able to translocate 
to the nucleus. Furthermore, it caused a dominant negative phenotype by prohibiting endogenous 
dLipin from entering the nucleus.  
To verify that ΔNLSdLipin retains PAP activity, and that ΔPAPdLipin lost PAP activity, 
I set up rescue experiments wherein I expressed WTdLipin, ΔNLSdLipin and ΔPAPdLipin in the 
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fat body of tranheterozygous dLipin mutant animals (dLipine00680/ Df(3R)Exel7095) and looked 
for improvements in fat body morphology. 
dLipine00680/ Df(3R)Exel7095 
 
dLipine00680/ Df(3R)Exel7095;  
FBGal4> ∆NLSdLipin!
 
dLipine00680/ Df(3R)Exel7095;  
FBGal4> ∆PAPdLipin!
 




Fig. 28: Expression of mutant and wildtype dLipin constructs in dLipin mutant background 
rescues defects in fat body morphology. WTdLipin, ΔNLSdLipin and ΔPAPdLipin were 
expressed in transheterozygous dLipin mutant (dLipine00680/ Df(3R)Exel7095) animals. 
Expression was limited to the fat body. Fat body defects visible in the dLipin mutant are rescued 
by expression of WTdLipin, and ΔNLSdLipin but not ΔPAPdLipin. Fat droplet morphology is 
visualized by Bodipy staining (green) and nuclei are stained with DAPI (blue). Scale bar: 
100µm. 
 
Expression of WTdLipin and ΔNLSdLipin rescued the fat body defects observed in dLipin 
mutants. This indicates that, like WTdLipin, ΔNLSdLipin possesses normal PAP function. Fat 
droplet size was increased and cell shape polygonal after expression of these two constructs. 
ΔPAPdLipin on the other hand was not able to compensate for loss of PAP activity in dLipin 
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mutants. The fat body defects observed in dLipin mutants were still present after expression of 
ΔPAPdLipin. These data are consistenet with a lack of PAP activity in the ΔPAPdLipin 
construct. .  
2.1.1. Expression of any dLipin construct in the fat body alone does not rescue developmental 
defects 
While performing rescue experiments, I noted that expression of any of the dLipin 
constructs in the fat body alone was not able to rescue lethality and developmental delay of 
dLipin mutant animals. To examine rescue effects, I set up crosses and compared the formation 
of pupae by transheterozygous dLipin mutants and transheterozygous dLipin mutants with 
concomitant expression of either WTdlipin or ΔNLSdLipin or ΔPAPdLipin in the fat body. I set 
up an individual rescue cross for each single dLipin construct (WTdlipin or ΔNLSdLipin or 
ΔPAPdLipin). As both genotypes (control: Df/Rb; Gal4; experimental genotype: Df/Rb; Gal4/ 
WTdlipin or Df/Rb; Gal4/ ΔNLSdLipin or Df/Rb; Gal4/ ΔPAPdLipin) emerge from the same 
cross, I knew the expected genotype frequency for each genotype. I compared the number of 
pupae with control genotype (dLipin mutant: Df/Rb; WTdlipin or ΔNLSdLipin or ΔPAPdLipin) to 
the number of pupae with experimental genotype (Df/Rb; Gal4/ WTdlipin or Df/Rb; Gal4/ 
ΔNLSdLipin or Df/Rb; Gal4/ ΔPAPdLipin). I was thus able to use pairwise Chi-square analyses 
to score for significant differences between control and experimental genotype. dLipin 
transheterozygous animals served as a control, thus I set the number of pupae formed by these 
animals as 100%. For a more detailed explanation please refer to Materials and Methods section.  
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Fig. 29: Expression of WTdLipin, ΔNLSdLipin and ΔPAPdLipin in the fat body of dLipin 
mutant animals (dLipine00680/ Df(3R)Exel7095, Df/Rb) does not rescue larval lethality. To 
screen for larval lethality, I scored pupation rates of dLipin mutant animals and dLipin mutant 
animals expressing one of three dLipin constructs (dLipine00680/ Df(3R)Exel7095; FBGal4/ 
WTdLipin, dLipine00680/ Df(3R)Exel7095; FBGal4/ ΔNLSdLipin, dLipine00680/ Df(3R)Exel7095; 
FBGal4/ ΔPAPdLipin ). Expression of the dLipin constructs was restricted to the fat body. No 
rescue effects on survival were present for either dLipin construct, in fact, expression of 
ΔPAPdLipin lowered pupation rates significantly. The transheterozygous dLipin mutant 
genotype (dLipine00680/ Df(3R)Exel7095) is abbreviated to Df/Rb in the graph. Two tailed Chi-
Square Test, *** p< 0.0001.  
 
Expression of dLipin rescue constructs in the fat body of dLipin mutants alone did not 
rescue larval lethality of dLipin mutants. No significant increase in the number of pupae formed 
was observed for either dLipin construct. To the contrary, expression of ΔPAPdLipin seemed to 
have a dominant negative effect, as pupation rates of these animals were even lower than those 
of dLipin mutant control animals. Furthermore, the dominant-negative effect observed after 
ΔPAPdLipin expression is a positive indicator that the transgene is indeed expressed. I also set 
up a rescue experiment with the daGal4 driver, but no rescue effects were observed. 
*** 
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2.1.2. Expression of ΔPAPdLipin results in a dominant negative phenotype  
To further investigate the possibility that expression ΔPAPdLipin results in a dominant 
negative effect, I expressed this construct with a strong ubiquitous driver, TubulinGal4 
(TubGal4), in a dLipin mutant background and in a wild-type genetic background. No difference 
in lethality was observed after ubiquitous ΔPAPdLipin expression in a wild-type genetic 
background (data not shown), but ubiquitous expression of ΔPAPdLipin in a dLipin mutant 
background significantly reduced viability (Fig. 30). Both genotypes resulted from the same 
cross with known genotype frequencies, hence I was able to use Chi-Square analyses to score for 
statistical significance. 
	   
Fig. 30: Ubiquitous expression of ΔPAPdLipin in dLipin mutant background causes 
dominant negative effect. Expression of ΔPAPdLipin driven by TubulinGal4 in a dLipin mutant 
genetic background (dLipine00680/ Df(3R)Exel7095; ΔPAPdLipin/TubGal4) resulted in reduced 
viability. The number of larvae reaching the pupal stage was significantly reduced in animals 
expressing ΔPAPdLipin, compared to dLipin mutants (dLipine00680/ Df(3R)Exel7095, Df/Rb). The 
transheterozygous dLipin mutant genotype (dLipine00680/ Df(3R)Exel7095) is abbreviated as 
Df/Rb in the graph. Two tailed Chi-Square Test, *** p= 0.0009.  
 
*** 
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Expression of a dLipin construct with a mutation in the motif responsible for its PAP 
activity resulted in a dominant negative phenotype with regard to viability only when expressed 
in a dLipin mutant genetic background, but not when expressed in a wild-type genetic 
background. 
2.2.2. PIP3 synthesis depends on PAP activity 
To determine whether the impact dLipin has on PI3K activity requires its transcriptional 
co-regulator activity or its PAP activity and to further explore whether it is indeed fat synthesis 
that is key to insulin sensitivity of the fat body, I set up crosses in which I expressed WTdLipin, 
ΔNLSdLipin and ΔPAPdLipin in a background of fat body-specific dLipin knockdown (FBGal4> 
dLipinRNAi; tGPH/WTdLipin; FBGal4>dLipinRNAi; tGPH/ΔNLSdLipin; FBGal4>dLipinRNAi; 
tGPH/ΔPAPdLipin). To monitor PIP3 synthesis I expressed the PIP3 marker tGPH. I had already 
shown that dLipin knockdown interferes with PIP3 synthesis (Fig. 13, Fig. 14). Expression of 
WTdLipin in a dLipin knockdown background should rescue the loss of PIP3 from the cell 
membrane. Expression of this construct therefore served as a positive control.  ΔNLSdLipin and 
ΔPAPdLipin expression may, or may not reconstitute PIP3 synthesis in animals with loss of 
dLipin activity. Results of this experiment are depicted in Fig. 31.  
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FBGal4> dlipinRNAi; dLipinWT 
FBGal4> dlipinRNAi; dLipin∆NLS 
FBGal4> dlipinRNAi; dLipin∆PAP 
LipiTOX PIP3 specific PH-GFP 
 
Fig. 31: PAP activity of dLipin is required for PIP3 synthesis. Expression of both WTdLipin 
and ΔNLSdLipin is sufficient to restore PIP3 synthesis after dLipin knockdown 
(FBGal4>dLipinRNAi; WTdLipin and FBGal4>dLipinRNAi; ΔNLSdLipin). PIP3 was again 
located at the cell membrane (arrows). In contrast, expression of ΔPAPdLipin could not rescue 
the loss of PIP3 synthesis in animals with a loss of dLipin activity (FBGal4>dLipinRNAi; 
ΔPAPdLipin). PIP3 was not located at the cell membrane. PIP3 was visualized by expression of 
PIP3 marker tGPH (green). Furthermore, fat droplet size was increased in fat body tissue from 
animals with WTdLipin and ΔNLSdLipin expression but not in animals with of ΔPAPdLipin 
expression. Fat droplet morphology was visualized by LipiTOX staining (red). Nuclei were 
stained with DAPI (blue). Scale Bar: 100 µm.  
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 The results show that PAP activity is required for PIP3 synthesis in the fat body. 
Expression of WTdLipin and ΔNLSdLipin was able to reconstitute PIP3 synthesis in fat body 
cells in concert with rescuing the reduction of fat droplet size. Expression of ΔPAPdLipin on the 
other hand, could not reestablish PIP3 synthesis or increase the size of fat droplets. Therefore it 
is likely that fat content and PIP3 synthesis are linked and that dLipin’s transcriptional co-
regulatory function is not responsible for the effects on the insulin pathway.  
2.2.3. Expression of AtPAH1 in animals with fat body-specific dLipin knockdown 
To validate the results described in the previous section, I attempted to rescue PIP3 
synthesis by expressing one of the Arabidopsis thaliana lipin homologs, AtPAH1. The encoded 
Arabidopsis Lipin protein does not seem to function as transcriptional co-regulators, only as 
phosphatidate phosphatase enzymes as sequence alignments show that Arabidopsis Lipins lack a 
co-regulator motif (Peterfy et al., 2001). Using the AtPAH1 lipin homolog one can thus 
investigate whether PAP activity alone is enough to restore insulin sensitivity in dLipin deficient 
animals.	  Fat body-specific expression of AtPAH1 from a UAS construct did not rescue fat body 
defects following dLipin knockdown (Fig. 32). This might have been due to either failed 
construct expression or due to the fact that dLipin and AtPAH1 have diverged to a point where 
functions are no longer conserved between the two encoded proteins. Further experimentation is 
required to distinguish between these possibilities.  
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Fig. 32: The Arabidopsis thaliana homolog of dLipin cannot rescue the loss of PIP3 
membrane association after dLipin knockdown. The Arabidopsis homolog of Lipin was 
expressed to rescue the loss of PIP3 from the cell membrane. No rescue of the dLipinRNAi 
phenotype was observed.	  The	  Arabidopsis homolog of Lipin was not able to rescue either the 
reduced fat droplet size (red) or the loss of PIP3 from the cell membrane (green). Scale bar 
100µm. 
 
3. Dp110 transcript levels are reduced following dLipin knockdown  
dLipin in its function as a transcriptional co-regulator could manipulate expression levels 
of genes involved in the insulin signaling cascade, and thus influence insulin pathway activity. 
Previously I had established that dLipin is able to attenuate Dp110 function in the fat body 
(5.2.1.). I therefore investigated whether Dp110 expression levels were reduced in animals with 
knockdown of dLipin in the fat body (FBGal4>dLipinRNAi). qRT-PCR was conducted and 
transcript levels of Dp110 quantified (Fig. 33). 
	   118 
 
Fig. 33: Levels of Dp110 RNA are reduced following dLipin knockdown. Levels of mRNA 
encoding the PI3K subunit Dp110 were reduced 2-fold in fat body of larvae expressing a 
dLipinRNAi transgene. Dp110 RNA was quantified by qRT-PCR; rp49 RNA served as the 
normalizer. The difference between control (w1118) and knockdown animals was statistically 
significant. RNA was extracted from fat body tissue. * p< 0.05. 
 
Knockdown of dLipin in the fat body led to a moderate reduction of Dp110 transcript 
levels, suggesting that dLipin participtes directly or indirectly in the transcriptional regulation of 
the Dp110 gene.  
4. Summary part B Results 
I was able to establish a link between TAG synthesis and insulin pathway activity. Loss 
of dLipin’s PAP activity was responsible for reduced PIP3 synthesis following dLipin 
knockdown. Nuclear dLipin activity might play a contributory role, but did not appear to have a 
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C. To elucidate the relationship between dLipin and TOR in D. melanogaster 
One of the downstream targets of insulin signaling is the TOR kinase, more specifically 
TOR Complex 1 (TORC1). Having shown that dLipin is an important contributor to insulin 
pathway activity in the fat body of developing larvae, I proceeded to illuminate dLipin’s 
potential interaction with the TOR signaling pathway.  
In mammals, mTOR signaling is implicated in lipid biosynthesis (Laplante and Sabatini, 
2009) and is responsible for Lipin1 phosphorylation (Huffman et al., 2002). So far, no interaction 
studies have been conducted for dLipin and TOR interaction(s) in Drosophila melanogaster. As 
was the case with insulin signaling, I focused my research on the major metabolic organ of the 
developing larvae, the fat body.  
1. dLipin levels and subcellular localization are dependent on TORC1 activity 
In mammals Lipin1 was shown to be posttranslationally modified in a TOR-dependent 
manner (Huffman et al., 2002). Numerous rapamycin-sensitive phosphorylation sites within 
Lipin1 were identified. Rapamycin acts as a TOR antagonist. Posttranslational modifications of 
Lipin1 in response to TOR signaling are connected to changes in Lipin1’s subcellular 
localization (Peterson et al., 2011). Therefore, I investigated the spatial distribution of dLipin 
after TOR knockdown (FBGal4>TORRNAi).  
I looked at dLipin in fat body cells from third instar wandering larvae (Fig. 34). While 
investigating subcellular localization, I noticed that overall dLipin levels appeared to be lowered 
after TOR knockdown. To measure overall dLipin levels, I conducted a western analysis with fat 
body tissue from animals expressing TORRNAi in the fat body (FBGal4>TORRNAi) probed with 
dLipin antibodies (Fig. 34).  
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Fig. 34: TOR knockdown results in diminished levels of dLipin and translocation of dLipin 
into the nucleus in fat body tissue of third instar larvae. A) TORRNAi was expressed in the 
fat body (FBGal4>TORRNAi) and dLipin detected using dLipin antibody (red). Cells were 
counterstained with DAPI to visualize the nuclei. dLipin is noticeably more concentrated in the 
nuclei compared to the cytoplasm. Furthermore, dLipin levels seemed to be decreased compared 
to the control (w1118). Scale Bar 100µm. B) Reduction of dLipin levels was also observed when 
western blot analysis was conducted with fat body tissue samples from control (w1118) and 
experimental animals (FBGal4>TORRNAi). The blot was treated with dLipin antibody and Actin 
was used as a loading control.  
 
Subcellular localization and total dLipin levels are indeed influenced by TOR activity. A 
reduction of TOR resulted in lowered dLipin levels and the residual dLipin translocated into the 
nucleus, leaving little dLipin in the cytoplasm. It is interesting to note that although dLipin levels 
were strongly reduced, fat droplet size appeared normal (data not shown). Cell size of fat body 
cells after TOR knockdown was smaller compared to cells from control animals, a known effect 
of TOR deficiency (Oldham et al., 2000).  
A knockdown of TOR not only affects TORC1 but also TORC2, as TOR is an integral 
member of both complexes. To determine whether the effects observed were due to a loss of 
TORC1 or TORC2 activity, I studied the interaction of dLipin with raptor and rictor. Raptor is a 
member of TORC1 only, and Rictor only associates with TORC2 (Loewith and Hall, 2011). 
raptor and rictor were specifically downregulated using RNAi in the larval fat body, and fat 
body cells examined for dLipin levels and localization. I did not observe any altered phenotype 
after rictor knockdown. To determine if rictorRNAi was effective, I analyzed at S505 
phosphoAKT levels in fat body cells expressing rictorRNAi and control cells. S505 
phosphorylation is catalyzed by TORC2, which means that if rictor knockdown is efficient, AKT 
phosphorylation should be lowered. I was not able to detect an effect on AKT phosphorylation 
(data not shown). Thus, RNAi-mediated knockdown of rictor seemed to be inefficient. However, 
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raptor knockdown was effective as fat body cell size of animals expressing raptorRNAi was 
smaller. Next I examined the amount and distribution of dLipin protein in fat body tissue after 
raptorRNAi expression (Fig. 35). 
FBGal4> raptorRNAi control 
dLipin A) dLipin 
dLipin + DAPI dLipin + DAPI 
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Fig. 35: raptor knockdown results in diminished levels of dLipin and translocation of 
dLipin into the nucleus of fat body cells of third instar larvae. A) raptorRNAi was expressed 
in the fat body (FBGal4>raptorRNAi) and dLipin detected using dLipin antibody (red). Cells 
were counterstained with DAPI to visualize the nuclei. dLipin was noticeably more concentrated 
in the nuclei compared to the cytoplasm. Furthermore, dLipin levels seemed to be decreased 
compared to control (w1118). Scale Bar 100µm. B) Reduction of dLipin levels was also observed 
when western blot analysis was conducted with fat body tissue samples from control (w1118) and 
experimental animals (FBGal4>raptorRNAi). The blot was incubated with dLipin antibody and 
actin was used as a loading control.  
 
Comparing Fig. 34 and Fig. 35, it is clear that the effects of raptor and TOR knockdown 
were identical. It therefore appears that the phenotype observed after TOR knockdown is most 
likely caused by a decrease in TORC1 activity. This experiment thus linked dLipin activity and 
TORC1 signaling. Nuclear translocation of dLipin indicates an increased need for dLipin’s 
nuclear function under conditions when TORC1 activity is low. In mammalian and yeast 
systems, it has been shown that Lipin acts as a transcriptional co-regulator (Donkor et al., 2009; 
Finck et al., 2006; Koh et al., 2008; Santos-Rosa et al., 2005). However, so far no nuclear 











	   124 
1.1. Binding of dLipin to polytene chomosomes  
One way to determine whether dLipin is likely to affect transcriptional activity is by 
looking at the binding of dLipin to chromosomes. Therefore, I stained chromosomes of fat body 
and salivary gland cells with dLipin antibody. As salivary gland chromosomes go through more 
cycles of endoreplications, they contain a higher DNA content and are bigger and easier to stain 
than fat body chromosomes. Hence, I expressed dLipin in the salivary gland and tried to detect 
target loci of dLipin binding. To express dLipin in the salivary gland, I used a ubiquitous heat 
shock driver. I looked at chromosomes at different time points after heat shock induction to 
analyze binding at different titers of dLipin protein (Fig. 36).  
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Fig. 36: Chromosome staining of salivary gland chromosomes does not reveal specific 
binding loci for dLipin. dLipin expression was induced by heat shock (hsGal4>dLipin), and 
salivary gland chromosomes were stained with dLipin antibody (purple). dLipin antibody 
staining was conducted immediately after heat shock treatment, 2 hours after heat shock and 24 
hours after heat shock.  DNA was stained with DAPI. No binding sites for dLipin were detected. 
Scale Bar 50µm.  
 
I was not able to detect any specific signals on chromosomes for dLipin. Only 
background staining of the dLipin antibody was detected. As dLipin did not appear to bind to 
	   126 
salivary gland chromosomes, I proceeded with fat body chromosome staining. I prepared 
chromosome squashes with wild-type fat body chromosomes, and with fat body chromosomes 
from animals expressing TORRNAi (FBGal4>TORRNAi). I was not able to detect any specific 
loci of dLipin binding for any of the genotypes (data not shown).  
To further elucidate the relationship between dLipin and TORC1, I conducted genetic interaction 
studies.  
2. dLipin and raptor interact in larval development  
I focused on raptor to test for a possible genetic interaction between TORC1 and dLipin. 
Raptor functions as an integral part of TORC1. Thus raptor knockdown will diminish TORC1 
activity. I concomitantly expressed dLipinRNAi and raptorRNAi with FBGal4, thereby achieving 
a fat body-specific knockdown of both RNAi targets. I examined fat body morphology, PIP3 
localization and larval development of both single and double-knockdown animals. 
2.1. raptor and dLipin together regulate larval development  
I noticed a strong decrease of larval size after dLipin and raptor double knockdown. 
dLipin knockdown animals behaved and looked like wild-type animals. Animals with only 
raptor knockdown showed a minor delay and slightly decreased larval size. Larvae pupariate 1-2 
days later compared to dLipin knockdown animals. Raptor knockdown larvae develop into pupae 
that die before adult flies can eclose. Thus, knockdown of raptor leads to a developmental delay. 
This developmental delay was further enhanced in animals with combined dLipin and 
raptor knockdown as they never entered the wandering stage and perished in the food between 
8-12 days after egg deposition (AED) (Fig. 37). Larvae were translucent, which suggests that fat 
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body tissue was underdeveloped. Figure 37 documents the developmentof larvae of the different 
genotypes (Fig. 37).  




Fig. 37: Fat body specific knockdown of dLipin and raptor together results in a 
developmental delay and larval lethality. Animals expressing dLipinRNAi develop normally 
(FBGal4>dlipinRNAi); animals with raptorRNAi are delayed by 1-2 days (FBGal4> 
raptorRNAi). This delay is further enhanced in animals with concomitant dLipin knockdown 
(FBGal4>dLipinRNAi; raptorRNAi). Animals displayed a slow growth rate, hence their 
diminutive body size. They never entered the wandering stage and never formed pupae. Animals 
were photographed 5 days AED.  
 
Knockdown of dLipin in a raptor deficient background enhanced the developmental 
delay observed after raptor knockdown. A possible explanation for this is that dLipin activity is 
further reduced in animals with concomitant dLipin/raptor knockdown, leading to a severe fat 
body underdevelopment. As dLipin knockdown also results in a down regulation of insulin 
pathway activity, the developmental delay could alternatively be explained by reduced insulin 
pathway activity in dLipin/raptor knockdown animals. Another possibility is that further reduced 
TORC1 activity in animals with concomitant raptor and dLipin knockdown could have elicited 
the enhancement in developmental delay.  
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2.2. dLipin and raptor interaction affects fat body morphology  
raptor knockdown led to a cellular growth defect that resulted in smaller fat body cells. 
Fat body cells continued to be smaller until pupariation, an indication that the smaller cell size 
resulted from a true growth defect rather than developmental delay. Insulin pathway activity 
following raptor knockdown appeared to be unaffected, as PIP3 membrane association was 
conserved. When combined with dLipin knockdown, fat body cell size was further reduced and 
PIP3 membrane association was no longer detectable (Fig. 38). The fat body seemed to be 
substantially underdeveloped. The fact that PIP3 synthesis was not reconstituted in animals with 
dLipin knockdown by concomitant raptor knockdown indicates that insulin resistance in animals 
with dLipin knockdown is not caused by TORC1 overactivation, as is the case in type2 diabetes.  
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Fig. 38: Simultaneous dLipin and raptor knockdown affects fat body development. Fat body 
of larvae (5 days AED) was dissected and fat droplet morphology visualized by LipiTOX 
staining (red). PIP3 localization was determined by expression of the PIP3 reporter tGPH 
(green). DAPI was used to stain cell nuclei. The size of fat body cells from animals expressing 
raptorRNAi (FBGal4>raptorRNAi) is reduced when compared to dLipin knockdown alone 
(FBGal4>dLipinRNAi). This phenotype is strongly enhanced by concomitant loss of dLipin 
(FBGal4>dLipinRNAi; raptorRNAi). PIP3 localization is not altered after raptor knockdown, 
but dLipin knockdown as well as dLipin knockdown with concomitant raptor knockdown, 
showed a loss of PIP3 membrane association. Scale Bars: 100 µm. 
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To further document the decrease in cell size observed after dLipin knockdown with 
concomitant raptor knockdown, I measured cell area, nuclear area and nucleocytoplasmic ratio 
(Fig. 39).  
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Fig. 39: Concomitant knockdown of dLipin and raptor in the fat body leads to diminished 
cell area and increased nucleocytoplasmic ratio. A) Cell area was measured in animals with 
dLipin knockdown (FBGal4>dLipinRNAi), animals with raptor knockdown 
(FBGal4>raptorRNAi) and animals carrying both knockdown transgenes (FBGal4>dLipinRNAi; 
raptorRNAi). Cell area of timed larvae was measured (5 days AED). Cell area after raptor 
knockdown is significantly reduced compared to dLipin knockdown cell area. When dLipinRNAi 
is introduced into raptorRNAi the growth deficit is significantly enhanced compared to 
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size and dLipinRNAi/raptorRNAi cell size is indicated by the ***	  above	  the	  bracket.	  B) Nuclear 
area measured in animals with dLipin knockdown (FBGal4> dLipinRNAi), animals with raptor 
knockdown (FBGal4> raptorRNAi) and animals carrying both knockdown transgenes (FBGal4> 
dLipinRNAi; raptorRNAi). Nuclear area of timed larvae was measured (5 days AED). Nuclear 
area after raptor knockdown is significantly reduced compared to dLipin knockdown. This 
reduction in nuclear size is only slightly more pronounced after combining both raptor and 
dLipin knockdown, but no statistical difference was found. C) Nucleocytoplasmic ratio of timed 
larvae (5 days AED) was measured. The ratio was significantly increased after knockdown of 
dLipin in concert with raptor, whereas no significant difference could be found between the 
single knockdowns. Error bars indicate standard deviation. Unpaired t –Test, ∗∗∗P < 0.0001. 
 
Fat body cell size of larvae (5 days AED) was reduced in animals with raptor 
knockdown; a phenotype further enhanced in animals with concomitant dLipin knockdown. 
Nuclear area of larvae with raptor knockdown in the fat body was also significantly smaller 
when compared to dLipin knockdown nuclei. Knocking down both dLipin and raptor did not 
significantly decrease nuclear size any further, but had a strong effect on cytoplasmic growth. 
This resulted in a strongly increased nucleocytoplasmic ratio of cells after concomitant dLipin 
and raptor knockdown. raptor knockdown, which affected cytoplasmic growth and DNA 
replication to the same extent, led to a proportional growth defect.  
The data presented suggests that a concomitant reduction of dLipin and TORC1 activity 
strongly reduces cytoplasmic growth of cells, but not DNA replication. This effect might be 
caused by the reduced insulin pathway activity after dLipin knockdown in cells with concomitant 
raptor knockdown.  
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2.3. Interaction between raptor and dLipin is dependent on the PAP activity of dLipin, but not 
the co-regulator activity 
As mentioned before, dLipin has the ability to act in two different ways, as a PAP 
enzyme and a co-regulator of transcription. To determine whether it was indeed the loss of 
dLipin’s PAP activity or its co-regulator activity that resulted in enhanced developmental delay 
and reduced cytoplasmic growth in animals with concomitant dLipin and raptor knockdown, I 
co-expressed WTdLipin, ΔNLSdLipin or ΔPAPdLipin with dLipinRNAi and raptorRNAi in the fat 
body and examined developmental delay and fat body cell size.  
2.3.1. dLipin is no longer detectable in the nucleus after concomitant raptor/dLipin knockdown 
As shown before (Fig. 35), dLipin migrates into the nucleus upon raptor knockdown. 
Thus, a loss of nuclear activity of dLipin in dLipin/raptor double knockdown animals might 
explain the enhanced phenotype. To test this, I first determined that indeed no dLipin is present 
in nuclei of animals with simultaneous dLipin/raptor knockdown. Nuclear localization of dLipin 
was greatly reduced in animals with concomitant reduction of dLipin and Raptor activity (Fig. 
40).  
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Fig. 40: dLipin is reduced in the nucleus after concomitant knockdown of dLipin and 
raptor. dLipin was detected using dLipin antibody in fat body of feeding third instar larvae. 
Larvae either expressed only raptorRNAi (FBGal4>raptorRNAi), or only raptorRNAi as well as 
dLipinRNAi (FBGal4>dLipinRNAi; raptorRNAi) in the fat body. After raptor knockdown, 
dLipin was concentrated in the nucleus. This nuclear concentration of dLipin was no longer 
present in most cells after simultaneous knockdown of dLipin and raptor. dLipin appears red and 
nuclei are stained with DAPI and appear blue. Scale Bar: 100µm. 
 
2.3.2. PAP activity mediates the raptor/dLipin interaction in larval development 
To test whether the deficit in nuclear activity of dLipin is responsible for the growth rate 
defect observed after simultaneous dLipin/raptor knockdown or whether a reduction in PAP 
activity causes the developmental delay, I tried to rescue larvae with dLipin/raptor knockdown 
by individually expressing WTdLipin, ΔNLSdLipin and ΔPAPdLipin in the fat body of these 
animals. I timed the larvae and looked at the morphology of whole larvae 5 days AED.  
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Fig. 41: Developmental delay caused by simultaneous raptor/dLipin knockdown can be 
rescued by expression of WTdLipin and ΔNLSdLipin, but not ΔPAPdLipin. Concomitant 
knockdown of dLipin and raptor in the fat body resulted in a severe developmental delay. This 
delay can be reversed by expression of WTdLipin and ΔNLSdLipin. Larval size was significantly 
bigger when compared to dLipin/raptor double knockdown animals. Expression of dLipin 
lacking PAP activity, ΔPAPdLipin, was not able to reverse the developmental delay. Larvae were 
timed and pictures taken 5 days AED.  
 
The enhanced developmental delay observed after simultaneous knockdown of dLipin 
and raptor in the fat body was reversed after expression of WTdLipin and ΔNLSdLipin. Larval 
size was significantly increased in these animals and animals underwent pupariation. However, 
expression of ΔPAPdLipin did not rescue the enhanced developmental delay. Larval size was the 
same as after the dLipin/raptor knockdown. This suggests that loss of PAP activity was 
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2.3.3. PAP activity mediates the raptor/dLipin interaction with regard to fat body development 
To verify that loss of PAP activity is responsible for the enhanced cell growth defect after 
concomitant dLipin/raptor knockdown, I expressed WTdLipin, ΔNLSdLipin and ΔPAPdLipin in 
raptor/dLipin double knockdown animals. Furthermore, distance between neighboring nuclei 
was measured as an estimate for cell size. It was not possible to measure cellular area directly, as 
cell boundaries were not visible in animals with FBGal4>dLipinRNAi; raptorRNAi and 
FBGal4>dLipinRNAi; raptorRNAi/ΔPAPdLipin genotypes. 
A) FBGal4> dLipinRNAi FBGal4> dLipinRNAi;  
raptorRNAi 
FBGal4> dLipinRNAi;  
raptorRNAi/ΔNLSdLipin 


































Fig. 42: Fat body cell size of larvae with dLipin and raptor knockdown is rescued by 
expression of WTdLipin and ΔNLSdLipin, but not ΔPAPdLipin. A) Expression of raptorRNAi 
in the fat body resulted in a growth defect reflected by smaller cell size. dLipin knockdown in the 
fat body did not cause growth defects. When combining dLipin and raptor knockdown in the fat 
body, cell size was further decreased. Expression of WTdLipin and ΔNLSdLipin, but not 
ΔPAPdLipin increased cell size significantly. Larvae were timed (5 days AED) and fat body 
tissue stained with Bodipy (green) to visualize fat droplets, and DAPI (blue) to visualize cell 
nuclei. Scale Bar: 100µm. B) When expressing WTdLipin or ΔNLSdLipin in dLipin/raptor 
knockdown fat body cells, the reduction in cell size after double knockdown was no longer 
present. Instead, cells were the same size as raptor knockdown cells. Expression of ΔPAPdLipin 
did not rescue the growth defect. Error bars reflect SD. Unpaired t –Test, ∗∗∗ p< 0.0001. 
 
Reduced size of fat body cells observed after raptor knockdown was enhanced by 
concomitant dLipin knockdown. This was no longer the case when either WTdLipin or 
ΔNLSdLipin were expressed in the knockdown animals. Thus, WTdLipin and ΔNLSdLipin were 
capable of rescuing the enhancement. However, they were not able to compensate for the loss of 
raptor activity, as cell size after WTdLipin and ΔNLSdLipin expression was not significantly 
increased compared to cell size after raptor knockdown alone.  
B) 
 ***  *** 
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The observation that expression of WTdLipin and ΔNLSdLipin, but not ΔPAPdLipin, can 
abolish the enhancement of fat body defects strongly suggests that loss of PAP activity, but not 
of the transcriptional co-regulator activity of dLipin caused a cytoplasmic growth defect in 
animals with concomitant raptor knockdown.  
3. Overactivation of TOR activity in the fat body 
I pursued two approaches to determine whether elevated TOR activity can rescue 
phenotypes observed after dLipin knockdown. First, I tried to activate TOR in the larval fat body 
of animals with dLipin knockdown by simultaneously knocking down both Tsc1 and Tsc2. Both 
Tsc1 and Tsc2 function as inhibitors of TORC1 activity. Thus, downregulation of Tsc1 and Tsc2 
should activate TORC1 signaling. Unfortunately, I was not able to observe any effect of Tsc1 
and Tsc2 knockdown alone on cell morphology. TORC1 overactivation should result in cell 
overgrowth. Hence, efficient Tsc1 or Tsc2 knockdown should have resulted in cell overgrowth. 
However, I was not able to detect any growth effects. Second, I tried to activate TOR by 
overexpressing the TORC1 activator Rheb in animals of the genotype FBGal4/dLipinRNAi; 
Rheb/InRdom.neg.  Expression of Rheb alone did not lead to any discernible growth effect in fat 
body tissue. Hence, expression of Rheb was not able to activate TORC1.  
I was not able to achieve TORC1 activation either by knocking down its inhibitors or activating 
its activators.  
4. dLipin deficiency does not affect TORC1 activity 
At this point I had established that a strong interaction exists between dLipin and TORC1 
(Raptor). I was able to show that dLipin protein level and dLipin’s subcellular localization 
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depend on TORC1 activity and that a reduction of dLipin’s PAP activity in a raptor-deficient 
background strongly enhances developmental delay and cell growth defects.  
The enhancement of the raptor phenotype could result from a further decrease of TORC1 
activity following dLipin knockdown. To measure TORC1 activity, I assayed phosphorylation 
levels of the TOR target 4EBP1 an inhibitor of translation (Hara et. al., 1997). 4EBP1 
phosphorylation deactivates 4EBP1 and thereby promotes translational activity. 4EBP1 
phosphorylation levels of fat body cells were examined after knockdown of dLipin and compared 













Fig. 43: dLipin knockdown does not reduce 4EBP1 phosphorylation levels. Western blot 
analysis was performed with fat body samples from feeding third instar larvae. The membranes 
were probed either with antibodies for phospho4EBP1 or pan4EBP1. Samples from animals with 
dLipin knockdown in the fat body (FBGal4>dLipinRNAi) were compared to samples from 
control animals carrying only the Gal4 transgene (FBGal4). Tubulin was used as a loading 
control.  
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Western analysis revealed that dLipinRNAi expression did not reduce TORC1 activity. 
4EBP phosphorylation levels in the fat body of experimental and control animals were similar. 
raptor knockdown alone led to a complete loss of 4EBP1 phosphorylation (data not shown). This 
made it impossible to look into a possible enhancement of the effect of reduced Raptor activity 
on 4EBP1 phosphorylation by concomitant knockdown of dLipin.  
Thus, the enhancement of cell growth defects and organismal developmental delay 
observed after dLipin knockdown in raptor-deficient background may not be due to a further 
decrease of TORC1 activity in these animals. 
5. Summary of part C Results 
I discovered a strong genetic interaction between dLipin and raptor during larval and fat 
body development. This interaction appeared to influence fat body cell size and larval growth 
and it required the PAP activity of dLipin. I furthermore showed that Raptor, and therefore 
TORC1, regulates not only dLipin abundance, but also its subcellular localization. This indicates 
that dLipin activity is regulated by TORC1 and therefore, is subject to control by nutrient 
signaling.  
D. Experiments not directly linked to insulin or TOR signaling 
1. dLipin’s subcellular localization is not influenced by intracellular dLipin levels 
When looking at dLipin distribution within fat body cells, I discovered that knockdown 
of insulin pathway activity via expression of PI3K21BHA, and knockdown of TORC1 pathway 
activity via expression of raptorRNAi each resulted in a reduction of dLipin levels. At the same 
time, reducing TORC1 activity led to translocation of dLipin into the nucleus whereas reducing 
insulin pathway activity did not affect dLipin localization. One possible explanation for this 
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difference could be that intracellular dLipin levels influence its distribution. it could be that 
dLipin only navigates into the nucleus after knockdown of TORC1 activity because dLipin levels 
are lower in these cells than in cells with a reduction in PI3K21B activity.  
To address this possibility, I determined the amount of dLipin protein in samples from fat 
body of feeding third instar larvae expressing either PI3K21BHA (dominant negative form of 











Fig. 44: dLipin levels are similar after knockdown of raptor and expression of PI3K21BHA. 
To determine whether more dLipin is present after PI3K21BHA (FBGal4>PI3K21BHA) 
expression compared to raptorRNAi (FBGal4>raptorRNAi) expression, I conducted a western 
blot analysis with dLipin antibodies. Control sample was from w1118 animals. Fat body was from 
wandering third instar larvae. Actin served as a loading control.  
 
The western analysis showed that dLipin levels were comparably low after PI3K21BHA 
expression and raptor knockdown. This indicates that differences in subcellular localization 
following PI3K21BHA expression and raptor knockdown were not caused by differences in 
intracellular dLipin levels.  
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2. Generation of donor fly lines for ends-in-targeting gene replacement 
In order to study the two different dLipin functions, PAP activity and transcriptional co-
regulator activity, I attempted to create fly lines in which the endogenous dLipin gene was 
replaced by a dLipin gene with a mutation that either interferes with PAP activity or co-regulator 
activity. In theory, this would allow us to determine the direct effects of loss of either dLipin 
activity on metabolism and development. A fly strain carrying the dLipin gene with a mutation in 
the PAP motif was successfully generated. This fly line proved to be homozygous lethal, which 
showed that the PAP function of dLipin is essential for survival. Characterization of this fly line 
was performd by Qiuyu Chen and is described elsewhere (Qiuyu Chen, Investigation of Nuclear 
and Cytoplasmic Functions of the dLipin Protein of Drosophila Melanogaster, Masters Thesis, 
2014).  
The ends-in-targeting gene replacement method (Rong and Golic; 2000) was chosen to generate 
flies with a replacement of endogenous dLipin with either ΔPAPdLipin or ΔNLSdLipin. This 
method employs a two-step approach. First, a mutated copy of the targeted gene is introduced in 
the genome, and second, part of the endogenous gene is replaced with the mutated copy, which 
leaves only one (mutated) copy of the gene in the genome.  
I participated in the mutagenesis experiment by creating transgenic donor fly lines that 
carry both the endogenous dLipin gene and the donor construct with the mutant copy of dLipin. 
dLipinΔPAP and dLipinΔNLS donor constructs were inserted into the genome by P-element 
transformation. Each construct contained two flanking FRT sites, an I-CreI-recognition site as 
well as an I-SceI recognition site. The fly lines carrying either of these constructs within their 
genomes are called donor stocks.  
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Fig. 45: Depiction of donor constructs. FRT sites are flanking the construct. The mutated 
dLipin gene carried either the NLS deletion or nucleotide change in the PAP motif. The I-SceI 
site is located in the middle of the dLipin gene. The construct further contains the I-CreI 
recognition site and the white marker gene. 
 
After I had created the two donor stocks, I handed them over to fellow graduate student 
Qiuyu Chen. She continued the mutagenesis experiment that was meant to provide dLipin 
mutants for both of our projects. For the sake of completeness, I will shortly explain the steps she 
took to obtain the mutants. First, the donor line was crossed with flies expressing FLP 
recombinase and I-SceI endonuclease. This leads to the excision of the construct at the FRT sites 
and induces a double strand break at the I-SceI site. The double strand break triggers 
homologous recombination between the endogenous dLipin gene and the mutated version. 
Homologous recombination results in a duplication of the dLipin gene, with the mutated and the 
endogenous copy lying next to each other, separated by the white gene and I-CreI site. To 
remove one copy of the dLipin gene, flies were crossed with flies expressing the I-CreI 
recombinase. This resulted in another homologous recombination step that left only one copy of 
the dLipin gene in the genome. Flies were then examined to see if they contain the mutated 
dLipin gene or the wild-type dLipin gene by PCR. Qiuyu Chen was able to generate a fly line in 
which dLipin carried the mutation in its PAP active site. She did not obtain a fly line in which the 
endogenous dLipin was replaced by dLipin lacking its NLS.  
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3. Ecdysone treatment rescues the dominant negative effect of ΔNLSdLipin expression on larval 
development and lethality  
While carrying out experiments with the ΔNLSdLipin construct, I observed that strong 
ubiquitous overexpression of ΔNLSdLipin with the Tubulin driver (TubGal4>dLipinΔNLS) 
resulted in developmental delay and larval lethality. As fat body morphology of these animals 
looked normal (data not shown), developmental delay and larval lethality were likely caused by a 
defect in another tissue. As already shown (Fig. 27), like dLipinΔPAP overexpression, 
dLipinΔNLS overexpression had a dominant negative effect leading to the exclusion of 
endogenous dLipin from the nucleus. A potential tissue in which a complete loss of dLipin’s 
nuclear activity could cause developmental effects is the ring gland. Ugrankar et al. (2011) 
showed that dLipin is abundantly present in ring gland tissue of third instar larvae. The 
prothoracic gland, which is part of the ring gland, is the primary location of ecdysone synthesis 
and release. Ecdysone is then converted into the steroid hormone 20-hydroxyecdysone (20HE) in 
peripheral tissues. This steroid hormone controls developmental progression from embryogenesis 
to adult development. 20-HE binds to the Ecdysone Receptor (EcR), which is a nuclear receptor 
that regulates expression of ecdysone-responsive genes as part of a heterodimeric complex with 
Ultraspiracle (Usp) (Yamanaka et al., 2013). 
To test whether expression of ΔNLSdLipin affects ecdysone synthesis or release, I fed 
larvae that ubiquitously expressed ΔNLSdLipin with food containing 20-HE. I let animals 
develop on food with or without 20-HE and compared larval development and lethality. I 
examined animals with expression of dLipinΔNLS (TubGal4>dLipinΔNLS) as well as animals 
only carrying the dLipinΔNLS transgene but no driver (control). Both genotypes arose from the 
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same cross. Therefore, I was able to directly compare the number of pupae formed and 
developmental delay of these two genotypes. 
	    
*** 
A) 
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Fig. 46: 20-HE treatment can rescue larval lethality and developmental delay caused by a 
dLipinΔNLS overexpression. A) Feeding 20-HE to larvae expressing dLipinΔNLS driven by 
TubGal4 strongly reduced the larval lethality normally observed in animals with dLipinΔNLS 
overexpression. No statistically significant difference between numbers of pupae was found 
when experimental animals (TubGal4>dLipinΔNLS) were compared to control animals (only 
dLipinΔNLS, no driver transgene). Without 20-HE treatment significantly fewer experimental 
animals reached the pupal stage compared to control animals. Two tailed Chi-Square Test, *** 
p= 0.0001. B) Developmental delay of animals that overexpress dLipinΔNLS was rescued by 
20HE treatment. The majority of larvae reached the pupal stage earlier when fed 20-HE. Newly 
formed pupae/prepupae were counted and plotted as percent of total number of pupae formed. 
Day 1 represents the day of first puparium formation.  
 
20-HE treatment rescued the developmental delay and larval lethality observed after 
ΔNLSdLipin overexpression. This points to a defect in either ecdysone synthesis or ecdysone 
release in larvae with ΔNLSdLipin overexpression. To further confirm this result, I tried to rescue 
developmental delay and larval lethality of transheterozygous dLipin mutants (dLipine00680/ 
Df(3R)Exel7095) (Ugrankar et. al., 2011) by feeding 20-HE to these animals. However, 20-HE 
B) 
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treatment had no rescue effect on dLipine00680/Df(3R)Exel7095 mutants (data not shown). This 
indicates that providing 20-HE alone cannot overcome the severe developmental delay in 
transheterozygous dLipin mutant animals. The may be due to the severe underdevelopment of the 
fat body that characterizes these animals, in contrast to animals that overexpress ΔNLSdLipin, 
which have a fat body that appears normal.  
4. Expression of human lipin homologs can rescue larval lethality of transheterozygous dLipin 
mutants 
dLipin has 3 homologous genes in Homo sapiens, lipin1, lipin2 and lipin3. The three 
paralogs have diverged over time and display different spatial expression patterns (Donkor et al., 
2007). To test whether the three human lipin genes can compensate for loss of dLipin in 
Drosophila, or whether one or more of these genes diverged to where they have lost this ability, I 
expressed lipin1, lipin2 and lipin3 in transheterozygous dLipin mutants 
(dLipine00680/Df(3R)Exel7095). 
An important aspect of this experiment is the assessment to what degree results attained 
in Drosophila can be translated to mammalian systems. If lipin1, lipin2 and lipin3 retained 
known dLipin functions, it is more likely that they will affect fat metabolism and diabetes in a 
way similar to dLipin, and results gathered in Drosophila can be extrapolated, at least to a certain 
degree, to lipin function(s) in mammals.  
As described in Ugrankar et al. (2011) many dLipin transheterozygous mutant animals 
die during larval development, with only 23 % reaching the wandering stage, and only very few 
of these successfully pupariate. Therefore, to assess the rescue effects of lipin1, lipin2 and lipin3 
expression, I examined the number of pupae formed. Both control genotype 
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(dLipine00680/Df(3R)Exel7095; either lipin transgene alone) and either experimental genotype 
(dLipine00680/Df(3R)Exel7095; Gal4/lipin1, dLipine00680/Df(3R)Exel7095; Gal4/lipin2, 
dLipine00680/Df(3R)Exel7095; Gal4/lipin3) arose from the same cross, which allowed me to 
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Fig. 47: Rescue of transheterozygous dLipin mutants (dLipine00680/ Df(3R)Exel7095) by 
expression of human dLipin homologs (lipin1, lipin2, lipin3). Using three different driver 
lines, I examined the rescue potential of the human lipin genes. To score for rescue effects I 
examined the number of pupae formed. A) Weak, nearly ubiquitous expression using the DJ761 
driver results in a significant rescue effect for lipin2 and lipin3, and a clear trend for lipin1. 
DJ761Gal4 is expressed in all larval tissues except CNS and imaginal discs (M. Lehmann 
personal communication) B) Strong ubiquitous expression with TubGal4 of lipin1, lipin2 and 
lipin3 significantly lowered the ability of dLipin mutants to pupariate. C) Fat body-specific 
expression driven by FBGal4 of lipin1, lipin2 and lipin3 did not affect the number of pupae 
formed. The transheterozygous dLipin mutant genotype (dLipine00680/ Df(3R)Exel7095) is 
abbreviated to Df/Rb in the graph. Two tailed Chi-Square Test, ∗∗∗ p < 0.0001. 
 
Nearly ubiquitous but weak expression of lipin2 and lipin3 significantly reduced lethality 
of dLipin mutants. lipin1 expression also seemed to have an effect on the number if pupae 





























	   151 
Strong ubiquitous expression of any of the human lipin paralogs seemed to further decrease 
viability of dLipin mutants. Specific expression of human lipin paralogs in the fat body had no 
rescue effect. On the contrary, similar to the strong ubiquitous expression data, these data 
revealed that fat-body specific expression of the human lipin genes may have a negative effect as 
well.  
Weak ubiquitous expression of human lipin genes in dLipin mutant animals was able to 
significantly increase the pupariation rate and improve fat body morphology. Hence, one can 
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IV. Discussion 
Mammalian dLipin homologs have long been implicated in mediating insulin sensitivity 
(Reue et al., 2000; Ryu et al., 2009; Suviolathi et al., 2006) and insulin signaling itself has been 
shown to influence Lipin1 activity (Harris et al., 2007, Huffman et al., 2002; Peterfy et al., 2010) 
and lipin expression (Manmontri et al., 2008). It is known that TOR signaling has an effect on 
Lipin1’s subcellular localization and posttranslational modification (Eaton et al., 2013; Huffman 
et al., 2002; Peterson et al., 2011) and it has been demonstrated that TORC1 and Lipin1 interact 
in the control of lipid metabolism (Peterson et al., 2011). dLipin, the Drosophila counterpart of 
the mammalian Lipin proteins, has been shown to be a regulator of larval metabolism by 
contributing to fat body development and fat synthesis (Ugrankar et al., 2011). Goal of my 
research was to address the question of whether dLipin is, as its mammalian homologs, a 
mediator of insulin sensitivity, and whether the association between Lipin and TORC1 is 
evolutionarily conserved. An additional aim was to elucidate the link between Lipin’s dual 
molecular functions, PAP activity and co-regulator activity, and the insulin and TORC1 
pathways.  
1. Background 
Cell growth defects often result from a deregulation of insulin signaling or TORC1 
signaling. Cells show overgrowth phenotypes under conditions with insulin pathway 
overactivation, whereas down regulation of the insulin pathway leads to a decrease in cell size 
(Britton et al., 2002).  
It is widely assumed that growth defects brought about by changes in the insulin signaling 
pathway are in part caused by subsequent modifications of TORC1 activity (Saucedo et al., 
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2003). To date, it has not been shown that this pathway exists as proposed in the fly under 
physiological conditions (Dong and Pan, 2004; Oldham et al., 2000; Pallares-Cartes et al., 2012; 
Schleich and Teleman, 2009). It is therefore not clear to what extent the TORC1 and insulin 
signaling pathways act in concert or independently in cell growth and metabolic control in 
Drosophila melanogaster.  
2. dLipin and insulin pathway interact in fat body of D. melanogaster 
To characterize the relationship between dLipin and the insulin pathway I conducted experiments 
to investigate the effects of dLipin on insulin pathway activity. I also examined the effects of 
insulin pathway signaling on dLipin activity.  
2.1. dLipin is required for cell growth and TAG production cell-autonomously 
Knocking down dLipin activity in a cell-autonomous fashion in the larval fat body 
reduced cell size. This reduction in cell size was accompanied by a near absence of fat droplets 
(Fig. 9). Nuclear area, although also significantly reduced compared to control cell nuclei, was 
disproportionally big in relation to cell area (Fig. 12). The reduction in nuclear size strongly 
suggests that cell growth was indeed interrupted, and the decreased amount of fat in cells 
deprived of dLipin activity did not cause the reduction in cell size.  
The increase in the nucleocytoplasmic ratio in fat body cells was also observed after 
system-wide loss of dLipin activity (Fig. 12). This phenotype can be interpreted as an indication 
of reduced cytoplasmic growth during endoreplication cycles. Cell growth and DNA replication 
in endoreplicating tissues are tightly regulated in response to nutritional signals mediated 
primarily by circulating growth factors (Britton and Edgar, 1998). The increase in the 
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nucleocytoplasmic ratio could thus result from a deregulation of insulin/TOR activity in cells 
with cell-autonomous dLipin knockdown. 
Taken together, the decrease in nuclear area in concert with the reduction of cellular area 
following cell-autonomous knockdown of dLipin strongly suggests that dLipin is required for 
cell growth in a cell-autonomous fashion. Cells also displayed a severe reduction in fat droplet 
accumulation. Thus, dLipin is also essential for proper fat synthesis cell-autonomously.  
To determine whether cell growth is affected due to a change in the activity of the insulin 
pathway upon dLipin knockdown, I looked at PIP3 localization in fat body tissue from animals 
with fat body-specific knockdown of dLipin activity and dLipin transheterozygous mutants.  
2.2. dLipin is required for fat body insulin sensitivity 
PIP3 synthesis was disrupted in fat body cells upon knockdown of dLipin activity (Fig. 
13 and 14). PIP3 is a second messenger generated by PI3K at the cell membrane under 
conditions of active insulin signaling. The deficiency in PIP3 was not caused by scarcity of its 
precursor PIP2, as PIP2 membrane levels appeared unaffected (Fig. 13 and 14). When dissecting 
fat body tissue from dLipin mutants and dLipin knockdown animals, it was apparent that 
membrane integrity was negatively affected. Cells tended to easily dissociate from each other 
resulting in an increased fragility of the tissue. DAG synthesis is catalyzed by the activity of 
Lipin proteins. DAG serves as a precursor for membrane phospholipids (Bishop and Bell, 1988). 
Therefore, loss of dLipin activity may have mediated changes in cell membrane composition. 
Furthermore, PAH1, a yeast homolog of dLipin, participates in the transcriptional control of 
phospholipid synthesis (Santos-Rosa et al., 2005). Thus, changes in phospholipid content of the 
cell membrane might have prohibited proper PIP3 synthesis at the cell membrane. However, as 
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PIP2 membrane localization seemed to be unaffected it seems likely. It is more likely that the 
absence of PIP3 from the plasma membrane after dLipin knockdown was caused by a defect in 
its synthesis and not by alterations in membrane structure.  
Another parameter required for insulin pathway activity is phosphorylation of AKT. 
Under normal insulin signaling conditions, AKT is recruited to the cell membrane by PIP3 and 
subsequently phosphorylated at two specific residues in order to attain full activity (Liao and 
Hung, 2010). Measuring AKT phosphorylation in fat body from animals with fat body-specific 
dLipin knockdown and dLipin transheterozygous mutants showed a clear reduction of AKT 
phosphorylation (Fig. 18). I specifically examined phosphorylation at residue 505 (S505), which 
is catalyzed by TORC2. The reduction of phosphorylation after loss of dLipin activity points to a 
reduction in TORC2 and subsequently, AKT activity.  
The reduction in PIP3 synthesis taken together with decreased phosphoAKT levels shows 
that reduced dLipin activity leads to reduced insulin pathway activity in the fat body.  
2.3. dLipin affects PI3K activity 
I was able to place dLipin at the level of PIP3 synthesis in the insulin signaling cascade 
by showing that a decrease in dLipin activity ameliorates the effects of PI3K over activation 
(Fig. 19) and that dLipin is required for PI3K activity (Fig. 20, Fig. 21). I expressed 
Dp110CAAX, a constitutively active Dp110, and observed a strong increase in cell size. When 
dLipin activity was down regulated in fat body cells with Dp110 overactivation, the overgrowth 
phenotype was reversed (Fig. 19). Furthermore, PIP3 synthesis (Fig. 20) and AKT 
phosphorylation levels (Fig. 21) were strongly reduced in cells with concomitant Dp110AAX 
expression and dLipin knockdown compared to cells with Dp110CAAX expression only. Because 
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PIP3 synthesis is negatively affected, even in the presence of PI3K overactivation, it seems likely 
that dLipin affects insulin pathway activity by either modulating PI3K or PTEN activity.  
Another possible explanation for the loss of PI3K activity after dLipin knockdown is that 
dLipin’s effect on AKT S505 phosphorylation is enough to blunt overexpression effects of PI3K. 
As mentioned before, phosphorylation of AKT at residue 505 was reduced upon a decrease of 
dLipin activity (Fig. 18). This phosphorylation step is catalyzed by TORC2. It has been shown 
that reduction of AKT phosphorylation by TORC2 is sufficient to attenuate hyperactivation of 
PI3K (Hietakangas and Cohen, 2007). However, this would not explain why PIP3 synthesis, and 
thus PI3K activity itself, was reduced.  
Taken together, these data strongly suggest that dLipin is necessary for insulin pathway 
activity in the fat body at PI3K or PTEN level, and that loss of dLipin activity is sufficient to 
weaken PI3K signaling.  
Further experiments will have to be conducted in order to be able to pinpoint where 
exactly dLipin influences the signaling cascade. Examining PTEN activity in cells with reduced 
dLipin expression may elucidate which step in PIP3 synthesis is affected by diminished dLipin 
activity.   
It deserves to be noted that in addition to fat body hypertrophy, I observed animals with 
severe hypotrophy of the fat body after Dp110CAAX expression. It would be interesting to 
examine the expression levels of genes involved in fat synthesis, adipogenesis and lipolysis in 
these animals using RNASeq to further investigate whether fat synthesis is inhibited or whether 
lipolysis is increased.  
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I was not able to conduct experiments in which dLipin knockdown or knockdown of the 
insulin signaling pathway was combined with overactivation of TORC1. This would have been 
helpful to better understand the crosstalk between TORC1 and insulin pathway in vivo. I was not 
able to overactivate TORC1, neither by knocking down its repressors (Tsc1 and Tsc2) nor by 
overexpression of an activator (Rheb).  Future experiments should concentrate on finding 
alternative ways to activate TORC1, possibly by feeding flies a diet high in amino acid content 
or by overexpression of amino acid transporters. This would help to examine possible rescue 
effects of TORC1 on insulin resistance caused by a lack of dLipin.  
2.4. Disrupting dLipin activity in the fat body results in fat body insulin resistance but has no 
apparent systemic effect 
Transheterozygous dLipin mutants displayed a significant increase in circulating sugar 
levels (Fig. 22), but no overall systemic growth defect. Two sugars circulate in Drosophila 
hemolymph, glucose and trehalose, with trehalose being the major circulating sugar (Wyatt and 
Kale, 1957). Trehalose is a disaccharide synthesized in the fat body. The rise in circulating 
hemolymph sugars may indicate that glycogen breakdown in the fat body is increased in dLipin 
mutant larvae. This rise in circulating sugar suggests that the fat body is insulin resistent. The 
fact that transheterozygous dLipin mutants showed no defect in systemic growth implies that the 
influence of dLipin on insulin pathway activity is largely or exclusively restricted to the fat body. 
Disrupted insulin pathway activity in combination with normal growth was also present on the 
cellular level, as fat body cells of animals with fat body-specific dLipin knockdown were not 
reduced in size, although PIP3 synthesis was strongly reduced. This result implies that the 
disruption in insulin pathway activity observed in fat body cells with fat body-specific dLipin 
knockdown is not strong enough to induce obvious growth defects. Consistent with this 
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interpretation was the finding that overall 4EBP1 abundance was not increased in animals with 
fat body-specific dLipin knockdown (Fig. 43). 4EBP transcription is positively regulated by 
FOXO and FOXO activity is elevated upon insulin resistance (Teleman et al., 2005). Thus, 4EBP 
levels should have been elevated in cells after dLipin knockdown. Furthermore, data exists that 
indicates that AKT activity, although possibly reduced, is not abolished under conditions of 
reduced S505 phosphorylation. It was shown that under these conditions enough residual AKT 
activity is present to ensure downstream insulin pathway activity. Hence, investigation of S505 
phosphorylation alone might not be a reliable indicator for AKT activity or overall insulin 
pathway activity (Hietakangas and Cohen, 2007).  
These data all lead to the speculation that RNAi-induced knockdown of dLipin in fat 
body cells might only result in a weak reduction of insulin pathway activity, and that residual 
AKT activity was sufficient to trigger downstream signaling events. This suggests that the PIP3 
reporter tGPH might not be a very sensitive measure of PIP3 levels. To further assess this 
interpretation it would be informative to test FOXO activity in cells after dLipin knockdown, for 
instance, by directly visualizing its nuclear translocation.  
In addition, this result also points to a parallel pathway, that contributes to growth on a 
cellular level, and which functions independently of insulin input and promotes cell growth even 
in the presence of moderate or weak insulin resistance as caused by dLipin knockdown. Larvae 
with dLipin knockdown in the fat body seem to feed normally and therefore consume nutrients 
like amino acids. Amino acids activate the main nutrient-sensing pathway, the TORC1 pathway 
(Li et al, 2010). One can speculate that TORC1 activity alone may be enough to promote cell 
growth under conditions of weak or moderate insulin resistance in fat body cells. TORC1 
signaling promotes translation and other cellular growth processes, and thus in turn promotes cell 
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growth. It has been proposed that under physiological conditions TORC1 and insulin signaling 
are not necessarily interconnected, but rather act in parallel pathways (Dong and Pan, 2004; 
Oldham et al., 2000; Pallares-Cartes et al., 2012; Schleich and Teleman, 2009). Indeed, TORC1 
activity was not reduced in animals with fat body specific dLipin knockdown, as 4EBP1 
phosphorylation remained unchanged (Fig. 43). Thus, moderate or weak insulin resistance in 
animals with fat body-specific dLipin knockdown might be compensated for on a cellular level 
by TORC1 activity.  
Thus, the absence of any growth defect in fat body cells with RNAi-mediated dLipin 
knockdown may simply be due to the fact that this dLipin knockdown only elicits a very weak 
reduction in insulin pathway activity.  
As mentioned previously, unlike tissue-wide dLipin knockdown, cell-autonomous loss of 
dLipin activity has a clear negative effect on cell growth. This seems to be caused by a more 
severe loss of dLipin activity in these cells as compared to the fat body-specific knockdown of 
dLipin. Cells after cell-autonomous loss of dLipin contained few, if any, fat droplets; an 
indication that in these cells fat synthesis, and therefore dLipin activity was most severely 
affected (Fig. 9). This is also reflected in cells seen in system-wide RNAi knockdown, as cells 
that did not contain any fat droplets appeared to be the smallest cells (Fig. 10). A stronger 
reduction of dLipin activity after cell-autonomous reduction of dLipin might thus be responsible 
for a more pronounced loss of insulin pathway activity and consequently, a reduction in cell size. 
Whether this reduction in cell size could also be caused by a subsequent downregulation of 
TORC1 activity due to a stronger decrease of insulin activity is not clear at this point. If TORC1 
activity remained unchanged, this could possibly indicate the existence of a threshold measure 
for insulin pathway activity below which effects in cell growth become apparent.  
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The fat body represents the major metabolic organ of the developing larvae. 
Transheterozygous dLipin mutants displayed elevated circulating sugar levels, most likely 
caused by insulin resistance in the fat body. It would be interesting to explore whether systemic 
insulin signaling is subsequently modified to counteract the rise of hemolymph sugar levels in 
animals with reduced insulin sensitivity of the fat body. In mammalian systems, insulin 
resistance elicits increased insulin production in order to sensitize tissues for sugar uptake 
(Cavaghan et al., 2000). dILPs (Drosophila insulin-like peptides) represent signaling peptides 
secreted from the brain and other tissues, and act in neuroendocrine signaling and control 
carbohydrate and lipid metabolism as well as growth and reproduction (Brogiolo et al., 2001; 
Groenke et al., 2010; Colombani et al., 2012; Garelli et al., 2012). Although the exact 
mechanism that controls dILP release is not completely understood, it is known that a humoral 
signal originating from the fat body triggers dILP release from the neurosecretory cells in the 
brain (Geminard et al., 2009). This signal is most likely fat body produced dIPL6, which 
represses release of dILP2 and 5 from the brain (Bai et al., 2012). It has been previously 
documented that insulin resistance in the fat body can be accompanied by an increase in brain 
dILP expression, as seen for miR-278 mutant flies (Teleman et al., 2006). Thus, the possibility 
exists that a reduction of dILP6 release from the fat body triggers dILP2 and dILP5 release from 
the brain to increase dILP levels in response to insulin resistance in the fat body. This increase in 
dILP hemolymph levels could represent a systemic response to insulin resistance in the fat body, 
mirroring increased insulin production in individuals with type2 diabetes. Measuring expression 
levels of Dilps in transheterozygous dLipin mutants and animals with fat body-specific dLipin 
knockdown could help determine whether dILP production is influenced by reduced insulin 
sensitivity of the fat body caused by decreased dLipin activity.  
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Overall, these data allow for the speculation that RNAi-induced fat body-specific dLipin 
knockdown only elicits weak to moderate insulin resistance in the fat body. TORC1 activity in 
these cells remains unchanged and allows for normal cell growth. In cells with severely 
compromised dLipin activity on the other hand, insulin signaling pathway activity appears to be 
strongly downregulated and, hence, cell growth is reduced.   
2.5. Insulin pathway activity and dLipin activity are mutually dependent  
Genetic interaction experiments between dLipin and the Insulin receptor (InR) revealed a 
strong connection between dLipin and InR in the development of fat body tissue. Using a GFP 
marker for fat body tissue, I observed that loss of InR activity concomitant with dLipin 
knockdown results in a severe underdevelopment of the fat body in developing larvae (Fig. 16). 
It is known that Lipin1 is required for proper adipogenesis (Kim et al., 2013; Phan et al., 2004; 
Zhang et al., 2012). Zhang et al. (2012) showed that Lipin1 affects adipogenic gene expression 
by influencing phosphatidic acid (PA) levels. Elevated levels of PA inhibit expression of 
adipogenic genes, amongst them the key regulator peroxisome proliferator-activated receptor γ 
(Pparγ). It is also known that Lipin1 physically interacts with PPARγ, and thereby regulates 
PPARγ activity in adipogenic gene expression. This activity of Lipin1 is independent of its PAP 
activity, and relies on Lipin1’s nuclear activity (Kim et al., 2013).  Insulin signaling is also a 
positive regulator of adipogenesis, as AKT activation alone can promote differentiation of 3T3-
L1 cells into adipocytes by inducing Pparγ expression (Kohn et al., 1996; Xu and Liao, 2004). If 
the effects on adipogenesis in Drosophila are also mediated via PPARγ, or by a different 
adipogenic factor cannot be answered at this point. So far, no fly homolog for PPARγ has been 
identified (Hong et al., 2010).  
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It is possible that a reduction of insulin pathway activity further lowered dLipin activity 
in cells with dLipinRNAi and InRDN expression. Insulin pathway activity has been identified as a 
regulator of Lipin1 activity. Insulin influences phosphorylation and subcellular localization of 
Lipin1 (Harris et al., 2007; Peterfy et al., 2010). Reduction of InR activity in cells with dLipin 
knockdown could thus further lower PAP activity, and consequently increase PA levels. 
Increased PA levels might inhibit proper adipogenic gene expression. A disruption in 
adipogenesis would result in a decrease of fat body cell number and subsequently a reduction of 
larval fat body mass. This reduction of fat body mass concomitant with diminished TAG 
synthesis during larval development could explain the severe underdevelopment of the fat body 
in larvae with dLipinRNAi and InRDN expression. A loss of dLipin activity might also enhance 
insulin resistance in developing larvae expressing InRDN by further lowering AKT activity, and 
thus prohibiting adipocyte differentiation. This defect in adipogenic gene expression would also 
result in reduced fat body cell mass.  
It is most likely that a combination of reduced dLipin activity due to decreased insulin 
pathway activity in concert with reduced insulin pathway activity due to decreased dLipin 
activity led to the severe defects in adipogenesis. This would point to an interdependent 
relationship between dLipin and insulin pathway activity during adipogenesis.  
In addition to fat body mass, cell growth was altered in cells with concomitant expression 
of dLipinRNAi and InRDN in the fat body. Expression of InRDN alone significantly reduces cell 
area (Fig. 16), whereas dLipinRNAi expression has no effect on cell size (Fig. 15). When both 
transgenes were combined, cell size increased, cell shape became rounded and cell adherence 
decreased (Fig. 16). As this phenotype closely resembled the fat body phenotype of 
transheterozygous dLipin mutants (Ugrankar et al., 2011), one can speculate that the concomitant 
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dLipinRNAi and InRDN expression mimics the effect of a strong dLipin deficiency with regard to 
cell growth. As in the dLipin mutant, significant loss of fat body mass is being compensated by a 
secondary mechanism, which leads to the overgrowth of cells. The overgrowth is most likely 
induced to achieve critical weight required for larval maturation (Ugrankar et al., 2011). The 
strong reduction of fat body mass and TAG content may also be the cause of increased larval 
lethality observed after concomitant dLipinRNAi and InRDN expression.  It would be interesting 
to address the question whether the overgrowth of fat body cells observed in dLipin mutants and 
in larvae with concomitant dLipinRNAi/InRDN expression represents a phenotype that is specific 
for dLipin, or is the result of a general reduction in fat body mass. Investigation of strong 
mutants for other enzymes involved in glycerolipid synthesis  (e.g. AGPAT3, GPAT4, DGAT2) 
could shed light on this question.  
I was able to show that strongly reduced insulin pathway activity in the fat body led to a 
reduction in dLipin protein levels (Fig. 24). However, subcellular localization appeared to be 
unaffected (Fig. 23). Insulin signaling positively regulates cytoplasmic retention of mammalian 
Lipin1, either by phosphorylation or by mediating an interaction between Lipin1 and 14-3-3 
proteins (Harris et al., 2007; Peterfy et al, 2010). Thus, a decrease in insulin pathway activity 
should have caused a decrease in cytoplasmic dLipin localization and a translocation of dLipin to 
the nucleus or perinuclear region (ER). To further elucidate the effects of insulin pathway 
activity on dLipin activity, it would be interesting to measure PAP activity after insulin pathway 
overactivation and insulin pathway knockdown. In addition, dLipin phosphorylation status upon 
insulin pathway modifications should be investigated using native gel electrophoresis and mass 
spectrometry. These experiments would help elucidate whether PAP activity itself is modulated 
by insulin pathway activity and whether different stages of phosphorylation correlate with 
	   164 
differential PAP activity of dLipin. It would also be worthwhile to elucidate whether dLipin’s 
microsomal association is affected, using confocal microscopy. Furthermore, it would be 
interesting to investigate whether AKT is the kinase responsible for insulin-mediated Lipin 
phosphorylation.  
Thus, it appears that dLipin protein levels are regulated by insulin pathway activity. 
Subcellular distribution of dLipin on the other hand appears unaffected by insulin pathway 
activity. Whether the phosphorylation status of dLipin is modified by insulin pathway activity 
remains to be elucidated. It furthermore seems that dLipin activity during adipogenesis and in 
TAG synthesis is dependent on insulin pathway activity. These data also suggest that dLipin may  
regulate insulin pathway activity during adipogenesis.  
2.6. dLipin’s PAP activity is required for normal insulin sensitivity of the fat body  
Animals with a reduction in GPAT4 or AGPAT3 activity in the fat body displayed a 
reduction in fat droplet size and PIP3 synthesis, mirroring the phenotype caused by dLipin 
knockdown (Fig. 26). GPAT4 and AGPAT3 are enzymes of the canonical TAG synthesis 
pathway and act directly upstream of dLipin, producing lysophosphatidic acid (LPA) and 
phosphatidic acid (PA), respectively. The fact that a reduction in the activity of these 
glycerolipid synthesis enzymes caused a reduction in PIP3 synthesis suggests that the process of 
TAG synthesis itself represents a mechanism that controls insulin sensitivity in the fat body. This 
hypothesis was further validated by experiments that showed that dLipin with intact nuclear 
function, but no PAP activity, was capable of reconstituting insulin sensitivity in the fat body of 
animals with dLipin knockdown (Fig. 31). The reconstitution of insulin sensitivity went hand in 
hand with an increase in fat droplet size in the fat body. Insulin pathway activity and fat body 
	   165 
morphology in animals expressing dLipin lacking PAP activity concomitant with dLipin 
knockdown remained disturbed (Fig. 31). Thus, it appears that dLipin can influence the insulin 
pathway through its role as a PAP enzyme.  
TAG synthesis intermediates have been implicated as second messengers affecting 
insulin signaling. Elevated phosphatidic acid (PA) levels reduce activity of mTORC2 and 
increase mTORC1 activity (Blaskovich et al., 2013; Zhang et al., 2012). Preliminary data links 
PA to phospho kinase C (PKC) activation (Limatola et al., 1994; Stasek et al., 1993). PA levels 
are increased upon a reduction in Lipin activity (Han et al., 2006). Increased Lysophosphatidic 
acid (LPA) levels can lead to insulin resistance (Neschen et al., 2005; Rancoule et al., 2014). 
LPA levels might be elevated following AGPAT3 knockdown, as LPA is the substrate of 
AGPAT3. Elevated levels of diacylglycerol (DAG) result in insulin resistance through activation 
of phospho kinase C (PKC) and a subsequent reduction of PI3K activity (Erion and Shulman, 
2010). DAG accumulation would be expected after downregulation of DGAT activity. I was not 
able to detect changes in PIP3 synthesis after DGAT knockdown. This was most likely due to the 
fact that DGAT knockdown was not strong enough, as fat content of cells appeared nearly 
normal. As of now, no involvement of G-3-P in insulin sensitivity has been detected, but as all 
other lipid intermediates contribute to insulin sensitivity it appears plausible that the same might 
be true for glycerol-3-phosphate.  
Insulin resistance following GPAT4, AGPAT3 and dLipin knockdown in the fat body 
could hence be due to an unphysiological accumulation of lipid intermediates, which in turn 
negatively affects insulin sensitivity of the tissue. Consistent with the effect of AGPAT3 
knockdown in Drosophila, insulin resistance has been observed after a reduction of AGPAT 
activity in adipocyte cell culture (Subauste et al., 2012). PA levels should be elevated in cells 
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with reduced dLipin activity, as PA is the substrate for dLipin. As previously mentioned, in 
mammalian systems an elevation in PA levls is associated with increased TORC1 activity 
(Blaskovich et al., 2013). I did not observe an increase in TORC1 activity in fat body cells, as 
4EBP1 phosphorylation was not elevated (Fig. 43). This discrepancy might be due to the fact 
that results stem from research done in 2 different systems, namely Drosophila and mouse, or 
that the conditions under which results were obtained differed too much. Reduced TORC2 
activity caused by PA accumulation cannot explain the reduction in PI3K activity observed in fat 
body cells with reduced dLipin activity, as it would only affect AKT activity. Thus, it appears 
that PKC activity is increased upon PA accumulation due to dLipin knockdown and 
subsequently, PI3K activity diminished. This hypothesis should be tested further by conducting 
genetic interaction experiments between dLipin and the different PKC isoforms.  
Individuals with lipodystrophy display elevated levels of free fatty acids (Meiniger et al., 
2002). Therefore, it is possibile that a total reduction of TAG synthesis following GPAT, AGPAT 
or dLipin knockdown elicits insulin resistance through an increase in free fatty acids. An increase 
in free fatty acids has a negative impact on insulin sensitivity by inhibiting glucose uptake 
(Boden, 2003). Furthermore, SREBP activity is controlled by Lipin1, suggesting that under 
conditions of Lipin deficiency, SREBP activity, and therefore de-novo fatty acid synthesis, is 
deregulated (Peterson et al., 2011). Increased insulin levels positively control SREBP1 
expression even in the presence of insulin resistance (Shimomura et al., 2000). As dLipin 
knockdown results in insulin resistance, a possible increase in dILP levels could further raise 
SREBP activity, which would perpetuate the insulin resistant condition.   
Another effect of insulin resistance is a rise in FOXO activity that goes hand in hand with 
an upregulation of Fatty Acid Synthase (FAS) (Luong et al., 2006). It would be worthwhile to 
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measure free fatty acid levels following dLipin, AGPAT and GPAT knockdown to test whether 
fatty acid levels are indeed elevated.  Also, SREBP and FAS mRNA or protein levels should be 
investigated. In addition, the lipid profile of animals after a reduction of dLipin activity should 
be analyzed via chromatography.   
qRT-PCR measuring Dp110 transcript levels of fat body tissue from animals with fat 
body-specific dLipin knockdown showed that upon reduced dLipin activity, PI3K activity 
appears to be reduced as reflected in decreased Dp110 mRNA levels (Fig. 33). Whether this 
moderate reduction in Dp110 mRNA is a direct effect of dLipin deficiency, or a secondary effect 
of reduced insulin pathway activity caused by dLipin deficiency remains elusive at this point. As 
insulin sensitivity of the fat body appeared to be mainly dependent on dLipin’s PAP activity and 
not dLipin’s nuclear activity, the observed decrease of Dp110 transcript appears to have no 
major impact on insulin sensitivity.  
Overall, my data indicate that disrupted TAG synthesis is a cause for reduced fat body 
insulin sensitivity. A reduction in dLipin-mediated PAP activity thereby affected either PI3K or 
PTEN activity. Reduced insulin pathway activity upon dLipin knockdown manifested in cell 
growth defects and increased hemolymph sugar levels. Furthermore, dLipin’s activity during 
adipogenesis and in TAG synthesis appeared to be dependent on insulin pathway activity. Thus, 
TAG biosynthesis and insulin pathway activity are closely interconnected, and dLipin appears to 
be an important link between the two pathways. My data furthermore provides a novel insight 
into how lipodystrophy induces insulin resistance in Drosophila. Previous data linked HIV-
related lipodystrophy in humans with a disruption of the insulin cascade downstream of AKT 
activity (Haugaard et al., 2005). My data suggests that lipodystrophy-induced insulin resistance 
might develop via different mechanisms in Drosophila and humans. 
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3. Characterization of the relationship between dLipin and TOR signaling 
To elucidate the relationship between dLipin and TOR signaling in D. melanogaster, I 
evaluated the effects of TOR activity on dLipin function. Furthermore, I examined the combined 
effects of TORC1 and dLipin knockdown on cell growth and larval development.  
3.1. dLipin is a target of TORC1 signaling in the fat body 
I established that TORC1 signaling acts as a regulator of dLipin activity in vivo. dLipin’s 
subcellular localization as well as cellular abundance was clearly affected by a loss in TORC1 
activity (Fig. 35). Following a knockdown of TORC1 activity via raptor knockdown, dLipin 
migrated into the nucleus and overall dLipin levels were greatly reduced. The same nuclear 
redistribution was observed for Lipin1 after loss of TORC1 activity (Peterson et al., 2011). Thus, 
dLipin cytoplasmic retention is positively controlled by TORC1 and this interaction is 
evolutionary conserved.  
Several phosphorylation sites of Lipin1 in mammals are known to be rapamycin-
sensitive, which indicates that TOR activity is involved in phosphorylation at these sites (Harris 
et al., 2007). Peterson et al. (2011) found that mTORC1 directly phosphorylates Lipin1 and 
thereby positively regulates cytoplasmic retention of Lipin1 protein. Once located in the nucleus, 
Lipin1 interferes with SREBP activity and thus prohibits lipid biosynthetic gene expression 
(Peterson et al., 2011). Furthermore, Lipin1 has been identified as a transcriptional co-regulator 
of beta-oxidation genes and also influences adipogenic gene expression (Chen et al., 2012; Kim 
et al., 2013). To affect gene expression and SREBP activity, Lipin1 translocates to the nucleus. 
Thus, TORC1 negatively controls these specific nuclear functions of Lipin1.  
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In response to low TORC1 activity, dLipin showed nuclear translocation comparable to 
Lipin1. This suggests that dLipin’s cellular localization and hence its function is controlled by 
TORC1 activity and this furthermore implicates that dLipin’s role in lipid metabolism is 
similarly dependent on TORC1 activity.  
Upon nuclear entry, dLipin might like its mammalian counterpart participate in the 
transcriptional control of beta-oxidation and adipogenesis genes and other genes involved in 
starvation resistance. dLipin might also negatively affect SREBP activity, and thus lipogenesis 
(Finck et al., 2006; Zhang et al., 2008; Peterson et al., 2011). RNASeq using fat body tissue from 
animals with a reduction in TORC1 signaling in the presence or absence of a concomitant dLipin 
knockdown could help identify targets genes of dLipin.  
In addition to TOR, insulin signaling pathway activity appears to influence the 
phosphorylation status of Lipin1 (Harris et al., 2007; Peterfy et al., 2010). Similar to TOR, 
insulin appears to promote Lipin1’s cytoplasmic retention and opposes membrane association. It 
also appears that insulin and TOR regulate Lipin1 phosphorylation in concert (Huffman et al., 
2002).  
My data show that in contrast to reduced TORC1 activity, a reduction in PI3K activity 
did not lead to the nuclear concentration of dLipin (Fig. 23). It therefore appears that the 
posttranslational modifications of dLipin that are brought about by TOR, which promote 
cytoplasmic retention of dLipin, are not insulin-dependent. In accordance with this finding are 
results by Peterson et al. (2011) that show that nuclear translocation of Lipin1 cannot be reversed 
by activation of the insulin pathway. Therefore, my data points to the possibility that multiple 
phosphorylation states of dLipin exist, depending on TORC1 and/or insulin signaling pathway 
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activity. Some phosphorylation sites might thereby be controlled in concert by both pathways, 
and others independently.  
As intracellular dLipin levels could potentially influence subcellular dLipin localization, I 
measured dLipin protein levels in cells with TORC1 knockdown and PI3K knockdown. I found 
that dLipin levels were comparably low after both knockdowns. Thus, the translocation of dLipin 
into the nucleus is not affected by intracellular levels of dLipin (Fig. 44) but rather appears to be 
controlled by posttranslational modifications depending on TORC1 activity. I did not observe 
dLipin binding to chromosomes (Fig. 36). This may be due to the fact that dLipin functions as a 
transcriptional co-regulator and does not directly bind to DNA. During the experiment, the 
physical interaction between dLipin and its regulatory interaction partners might have been 
interrupted, which could have resulted in dLipin dissociating from the chromosome.  
 My data suggest that dLipin activity in lipid metabolism is regulated by TORC1 
independently of the insulin pathway. Subcellular localization of dLipin is determined by 
TORC1, as under conditions of reduced TORC1 signaling dLipin is found in the nucleus. This 
indicates that under conditions of reduced nutrient signaling, the requirement for dLipin’s 
nuclear function is increased, possibly in order to prohibit de-novo lipogenesis by SREBP and to 
activate genes involved in beta-oxidation and starvation responses. 
3.2. dLipin and TORC1 control larval growth in concert 
Larval growth appeared to be negatively affected by concomitant reduction of dLipin and 
TORC1 activity. Larval size 5 days after egg deposition was significantly reduced in animals 
with concomitant dLipin and raptor knockdown compared to dLipin and raptor single 
knockdowns (Fig. 37). Furthermore, larval development was terminally halted at the feeding 
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third larval instar stage. raptor knockdown itself resulted in a moderate developmental delay and 
a reduction of fat body cell size. As larvae with fat body-specific raptor knockdown did not 
appear to be bigger in size despite a prolonged larval feeding phase, one can speculate that larval 
growth rate during development was reduced. Fat body cell size reduction was not accompanied 
by a reduction in PI3K activity, as PIP3 synthesis remained intact (Fig. 38). dLipin knockdown 
did not result in a developmental delay or a reduction of cell size but, as mentioned before, 
interfered with PIP3 synthesis and AKT S505 phosphorylation.  
Rescue experiments with dLipin lacking either its co-regulator or PAP activity showed 
that the enhanced reduced larval growth in dLipin/raptor knockdown larvae was caused by a 
reduction of dLipin-mediated PAP activity (Fig. 41). raptor knockdown itself most likely does 
not elicit a strong reduction in PAP activity, as fat droplet size remained unchanged in the 
presence of a reduction in Raptor activity. dLipin was nearly absent from the cytoplasm and 
concentrated in the nucleus following raptor knockdown, suggesting that only small amounts of 
cytoplasmic dLipin are enough to provide cells with sufficient PAP activity.  
A combination of reduced TORC1 signaling via raptor knockdown in concert with 
decreased PIP3 synthesis via dLipin knockdown might be responsible for reduced larval growth 
and increased larval lethality. Both TOR activity and insulin pathway activity influence larval 
growth (Colombani et al., 2003; Gupta et al., 2013; Rulifson et al., 2002; Walkiewicz and Stern, 
2009). As TORC1 activity does not appear to be affected by dLipin input, a further reduction of 
TORC1 in animals with concomitant raptor/dLipin knockdown is likely not the cause of the 
growth defect (Fig. 43). Thus, these data support a model in which growth is controlled, at least 
in part, by the independent action of the TORC1 and insulin pathways.  
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One possible explanation for this result is that TORC1 and insulin pathway signaling in 
the fat body both influence a mechanism that integrates the overall energy status of the animal. 
Geminard et al. (2009) found that the fat body relays the nutritional status of the animals to the 
neurosecretory cell of the brain and thus the nutritional status of the fat body has a direct effect 
on dILP release. Increased dILP release then triggers larval growth (Geminard et al., 2009). 
raptor knockdown in the fat body alone slows down larval development, possibly due to reduced 
larval growth rate, suggesting that nutritional signals from the fat body affect growth. Thus, in 
larvae with reduced dLipin activity, and hence reduced insulin pathway activity and 
concomittantly reduced TORC1 activity via raptor knockdown, nutritional signaling from the fat 
body could have been significantly altered, decreasing larval growth even further.  
Taken together, these data indicate that larval growth is regulated in concert by the 
insulin pathway and TORC1 and that lack of dLipin can interfere with this interaction by 
reducing PIP3 synthesis and thus decreasing insulin pathway activity.  
3.3. dLipin and TORC1 control cytoplasmic growth 
Nucleocytoplasmic ratio was increased in fat body cells from animals with concomitant 
reduction in dLipin and TORC1 activity (Fig. 39). Likewise, severe loss of dLipin activity, either 
cell-autonomously or system-wide, also affected this tight connection between DNA replication 
and cytoplasmic growth (Fig. 12). As raptor knockdown alone did not result in an increase in the 
nucleocytoplasmic ratio, the rise in nucleocytoplasmic ratio observed after concomitant dLipin 
and raptor knockdown does not appear to result from an enhancement of the growth phenotype 
caused by raptor knockdown. This is also consistent with the fact that I did not observe a 
reduction in TORC1 activity after RNAi-mediated dLipin knockdown (Fig. 43). Hence, this 
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growth defect is most likely caused by a reduction in insulin pathway activity in concert with 
reduced TORC1 activity in animals with concomitant dLipin/raptor knockdown as opposed to 
further reduced TORC1 activity. 
 This increase in nucleocytoplasmic ratio may be due to a decoupling of endoreplicative 
genome replication from cytoplasmic growth. The larval fat body is an endocreplicative tissue, 
undergoing multiple rounds of G1/S phase transitions without cell division. Endoreplication uses 
much of the same machinery as standard mitotic G1/S transition, and it is usually assumed that 
genome replication and cytoplasmic growth are tightly coupled (Edgar and Orr-Weaver, 2001). 
Endoreplication is a process closely controlled by nutritional and growth factor signals (Britton 
and Edgar, 1998). A severe deficiency in dLipin, and thus insulin pathway activity, or a 
reduction in TOR activity could result in changes in growth factor and nutrient signaling and 
consequently influence cytoplasmic growth. The double fat body-specific dLipin and raptor 
knockdown might mirror this defect, and likewise inhibit cytoplasmic growth.  
Alternatively, autophagic activity may be increased in fat body cells upon strong cell-
autonomous dLipin knockdown and concomitant knockdown of dLipin and raptor. Autophagy is 
a catabolic process in which cytoplasmic component are degraded in autolysosomes to provide 
energy for the cell. Autophagy is usually triggered as a response to starvation (Codogno and 
Meijer, 2005). A reduction in TORC1 activity is known to induce autophagy (Castets et al., 
2013), and recently Lipin1 has been identified as a contributor to autophagic flux in muscle 
tissue (Zhang et al., 2014). Furthermore, insulin pathway activity controls autophagic activity, 
with a reduction in insulin signaling resulting in increased autophagy (Codogno and Meijer, 
2005). Autophagy can result in reduced cytoplasmic volume, as cells consume cytoplasmic 
components to provide energy (Neufeld, 2012). It is possible that in cells with concomitant 
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dLipin and raptor knockdown the decrease in TORC1 activity together with reduced insulin 
pathway activity due to dLipin knockdown upregulates autophagy and, hence, decreases 
cytoplasmic volume. Strong cell-autonomous knockdown of dLipin alone might also be enough 
to increase autophagic activity in fat body cells.  
Further experiments will need to be conducted to address the exact mechanism causing 
the increased nucleocytoplasmic ratio upon severe dLipin knockdown and concomitant 
dLipin/raptor knockdown. Investigating autophagic activity in animals with dLipin/raptor 
knockdown and in animals with cell-autonomous dLipin knockdown may be a first step in 
answering this question.  
4. Expression of dLipin with a mutation in the PAP active site or deletion of NLS motif has a 
dominant negative phenotype 
Expression of dLipin lacking an intact PAP active site or NLS motif resulted in dominant 
negative phenotypes (Fig. 27, Fig. 30). When ΔNLSdLipin was expressed in the fat body, it not 
only did not enter the nucleus, but it also prevented endogenous dLipin from entering the nucleus 
(Fig. 27). Expression of ΔPAPdLipin in dLipin transheterozygous mutants resulted in a decrease 
of larval viability (Fig. 30). Lipin1, 2 and 3 proteins are known to form hetero- and homo-
oligomers in adipocyte cell culture (Liu et al., 2010). dLipin might therefore form oligomers as 
well. Dominant-negative effects seen after expression of both ΔNLSdLipin and ΔPAPdLipin 
suggest that both functions of dLipin, PAP and co-regulator activity, require proper 
oligomerization. GST-pulldown experiments would help elucidate whether dLipin proteins can 
form oligomers in vitro, and co-immunoprecipitation experiments with animals expressing 
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tagged dLipin and endogenous dLipin may elucidate whether dLipin proteins oligomerize in 
vivo.  
5. dLipin might regulate ecdysone release or synthesis in larval ring gland 
Strong ubiquitous expression of ΔNLSdLipin resulted in larval lethality and 
developmental delay; a phenotype that could be rescued by adding 20-HE to the fly food (Fig. 
46). dLipin is abundantly expressed in the larval ring gland, the place of synthesis and release of 
the 20-HE precursor ecdysone (Ugrankar et al., 2011). Fat body tissue from these animals was 
well developed, which excludes fat body underdevelopment as a cause for the developmental 
delay. Another possibility is that dLipin may be involved in ecdysone synthesis in the ring gland 
itself, possibly through its role as a transcriptional co-regulator. 20-HE supplementation was not 
sufficient to compensate for dLipin deficiency in transheterozygous dLipin mutants. This may be 
because of the severe fat body underdevelopment in these animals that may prevent normal 
developmental progression despite supplementation with 20-HE.  
The fact that expression of WTdLipin in fat body of transheterozygous dLipin mutants 
cannot rescue developmental delay and larval lethality corroborates the hypothesis that dLipin 
function in tissues other than fat body is essential for larval survival and development.  
Specifically knocking down dLipin in the ring gland should help elucidate the role of 
dLipin in ecdysteroidogenesis. RNAseq experiments could be conducted to further investigate 
the involvement of dLipin in ecdysteroidogenesis. This would help identify genes controlled by 
dLipin in the ring gland, and clarify whether dLipin is indeed a critical regulator of ecdysone 
synthesis and release.  
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6. dLipin functions are conserved in Homo sapiens Lipin proteins 
Rescue experiments with the human dLipin paralogs revealed that they possess at least 
some dLipin function by partially compensating for loss of dLipin activity (Fig. 47). Lipin1 did 
not show a significant rescue effect, but a clear trend was seen and it is likely, a larger sample 
size would have resulted in statistical significance. It is interesting to note that stronger 
expression of either of the Homo sapiens lipin homologs in fat body or ubiquitous expression 
had a negative effect on the number of pupae formed. This indicates that strong expression of 
Homo sapiens lipin genes induces lethality. The reason for this effect may be that human lipin 
genes carry out some functions that dLipin does not have and that are detrimental to fly viability.  
In summary, I was able shed light on the effects of lipodystrophy elicited by a lack of 
dLipin activity on insulin pathway activity in the fly. I was also able to link insulin pathway 
acitivity and dLipin activity during adipogenesis and TAG synthesis. Additionally I further 
elucidated an interaction between TORC1 and dLipin in Drosophila melanogaster.  
In larvae with reduced dLipin activity the insulin pathway was disrupted, as evidenced by 
a lack of PIP3 synthesis and increased circulating sugar levels. Cell-autonomous reduction of 
dLipin resulted in cell growth defects, likely caused by reduced insulin pathway activity in these 
cells. Insulin resistance in the fat body of lipodystrophic larvae with dLipin knockdown was 
possibly caused either by an unphysiological accumulation of lipid intermediates, an overall 
reduction in cellular TAG stores or a combination of both. Additionally, dLipin activity during 
adipogenesis and in TAG synthesis appeared to be controlled by the insulin pathway. 
Furthermore, functions of the insulin pathway during adipogenesis appeared to be negatively 
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affected by reduced dLipin activity. Thus, the functions of the insulin pathway and of dLipin in 
lipid metabolism are in part mutually dependent. 
dLipin localization and abundance was controlled by TORC1, and therefore nutrient 
signaling. Reduced TORC1 activity promoted nuclear concentration of dLipin, which in turn 
may affect lipid metabolism by facilitating dLipin-mediated expression of beta-oxidation genes 
and by inducing dLipin-mediated SREBP inhibition. These data indicate that dLipin’s role in 
lipid metabolism might be strongly dependent on TORC1 activity.  
It further appeared that the insulin and TORC1 pathways are decoupled pathways in fat 
body of developing larvae. I was also able to attribute a possible novel function in 
ecdysteriodigenesis to dLipin and, thus help guide future dLipin research into a new and 
interesting direction.  
Taken together, my data revealed that TAG synthesis and the insulin and TOR signaling 
pathways are tightly interconnected in the fat body of Drosophila and that dLipin may represent 
an important link between anabolic lipid metabolism, catabolic lipid metabolism and insulin and 
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V. Summary 
I was able to further our understanding of underlying mechanisms that cause insulin 
resistance in lipodystrophic individuals by investigating the relationship between dLipin, the 
Drosophila homolog of mammalian Lipins, and insulin pathway activity. Lipin proteins are 
known to act as PAP enzymes and a disruption of mammalian Lipin1 function results in 
metabolic disturbances, including insulin resistance and lipodystrophy (Langner et al., 1991; 
Reue et al., 2000). Ugrankar et al. (2011) previously established that a loss of dLipin activity 
similarly results in lipodystrophy (Ugrankar et al., 2011). I was able to show that dLipin activity 
is also crucial for fat body insulin sensitivity in Drosophila. Reduced dLipin activity in the fat 
body interfered with PI3K-mediated PIP3 synthesis and reduced insulin pathway activity 
downstream of PI3K. Genetic interaction experiments shed light on the epistatic relationship 
between dLipin and the insulin pathway.  These experiments revealed that dLipin affects insulin 
pathway activity by modifying activity of either PI3K or PTEN. Levels of circulating sugars 
were significantly elevated in transheterozygous dLipin mutants, an indication that a loss of 
dLipin activity elicits insulin resistance. 	  
Strong cell-autonomous knockdown of dLipin activity significantly reduced fat body cell 
size. This is consistent with my findings that implicate dLipin in PI3K activity; as insulin 
pathway activity is a major driving force of cell growth. Thus, dLipin might affect cell growth by 
influencing insulin pathway activity. Additionally, fat synthesis was dependent on dLipin 
activity in a cell-autonomous fashion.  
Rescue experiment carried out with dLipin lacking PAP activity and dLipin lacking 
nuclear activity demonstrated that PIP3 synthesis was dependent on dLipin-mediated PAP 
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activity, and that loss of nuclear dLipin activity had no discernible effect on fat body insulin 
sensitivity. This indicates that dLipin affects insulin pathway activity via its role as a PAP 
enzyme, and not by regulating gene transcription as a putative transcriptional co-regulator.  
In addition, dLipin activity itself appeared to be regulated by the insulin pathway. 
Cellular abundance of dLipin was significantly reduced upon downregulation of insulin pathway 
activity. Subcellular localization of dLipin, however, appeared to be unaffected. Furthermore, 
insulin pathway activity appeared to regulate dLipin activity during adipogenesis and in TAG 
synthesis. My data also implicate dLipin as a possible contributor to insulin pathway activity 
during adipogenesis.   
To further investigate the relationship between Lipin and TOR activity, I examined 
dLipin’s subcellular localization upon reduction of TORC1 activity. Upon loss of TORC1 
activity, dLipin translocates into the nucleus. Thus, cytoplasmic retention of dLipin is positively 
regulated by TORC1 activity. The fact that dLipin translocates into the nucleus upon reduced 
TORC1 activity suggests that TORC1 influences dLipin activity in lipid metabolism. Nuclear 
Lipin1 is known to participate in the expression of beta-oxidation and adipogenesis genes and to 
inhibit SREBP-mediated lipogenesis (Finck et al., 2006; Zhang et al., 2008; Peterson et al., 
2011). Consequently, dLipin’s role in lipid metabolism seems to depend on TORC1 activity.  
Genetic interaction experiments between dLipin and TORC1 (raptor) revealed that 
dLipin and TORC1 influence larval growth rate and cell growth in concert, but not through the 
same pathway.  It appeared that growth is controlled, at least in part, by the independent actions 
of the TORC1 and insulin pathways and that dLipin can interfere with this interaction by 
reducing insulin pathway activity.   
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TORC1 activity itself, as measured by 4EBP1 phosphorylation, remained unchanged 
upon dLipin knockdown suggesting that insulin resistance and growth defects in cells with 
reduced dLipin activity are not caused by changes in TORC1 activity. This result furthermore 
suggests that TORC1 signaling and the insulin pathway are parallel pathways in the larval fat 
body.  
Additionally, I was able to uncover a potential new function of dLipin in ecdysone 
synthesis or release in the Drosophila ring gland. Strong ubiquitous expression of dLipin lacking 
nuclear function resulted in developmental delay and larval lethality, a phenotype that was 
rescued by 20-hydroxyecdysone supplementation.  
Investigation of dLipin lacking PAP activity and dLipin lacking nuclear activity pointed 
to the possibility that both functions of dLipin demand oligomerization, but further validation is 
required. Finally, rescue experiments with mammalian lipin homologs revealed that mammalian 
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